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Asymmetric C–H functionalization represents one of the central topics in modern 
organic chemistry, which allows for the direct installation of functional groups onto
ubiquitous C–H bonds in organic molecules. Among numerous elegant strategies, 
transition metal-catalyzed C–H alkylation with diazo compounds represents one of the 
most powerful methods for C–C bond formation. Different from Fischer metallocarbene-
based C–H insertion reactions, cobalt(II)-based metalloradical catalysis (MRC) is recently 
proven to be capable of activating acceptor/acceptor diazo compounds for radical C–H
alkylation reactions via H-atom abstraction. In this dissertation, we have developed several 
systems by utilizing less-explored aryl and alkyl diazomethanes as new radical precursors 
for highly enantioselective radical C–H alkylation reactions, which permit the efficient 
synthesis of different optically active heterocyclic compounds.
First, we have demonstrated the feasibility of using aryl aldehyde-derived 
sulfonylhydrazones as new radical precursors for enantioselective radical C–H alkylation 
 synthesis enantioenriched 2,3-dihydrobenzofuran derivatives. Notably, a 
general and mild way for in situ generation of diazo compounds have been identified by 
using 2,4,6-triisopropyl sulfonyl hydrazone as diazo precursor, which allow us to regulate 
the reaction temperature to achieve the high enantioselectivity for the desired radical 
reactions. Second, the utility of Co(II)-based MRC has been further highlighted by 
enantioselective indoline synthesis. Through the design and synthesis of new catalysts, 
the system is shown to have a broad spectrum of substrate scope, forming various 2-
substituted indolines with up to 98% yield and 96% ee. A series of mechanistic studies 
further support the underlying stepwise radical alkylation pathway. Finally, we further 
expand the applicability of MRC to even more challenging diazo compounds, aliphatic 
diazomethanes. Starting from alkyl aldehyde-derived sulfonylhydrazones as diazo 
precursors, the Co(II)-based radical alkylation reactions allow for the enantioselective 
synthesis for common 2-substituted tetrahydrofuran structures with high yields and 
excellent enantioselectivities.
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Chapter 1. Transition Metal-Catalyzed C–H Alkylation Reactions with Diazo Compounds
CHAPTER 1                    
RECENT DEVELOPMENTS IN TRANSITION METAL-CATALYZED C–H
ALKYLATION REACTIONS WITH DONOR- AND ALKYL-SUBSTITUTED 
DIAZO COMPOUNDS
1.1 INTRODUCTION
C–H functionalization, as one of the most central topics in modern organic 
chemistry for directly constructing C–C bonds, has attracted increasing attention by the 
community for synthetic applications.1 The successful development of these attractive 
transformations also leads to the rapid synthesis of target molecules from ubiquitous C–H 
bonds. However, such appealing processes are inherently challenging in part due to the 
inertness of unactivated C–H bonds, which require the design of robust and efficient 
systems to catalytically activate inert C–H bonds with good control of chemo-, regio- and 
stereoselectivity. Among recent advances,1 transition metal-catalyzed C–H alkylation 
reactions with diazo compounds represent one of the most effective methods for C–C bond 
formation,2 which typically undergo two different pathways as displayed in Scheme 1.1: 
A) concerted electrophilic C–H alkylation via metal-catalyzed carbene insertion, including 
Rh2, Cu, Ru, Ir, and Fe complexes; B) C–H alkylation via metalloradical catalysis, 
including Co(II)-Porphyrins [CoII(Por)]. So far, these existing metal catalysts are shown 
to be highly effective for C–H alkylation reactions with a wide range of diazo compounds, 
including acceptor-, donor/acceptor-, and acceptor/acceptor-substituted diazo compounds. 
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The methodology has been widely applied as a key strategy for the facile synthesis of 
various natural products and molecules with pharmaceutical interest.
Scheme 1.1| Transition Metal-Catalyzed C–H Functionalization with Diazo 
Compounds
Despite numerous catalytic systems are elegantly engineered, C–H alkylation 
reactions utilizing donor- or alkyl-substituted diazo compounds are still underdeveloped 
(Scheme 1.2).3 One of the major challenges lies in the low stability of these aryl or alkyl 
diazomethanes. Since the strong electron-donating substituents would result in the 
electron-rich character of the α-carbon of diazo species, the isolation and utilization of 
those less stabilized diazo compounds are thus difficult to handle. To address this practical 
issue, N-sulfonylhydrazones have been reported as user-friendly surrogates for the in situ-
generation of the reactive alkyl and aryl diazomethanes.4 This in situ-generation protocol 
has recently triggered a significant progress in the area of C–H alkylation reactions by 
utilizing the aforementioned less stabilized diazo compounds. Notably, as the aryl or alkyl 
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groups of diazomethanes are electronically and structurally different from unsaturated 
acceptor groups, some new reactivity and selectivity are also revealed. In this tutorial 
review, we will mainly overview the recent progress in transition metal-catalyzed C–H 
alkylation reactions by utilizing donor-, alkyl-substituted diazo compounds, which are 
generated in situ from the corresponding aldehyde or ketone-derived sulfonylhydrazones.
Scheme 1.2| Perspectives on Various Diazo Compounds Used for Metal-Catalyzed C–
H Alkylation Reactions
1.2 C–H ALKYLATION REACTIONS WITH IN SITU-GENERATED 
DIARYL DIAZO COMPOUNDS
Different from acceptor-, acceptor/acceptor- or donor/acceptor-substituted diazo 
compounds, which are typically synthesized from diazo-transfer reagents such as 4-
acetamidobenzenesulfonyl azide (P-ABSA), diaryl-substituted diazomethanes could be 
accessed through the oxidation of the corresponding ketone-derived hydrazone
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compounds. In 2013, Shaw and coworkers have, for the first time, developed a Rh2-
catalyzed asymmetric C–H insertion system by using donor/donor-substituted diazo 
compounds,5 where these diazo compounds could be accessed in situ through the oxidation 
of the corresponding diaryl ketone-based hydrazones (Scheme 1.3).
Scheme 1.3| The Identification of Rh2(PTDA)4 for Asymmetric C–H Insertion 
Reaction with in Situ-Generated Diaryl Diazomethane
They found that the newly-designed catalyst Rh2(PTDA)4 could enable the 
effective activation of in situ-generated diaryl diazomethane and undergo C–H insertion 
reaction in CH3CN at 0 oC, affording the desired 2,3-disubstituted dihydrobenzofuran 
compound in up to 90% yield with >99:1 dr and 99:1 er. The success of this reaction 
indicates that the metallocarbene system could be well incorporated with the in situ-
generation protocol of diazos. Partially benefit from the in situ generation protocol, this 
catalytic system could be achieved without the need of syringe pump for slow addition. 
Moreover, the system was also amenable to a gram-scale C–H insertion reaction.
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Scheme 1.4| Rh2(PTDA)4-Catalyzed Asymmetric C–H Insertion Reaction with in 
Situ-Generated Diaryl Diazomethanes
In their report, the Rh2-catalyzed C−H insertion reactions of donor-donor 
diazomethanes could streamline the synthesis of densely substituted benzodihydrofurans 
with high levels of both enantio- and diastereoselectivity, by activating various C−H bonds 
including benzylic, allylic, propargylic and alkyl C−H bonds (Scheme 1.4). In particular, 
with allylic C−H substrates, only C−H insertion reaction was observed without detection 
of cyclopropanation products. Also, substituted allylic substrates with either E- or Z-
configured alkene motifs only provided dihydrobenzofuran products with complete 
stereoretention. This work features the first example in metallocarbene-catalyzed 
alkylation reactions of diazo compounds with no pendant electron-withdrawing groups.
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Scheme 1.5| Shaw’s Method for Enantioselective Synthesis of E-δ-Viniferin
The utility of this new methodology has been further applied to the first 
enantioselective synthesis of an oligoresveratrol natural product (E-δ-viniferin), which is a 
resveratrol dimer containing a 2,3-diaryl-2,3-dihydrobenzofuran ring isolated from grapes 
in response to fungal infection.6 This novel 6-step synthetic route is highly efficient for the 
enantioselective synthesis of the oligoresveratrol family of natural products (Scheme 1.5).7
Scheme 1.6| Hashimoto’s Method for Enantioselective Synthesis of E-δ-Viniferin
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In 2015, Hashimoto and coworkers have further improved the synthetic route by 
improving the enantioselectivity of the C–H insertion step from 86% to 96% ee, and 
shortening the synthesis from 6 steps to 4 steps (Scheme 1.6).8 By identifying a different 
Rh2 complexes: dirhodium(II) tetrakis [N-tetrafluorophthaloyl-(S)-tert-leucinate] (Rh2(S-
TFPTTL)4), it was found that the intramolecular C–H insertion reaction of the
diaryldiazomethane derivative could afford the 2,3-diaryl-2,3-dihydrobenzofuran core 
structure with perfect cis diastereoselectivity and 96% ee.
Scheme 1.7| Proposed Mechanism for C–H Insertion Involving the Ylide Intermediate
that Proceeds to Dihydrobenzofuran Product with a very Low Barrier
After the demonstration of their first Rh2-catalyzed C–H insertion reactions with 
diaryl diazomethanes, Shaw and his coworkers have subsequently studied the detailed 
mechanism through computational study and proposed the following pathway as shown in
Scheme 1.7.9 Upon the formation of the metallocarbene intermediate, it most likely 
undergoes a subsequent hydride transfer step to deliver the ylide intermediate. Then, the 
ylide species converts into the desired C–H insertion product in a highly exothermic 
fashion, which might indicate that this step is a stereospecific process and the 
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diastereoselectivity is mainly governed by the transition state for ylide formation. The 
rationale is in accord with many previous C–H insertion examples.
Scheme 1.8| Asymmetric Synthesis of 2,3-Disubstituted Indolines via Rh2(PTDA)4-
Catalyzed C–H Insertion Reactions
Very recently, Shaw’s group has further expanded the C–H insertion chemistry for 
the synthesis of other important core structures in addition to the aforementioned 2,3-
disubstituted dihydrobenzofuran compounds. For example, indolines represent a common 
core structure among natural products and drug discovery candidates. In this work,10 they 
have documented the first enantioselective synthesis of 2,3-disubstituted indoline
derivatives from donor/donor-substituted diazo compounds (Scheme 1.8). A variety of 
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indolines, including fused indolines derived from cyclic anilines and indoline derived from 
a free amine, could be approached in high yields with high levels of diastereo- and 
enantioselectivity.
Scheme 1.9| Asymmetric Synthesis of 2,3-Disubstituted Dihydrobenzothiophenes via 
Rh2(PTDA)4-Catalyzed C–H Insertion Reactions
Dihydrobenzothiophenes are another interesting family of heterocycles, yet very
few stereoselective synthetic methods have been reported so far.11 In the context of 
metallocarbene-based C–H insertion, only a single report of a dihydrobenzothiophene
synthesis carbenes with acceptor-substituted diazo compounds was disclosed.12 Shaw and 
his team hypothesized that the sluggish development is largely due to the propensity of the 
highly nucleophilic sulfur atom that would attack the carbene directly to form an ylide.
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However, in the case of donor/donor carbenes, attributed to the reduced electrophilicity of 
the formed Fischer carbene intermediates, it can permit the smooth synthesis of a wide 
array of dihydrobenzothiophenes in high yields with excellent stereocontrol (Scheme 
1.9).10 Among the broad range of substrate scope, it is highlighted that the free alcohol 
motif could be well tolerated, which would create a useful chemical handle for further 
modification without lengthy protection/deprotection steps.
Scheme 1.10| Asymmetric Synthesis of 2,3-Disubstituted Indanes via Rh2(PTDA)4-
Catalyzed C–H Insertion Reactions
They have further expanded the scope of this chemistry to the asymmetric synthesis 
of a variety of carbocycle indanes (Scheme 1.10),10 which prevail in both natural products 
and drug candidates presumably due to the less easily oxidized electron-neutral benzene 
and benzylic carbon by enzymes responsible for drug clearance. Under the optimized 
conditions, the desired indane derivatives could be obtained in high yields (up to 91% 
yield) with excellent control of both diastereoselectivity and enantioselectivity.
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1.3 C–H ALKYLATION REACTIONS WITH IN SITU-GENERATED 
ARYL/ALKYL DIAZO COMPOUNDS
1.3.1 Intramolecular Alkylation of C(sp3)–H with in Situ-Generated Aryl/Alkyl 
Diazo Compounds
In 2003, Che and his team reported a ruthenium porphyrin-catalyzed system for 
stereoselective intramolecular C–H insertion reactions (Scheme 1.11).13 In this work, they 
can employ aryl ketone-derived tosylhydrazones as precursors for the in situ-generation of 
aryl/alkyl-substituted diazo compounds, where handling or accumulation of these unstable 
diazos could be avoided.
Scheme 1.11| Ru-Catalyzed C–H Insertion Reactions with in Situ-Generated 
Aryl/Alkyl Diazo Compounds for the Synthesis of cis-2,3-Disubstituted 
Dihydrobenzofurans
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With the employment of [RuII(TTP)(CO)] as catalyst, they found that the in situ-
formed diazo compounds could smoothly undergo intramolecular C–H insertion reactions
in good yields with remarkable cis selectivity. Specifically, the treatment of the hydrazone
salt with 1 mol % [RuII(TTP)(CO)] in toluene at 110 °C, the reaction could afford 2,3-
disubstituted dihydrobenzofuran derivatives in moderate to high yields.
Notably, for substrates containing electron-withdrawing ester substituents that are 
generally not reactive for the electrophilic Rh-catalyzed carbenoid C–H insertion reactions, 
they were still able to undergo facile C–H insertion with the formation of the desired 
product in 66% yield with >99% cis selectivity. However, allylic C–H substrate 
preferentially underwent intramolecular cyclopropanation to afford the corresponding 
cyclopropane in 56% yield without detectable C–H insertion product (Scheme 1.11).
Scheme 1.12| Ru-Catalyzed C–H Insertion Reactions with in Situ-Generated 
Aryl/Alkyl Diazo Compounds for the Synthesis of cis-β-Lactams
Furthermore, the Che group have explored this Ru-catalyzed intramolecular C–H
insertion protocol for synthesis of β-lactam ring structures (Scheme 1.12). Under the
standard conditions, reactions of the N-benzyl-N-tert-butylacetamide tosylhydrazones
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could deliver β-lactam compounds in 70%-89% isolated yields with exclusive cis-
selectivity. It is noteworthy to mention that the bulky tert-butyl protecting group is essential
for the success of this transformation.
In 2017, the Driver research group discovered a catalyst-controlled site-selective 
C–H insertion system by using in situ-generated aryl/alkyl diazo compounds.14 As drawn 
in Scheme 1.13, while copper-based aryl/alkyl carbenes typically react with the o-alkenyl 
substituent through a cyclization-migration pathway to afford α-alkoxy 2H-
naphthalenones, rhodium(II) carboxylate catalyst instead triggers interestingly
stereoselective allylic C−H alkylation reactions to produce 1H-indenes.
Scheme 1.13| Divergent Reactivity of Electron-Rich Metallocarbene Intermediates
from Alkyl/Aryl Diazo Compounds
With Rh2(esp)2 as catalyst and by using N-tosylhydrazones derived from ortho-
substituted aryl ketones as substrates, the C−H alkylation reactions allowed the formation 
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of indane derivatives in high yields with good to excellent diastereoselectivities (Scheme 
1.14). They were also able to vary the identity of the ortho substituent, such as changing 
from a carboxylate to a phenyl group, to undergo the C−H alkylation reactions with the 
formation of other multi-substituted indane derivatives. Moreover, the system was also 
found to effectively functionalize other activated C−H bonds. For example, substrates 
bearing ethereal, aminomethylene, or benzylic C−H bonds were all smoothly transformed 
into corresponding indane analogs.
Scheme 1.14| Rh2(esp)2-Catalyzed C–H Insertion Reactions with in Situ-Generated 
Aryl/Alkyl Diazo Compounds for the Formation of Disubstituted Indane Derivatives
Chapter 1. Transition Metal-Catalyzed C–H Alkylation Reactions with Diazo Compounds
To support a concerted insertion process of electron-rich metal carbenes into C−H 
bonds, they subjected the deuterated compound into the reaction conditions and only 
observed indanes without the scrambling of the stereogenic centers (Scheme 1.15). This 
result indicated that the C−H functionalization should go through the concerted 
mechanism. Moreover, an intramolecular KIE value of 2.2 is also similar to the kH/kD
values reported for the intermolecular insertion reactions of electron-poor carboxylic ester-
and imine-substituted rhodium(II) carbenes.
Scheme 1.15| Intramolecular Kinetic Isotope Effect for Rh2(esp)2-Catalyzed C–H
Insertion Reactions with in Situ-Generated Aryl/Alkyl Diazo Compounds
1.3.2 Intermolecular Alkylation of C(sp2)–H with in Situ-Generated Aryl/Alkyl 
Diazo Compounds
In addition to the aforementioned alkylation reactions of C(sp3)–H bonds, in 2011,
Wang and coworkers also reported a highly efficient Cu(I)-catalyzed system for direct 
benzylation or allylation of heteroaromatic C(sp2)–H compounds with N-tosylhydrazones
(Scheme 1.16).15 By using CuI as the catalyst in the presence of LiOtBu in toluene at 110 
oC, the system was applicable to different benzo[d]oxazoles or thiazoles, which could be 
facilely coupled with various tosylhydrazones to provide the corresponding benzylated 
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aromatic heterocycles in moderate to good yields. It is noteworthy to mention that other 
diazomethanes were also employed for this transformation, including aryl/alkyl, aryl/H, 
aryl/aryl, allyl/alkyl diazo compounds.
Scheme 1.16| Cu-Catalyzed Benzylation of Benzoxazoles or Thiazoles with in Situ-
Generated Diazomethanes
A plausible mechanism was also proposed, where the authors postulated that the 
reaction most likely is initialized by the deprotonation of the relatively acidic 
heteroaromatic C–H bonds (Scheme 1.17). Subsequent transmetalation and dediazotization 
of the in situ-generated diazo substrates lead to the formation of a copper carbene species, 
which then undergoes a migratory insertion process and finally delivers the desired 
coupling product.
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Scheme 1.17| Proposed Mechanism for Cu-Catalyzed Reaction of 1,3-Azole with N-
Tosylhydrazone
1.4 C–H ALKYLATION REACTIONS WITH IN SITU-GENERATED 
ARYL/H DIAZO COMPOUNDS
In addition to intramolecular C–H alkylation with in situ-generated aryl/aryl, 
aryl/alkyl diazo compounds, C–H alkylation reactions with aryl/H diazomethanes, formed 
through thermal decomposition of aryl aldehyde-derived sulfonylhydrazones, also allow 
the efficient construction of important organic molecules.
1.4.1 Intramolecular Alkylation of C(sp3)–H with in Situ-Generated Aryl/H Diazo 
Compounds
As mentioned earlier, chiral 2-substituted indolines exist ubiquitously in both 
natural and synthetic compounds with important biological properties. While tremendous 
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efforts have been made towards their asymmetric synthesis, including catalytic 
hydrogenation, metal-catalyzed intramolecular coupling and kinetic resolution, the 
construction of chiral 2-substituted indolines based on direct C2–C3 bond formation via 
asymmetric C–H alkylation has been much less developed. The underdevelopment may be 
attributed to the inherent challenge for enantioselective formation of C–C bonds between 
two sp3-carbon centers.
Scheme 1.18| [Co(P1)]-Catalyzed Enantioselective Radical C–H Alkylation for 
Construction of Chiral 2-Substituted Indolines
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Very recently, Zhang and coworkers have presented a new C–C bond formation 
strategy based on the concept of metalloradical catalysis (MRC) for asymmetric 
construction of 2-substituted indolines via direct C–H alkylation using donor/H-type diazo 
compounds (Scheme 1.18).16 With the design of a new chiral ligand, 2,6-DiPhO-
QingPhyrin, the [Co(P1)]-based metalloradical system enables the efficient activation of 
in situ generated aryldiazomethane with ortho-amino functionality at room temperature for 
enantioselective intramolecular radical alkylation of a broad range of C(sp3)–H bonds, 
including benzylic, heteroaromatic-adjacent, propargylic, alkyl substrates. A wide array of 
chiral 2-substituted indolines were obtained in high yields with excellent 
enantioselectivities. Among other attributes, this catalytic system features a remarkable 
level of functional group tolerance as well as excellent compatibility with heteroaryl units.
Scheme 1.19| Proposed Mechanism for Construction of 2-Substituted Indolines by 
Radical C–H Alkylation via Co(II)-MRC
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The proposed mechanism is shown in Scheme 1.19. It was reasoned that, upon 
metalloradical activation, the resulting α-Co(III)-benzyl radical intermediates undergo
intramolecular hydrogen atom abstraction (HAA) from the C–H bonds at the distal 5-
position to form ε-Co(III)-aminoalkyl radical, where the C-centered radical is considerably 
stabilized by the lone pair of the adjacent nitrogen. Subsequently, the pendant α-aminoalkyl 
radical likely proceeds through a 5-exo-tet radical cyclization at the α-carbon center to form
C–C bond in an asymmetric fashion.
Scheme 1.20| Mechanistic Study with TEMPO-Trapping Experiments
To further support the details of the underlying stepwise radical pathway, a series 
of mechanistic studies including TEMPO-trapping experiments of benzylic, allylic as well 
as cyclopropyl-tethered C–H substrates, were conducted by the group (Scheme 1.20).
Addition of TEMPO (2.5 equiv.) to the reaction of benzylic and allylic C–H substrates by 
achiral catalyst [Co(P2)] resulted in complete inhibition of the C–H alkylation process.
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Instead, the bis-TEMPO trapped products were isolated contain  two TEMPO units
at different positions. Collectively, all these experimental observations strongly support the 
proposed stepwise radical mechanism of the Co(II)-based C–H alkylation reaction.
At the same time, de Bruin and his team also disclosed a non-asymmetric method 
for the synthesis of 2-substituted indolines from o‐aminobenzylidine N‐tosylhydrazones 
with [CoII(TPP)] as catalyst. The desired indoline derivatives bearing different substituents 
were obtained in 80%-98% yields (Scheme 1.21).17 Computational investigations using 
density functional theory further supported the stepwise radical mechanism.
Scheme 1.21| [Co(TPP)]-Catalyzed Non-Asymmetric C–H Alkylation for 
Construction of 2-Substituted Indolines
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1.4.2 Intermolecular Alkylation of C(sp)–H with in Situ-Generated Aryl/H Diazo 
Compounds
Following up their aforementioned work on Cu(I)-catalyzed direct C−H bond
benzylation or allylation of 1,3-azoles with in situ-generated aryl/alkyl diazos, in 2012, the 
Wang group has developed another novel strategy for constructing C(sp)−C(sp3) bonds 
starting from N-tosylhydrazones and trialkylsilylethynes in the presence of copper catalyst
(Scheme 1.22).18
Scheme 1.22| Cu(I)-Catalyzed Cross-Coupling Reactions of Tosylhydrazones and 
Trimethylsilylethyne
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It was found that by using aryl aldehyde-derived tosylhydrazones and 
trimethylsilylethynes as substrates in the presence of CuI and LiOtBu in dioxane, the 
corresponding alkyne products were isolated in moderate to high yields. Further 
investigation revealed that N-tosylhydrazones derived from other carbonyl sources, such 
as aryl ketones, aliphatic aldehydes and ketones, were all suitable carbene candidates,
affording the target products in varied yields. The authors claimed that the reaction 
undergoes a similar reaction mechanism as shown in Scheme 1.17, which is 
mechanistically different from other transition metal-catalyzed cross-coupling reactions 
with terminal alkynes.
1.5 C–H ALKYLATION REACTIONS WITH IN SITU-GENERATED 
ALKYL/H DIAZO COMPOUNDS
To further challenge the capability of Co(II)-based metalloradical catalysis for C−H
alkylation, Zhang and coworkers have shown that linear aliphatic diazo compounds, which 
were generated in situ from alkyl aldehyde-derived sulfonylhydrazones, could also be 
utilized for enantioselective radical alkylation (Scheme 1.23).19 With a new D2-symmetric 
chiral porphyrin 2,4,6-TriMe-ZhuPhyrin as the supporting ligand, the Co(II)-based
metalloradical catalyst is capable of activating different aliphatic diazo compounds to 
generate the corresponding α-Co(III)-alkyl radicals and undergo effective alkylation of 
both activated and nonactivated C–H bonds, streamlining the synthesis of chiral α-
substituted pyrrolidines and other important 5-membered cyclic molecules in high yields 
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with excellent enantioselectivities. In addition to remarkable chemoselectivity and 
regioselectivity, the metalloradical C–H alkylation system is highlighted by its tolerance 
to functional groups and compatibility with heteroaryl substrates, as showcased in the 
enantioselective synthesis of naturally occurring nicotine and L-proline derivatives from 
open-chain molecules.
Scheme 1.23| Enantioselective Radical Cyclization for Synthesis of α-Substituted 
Pyrrolidines via [Co(P3)]-Catalyzed C–H Alkylation
Distinct from conventional radical cyclization modes that predominantly rely on 
radical addition to unsaturated bonds as the key cyclization step, this system renders a novel 
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cyclization pattern that involves radical H-atom abstraction and radical substitution (HAA-
RS), a general strategy for enantioselective radical construction of common cyclic 
molecules from linear C–H substrates.
Scheme 1.24| Proposed Radical Cyclization Mechanism via Metalloradical C–H 
Alkylation
The detailed mechanism was proposed in Scheme 1.24 and backed up by a series 
of experiments including intramolecular kinetic isotope effect and TEMPO-trapping 
experiment, supporting the detailed stepwise radical mechanism. This radical cyclization 
system may provide a new retrosynthetic paradigm to prepare five-membered cyclic 
molecules from readily available linear aldehydes through the union of C–H and C=O 
elements for asymmetric C–C bond formation.
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1.6 C–H ALKYLATION REACTIONS WITH IN SITU-GENERATED 
ALKYL/ALKYL DIAZO COMPOUNDS
In 2014, Che and coworkers has, for the first time, shown that ruthenium-porphyrin 
catalyst could successfully activate in situ-generated alkyl/alkyl diazomethanes for
intramolecular C(sp3)–H insertion reactions (Scheme 1.25).20
Scheme 1.25| Ruthenium-Porphyrin-Catalyzed Cyclization of Tosylhydrazones to
Construct Tetrahydrofurans and Pyrrolidines
With [Ru(TTP)(CO)] as the catalyst in the presence of NaOtBu in toluene at 110 
oC, aliphatic ketone-derived tosylhydrazones could be effectively converted into 
substituted tetrahydrofurans and pyrrolidines in up to 99% yield and with up to 99:1 cis
selectivity. The reaction was highlighted by the good tolerance of many functionalities, 
and the procedure is simple without the need of a syringe pump for slow addition. Since
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alkyl N-tosylhydrazones can be obtained by the treatment of alkyl-substituted ketones with 
tosylhydrazine, they also turned the reactions into a one-pot manner for stereoselective 
intramolecular C–C bond formation directly from alkyl ketones. Later on, the group also 
successfully applied this methodology for the concise synthesis of (±)-pseudoheliotridane.
Scheme 1.26| Proposed Reaction Mechanism of the Alkyl Carbene C–H Insertion 
Catalyzed by [Ru(TTP)(CO)]
For the reaction mechanism, they proposed a plausible catalytic cycle involving 
electrophilic Fischer carbene intermediates (Scheme 1.26), which is fundamentally 
distinctive from [Co(Por)]-catalyzed stepwise radical pathway involving hydrogen atom 
abstraction of C–H bonds. Further mechanistic evidences such as KIE study using 
monodeuterated N-tosylhydrazone and DFT calculation were also provided.
Based on Wang’s work involving Cu(I)-catalyzed C−H benzylation or allylation of 
1,3-azoles with in situ-generated aryl/alkyl diazo substrates, in 2012, Miura and coworkers 
further expanded the chemistry to more general substrates by using alkyl/alkyl diazo 
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compounds, where nickel- and cobalt-based catalysts are applied for the direct alkylation 
of azoles with tosylhydrazones.21
Scheme 1.27| Nickel-Catalyzed Direct C−H Alkylation of Benzoxazoles with N-
Tosylhydrazones
In particular, nickel catalysis enables the installation of unactivated secondary alkyl 
groups onto benzoxazole analogs in up to 82% yield (Scheme 1.27), whereas cobalt catalyst 
permits the possible alkylation of 5-aryloxazoles and benzothiazole in up to 81% yield 
(Scheme 1.28). 5-Aryloxazoles with electron- withdrawing group underwent the alkylation 
smoothly under standard conditions, while with the electron-donating methoxy substituent 
required the use of NaOtBu as the base. The catalytic systems are compatible with various 
unactivated secondary alkyl groups, including cyclic and even more challenging acyclic 
alkyl groups. This protocol might provide a concise access to azole cores tethering
unactivated secondary alkyl side chains, which are difficult to prepare by using the 
precedent C–H alkylation methodologies.
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Scheme 1.28| Cobalt-Catalyzed Direct C–H Alkylation of Azoles with N-
Tosylhydrazones
1.7 SUMMARY AND OUTLOOK
C–H functionalization is a cutting-edge area of significant importance in modern 
organic chemistry. Transition metal-catalyzed C–H alkylation reactions with diazo 
compounds lie at the center of this field as a key technology for effectively constructing 
C–C bonds. In addition to the well demonstrated diazo compounds such as 
acceptor/acceptor-, acceptor-, donor/acceptor-substituted diazomethanes, the successful 
utilization of donor- and alkyl-substituted ones for C–H alkylation in the past decade not
only significantly expands the scope of both substrates and products that are accessible by 
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using this chemistry, but also offers possible solutions to some of the key hurdles in this 
area. Starting from the hydrazones to generate the diazo species in situ, previously unstable 
and inaccessible substrates are now approachable from a method that circumvents the 
practical problems. Even though the related methodology is still in its infancy, this tutorial 
review summarizing its recent impressive applications strongly indicates that utilizing less 
stabilized diazo compounds has great potentials for the future growth in this area, including 
asymmetric intermolecular C–H alkylation reactions.
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CHAPTER 2                     
ENANTIOSELECTIVE SYNTHESIS OF CHIRAL DIHYDROBENZOFURANS 
WITH IN SITU-GENERATED DONOR-SUBSTITUTED DIAZO REAGENTS
VIA COBALT(II)-BASED METALLORADICAL C–H ALKYLATION
2.1 INTRODUCTION
Radical cyclization has been extensively explored for construction of molecular 
structures of different ring sizes with diverse substitution patterns.1 Despite its wide 
adoption, the control of stereochemistry, especially enantioselectivity, remains as one of 
the major hurdles that limits the applications of radical cyclization in stereoselective 
organic synthesis.2 To address this and other long-standing challenges associated with the 
"free" nature of radicals, metalloradical catalysis (MRC), as a conceptually different 
approach, seeks the use of metal-centered radicals to homolytically activate substrates for 
catalytic generation of metal-stabilized organic radicals. As they are controlled by the 
supporting ligand environment, these metal-stabilized organic radicals are no longer “free” 
and function as effective intermediates for achieving stereoselective radical 
transformations.3,4 As stable 15e metalloradicals with well-defined d7 low-spin electron 
configuration, Co(II) complexes of D2-symmetric chiral amidoporphyrins [Co(D2-Por*)] 
have been demonstrated with unique capability of activating different diazo compounds as 
radical precursors for the generation of the fundamentally new α-Co(III)-alkyl radicals 
(also known as Co(III)-carbene radicals).5 These Co-stabilized C-centered radicals, which 
are well confined within the pocket environment of the chiral porphyrin ligands, have been 
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employed as catalytic intermediates for the development of a number of asymmetric radical 
processes.6 Recently, the application of Co(II)-MRC has been further extended to the 
employment of donor-substituted diazo compounds such as α-aryldiazomethanes, 
generated in situ from sulfonylhydrazones, as new radical precursors for generation of the 
corresponding α-Co(III)-benzyl radicals that can serve as effective intermediates for 
different radical transformations,7 including asymmetric radical cyclopropanation7c and 
enantioselective radical synthesis of indolines.7a
Figure 2.1| Selective Examples of Natural Products and Biologically Active 
Compounds Containing Dihydrobenzofuran Moiety
Given that optically active dihydrobenzofurans are important motifs in a wide range 
of natural products and biologically active compounds (Figure 2.1),8 we were attracted to 
the possibility of constructing these core structures by enantioselective radical C–H
alkylation of the corresponding α-aryldiazomethanes from the readily accessible 2-
alkoxylbenzaldehyde-derived sulfonylhydrazones under Co(II)-MRC (Scheme 2.1). Upon 
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metalloradical activation of α-aryldiazomethane by [Co(D2-Por*)], the resulting α-Co(III)-
benzyl radical A was expected to have the capability to undergo 1,5-H atom abstraction to
form ε-Co(III)-phenoxyalkyl radical intermediate B. Considering the electronic and steric 
difference of α-alkoxyalkyl radicals in B from previously reported α-aminolkyl radicals,7,9
it was unclear whether the C(sp3)–C(sp3) bond formation through subsequent 
intramolecular radical substitution (5-exo-tet radical cyclization) could be effectively 
facilitated and enantioselectively controlled by [Co(D2-Por*)]. If achieved, it would offer 
a practical appealing approach for enantioselective synthesis of chiral 2-substituted 
dihydrobenzofurans from readily available salicylaldehyde-derived sulfonylhydrazones 
via a fundamentally new radical C–H alkylation process.
Scheme 2.1| Proposed Pathway for Synthesis of Chiral Dihydrobenzofurans via 
Co(II)-Based Radical C–H Alkylation
Asymmetric C−H alkylation with diazo compounds represents a powerful approach
for stereoselective C(sp3)−C(sp3) bond formation directly from prevalent C(sp3)–H
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bonds.10 In the past decades, tremendous progress has been accomplished on asymmetric 
C−H functionalization via transition metal-catalyzed carbene insertion with different types 
of diazo compounds such as acceptor- and donor/acceptor-substituted diazo compounds.11
Recently, Shaw and coworkers further extended the application to donor/donor-substituted 
diazo compounds, as demonstrated by their first example of Rh2-catalyzed C−H insertion 
of in situ-generated diazo compounds for asymmetric synthesis of disubstituted 
benzodihydrofuran derivatives.12 To the best of our knowledge, there has been no report 
on asymmetric catalytic system of C−H alkylation that employs donor-substituted diazo 
compounds for enantioselective synthesis of 2-substituted chiral dihydrobenzofurans.13 As 
a new application of Co(II)-MRC, we developed an asymmetric metalloradical system that 
can utilize in situ-generated α-aryldiazomethanes as radical precursors for enantioselective 
C−H alkylation. At room temperature, the Co(II)-based metalloradical system is suitable 
for alkylation of various C(sp3)–H bonds with varied electronic and steric properties, 
allowing for stereoselective construction of chiral dihydrobenzofuran derivatives in high 
yields with high enantioselectivities.
2.2 RESULTS AND DISCUSSION
2.2.1 Condition Optimization of Co(II)-Based Catalytic System for Enantioselective 
Radical C–H Alkylation
Initial experiments were carried out by using commercially available O-
benzylsalicylaldehyde-derived N-tosylhydrazone (1a) as model substrate to examine the 
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possibility of Co(II)-based metalloradical system for 2-phenyl dihydrobenzofuran 
synthesis by C–H alkylation (Table 1). Gratifyingly, with Co(II) complex of D2h-symmetric 
achiral amidoporphyrin [Co(P1)] (P1 = 3,5-DitBu-IbuPhyrin)14 as metalloradical catalyst 
(2 mol %), a productive reaction was achieved at 60 oC to deliver 2a in 81% yield (entry 
1). This result indicated that Co(II)-based metalloradical catalysis could well tolerate basic 
conditions as well as polar protic solvent for productive radical C–H alkylation. Aimed at 
developing an enantioselective radical process, we then turned our attention to chiral 
catalysts. When [Co(P2)] (P2 = 3,5-DitBu-ChenPhyrin)6d was employed under the same 
conditions, the desired C–H alkylation product 2a was produced in 67% yield with a 
significant level of enantioselectivity (entry 2). Further investigation of the solvent effect 
revealed that the catalytic process could be carried out in a wide array of mediums to deliver 
2a in moderate yields with comparable enantiomeric ratios (entries 2–6). Among them, 
methanol was identified as the solvent of choice. To further enhance the asymmetric 
induction, the reaction was attempted at a lower temperature. However, the reaction with 
catalyst [Co(P2)] at 40 oC was less productive albeit with a slightly increased er (entry 7).
Encouragingly, both the reactivity and selectivity were greatly enhanced when [Co(P3)] 
(P3 = 2,6-DiMeO-ChenPhyrin)6d was used, where the ligand has sterically more 
demanding environment at the non-chiral meso-aryl substituents (entry 8). This observed 
buttressing ligand effect might facilitate the intramolecular 1,5-H abstraction process in a 
sterically more congested pocket. To further amplify the enantioinduction by lowering the 
reaction temperature to room temperature, it was found that the enantiomeric ratio was 
increased to 92:8 while the yield was relatively low (entry 9), which was mainly due to the 
slow generation of diazo compound from tosylsulfonyl hydrazone in the presence of base.
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Table 2.1| Condition Optimization of Co(II)-Catalyzed Enantioselective Radical C–H 
Alkylationa
a Reactions were carried out with 1a (0.1 mmol) in the presence of Cs2CO3 (2 equiv.) by 
[Co(Por)] in solvent (1.0 mL) for 24 h. b Ts = 4-toluenesulfonyl. c Isolated yields. d
Enantiomeric ratio was determined by chiral HPLC. DCE = 1,2-dichloroethane; MTBE = 
methyl tert-butyl ether; DME = dimethoxyethane
To accelerate the rate of diazo generation under ambient conditions, we then 
attempted to screen different hydrazone sources by tuning both electronics and steric 
hindrance (Table 2.2), which may affect the leaving speed of the aryl sulfonyl group, and 
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thus facilitate the generation rate of diazo reagents. Different substituted sulfonyl 
hydrazones were then synthesized and tested at room temperature. Surprisingly, when we 
changed the –CH3 group to –NO2 group, almost no product was formed (entry 2), and other
groups such as –CF3 and –OCH3 only gave moderate yield under the same conditions 
(entries 3-4). Intriguingly, when the highly sterically hindered triisopropyl sulfonyl 
hydrazone was subjected to the catalytic reactions, the desired product was formed in 77% 
yield with the same level of high enantiomeric ratio 92:8. It was worth mentioning that the 
same enantioselectivity was observed when different sulfonyl hydrazones were utilized as 
the starting materials, which may suggest that the chiral catalyst was not involved in the 
diazo generation step.
Table 2.2| The Reactivity of Different Sulfonyl Hydrazones on Stereoselective Radical 
C–H Alkylationa
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a Reactions were carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2 equiv.) by 
[Co(P3)] in MeOH (1.0 mL) for 24 h. b Isolated yields. c Enantiomeric ratio was determined 
by chiral HPLC
2.2.2 Asymmetric Radical Alkylation of Different C–H Substrates for Chiral 2,3-
dihydrobenzofuran Synthesis
Under the optimized conditions, the scope of this Co(II)-based radical alkylation 
system was evaluated by using different C–H substrates (Table 2.3). Like model substrate 
1a, other benzylic C–H substrates bearing either electron-donating or electron-withdrawing 
groups with different substitution patterns could readily undergo radical alkylation,
generating 2-substituted dihydrobenzofurans 2b–2f in high yields with high enantiomeric 
ratios (entries 2–6). The catalytic system could also efficiently alkylate C–H bonds adjacent 
to encumbered aryl groups as shown with the successful reaction of the 2-naphthyl-based 
substrate 1g (entry 7). Attributed to the easy accessibility of salicylaldehyde derivatives, 
dihydrobenzofurans with substituents on both aryl groups could also be achieved through 
this enantioselective radical alkylation, as demonstrated by the high-yielding synthesis of 
optically active natural product corsifurans A (2l) and other alkylation products 2h–2k
(entries 8–12). The absolute configuration of 2l was confirmed to be (S) by X-ray structural 
analysis. In particular, the productive formation of bromine-tethered products 2h–2i would 
allow for the facile further transformations via metal-catalyzed coupling reactions (entries 
8 and 9). It was noteworthy to mention that the metalloradical system could even tolerate 
heteroaryl functionalities, as exemplified by radical alkylation of C–H substrates bearing 
pyridine, thiophene and benzothiophene moieties, affording the linked biheterocyclic 
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compounds 2m–2o with good to excellent er (entries 13–15). Considering that both 
heteroarene and dihydrobenzofuran are prevalent as key structural elements in many 
bioactive natural and synthetic compounds, the readily access of these linked 
biheterocyclic compounds in high optically enriched form are appealing and may find 
applications in pharmaceutical research and development.
Table 2.3| Enantioselective Synthesis of Optically Active Dihydrobenzofurans via 
Radical C–H Alkylation by [Co(P3)]
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a Carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2 equiv.) by [Co(P3)] (4 mol 
%) in MeOH (1.0 mL) for 24 h; Yield refers to isolated yields; Enantiomeric excess was 
determined by chiral HPLC; Tris = (2,4,6-triisopropyl)phenylsulfonyl; MeOH = Methanol.
2.2.3 Mechanistic Insights for Radical C–H Alkylation
To shed light on the postulated stepwise radical pathway, several mechanistic 
experiments were performed. First, the effect of radical scavenger TEMPO on the catalytic 
C–H alkylation reaction was examined (Scheme 2.2).
Scheme 2.2| TEMPO Trapping Reaction as Supportive Evidence for the Proposed 
Radical Pathway
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Under standard conditions, the addition of 2.5 equivalent of TEMPO to the catalytic 
reaction of benzyl C–H substrate 1d by the achiral catalyst [Co(P1)] resulted in a complete 
inhibition of the C–H alkylation process. Instead, compound 3d was isolated in 53% yield, 
the structure of which was confirmed to contain two TEMPO units at both 1- and 5-
positions (Scheme 2.2).
The formation of 3d is indicative of the presence of the initial α-Co(III)-benzyl 
radical A and the ε-Co(III)-alkyl radical B after 1,5-HAA, which might be subsequently
capped by one molecule of TEMPO at the ε-position through radical recombination to 
generate intermediate C, then followed by radical substitution with a second molecule of 
TEMPO at the α-position to cleave the weak Co(III)–C bond and yield the formation of 
3d.
In addition to the TEMPO trapping experiment, the resulting Co(III)-supported 
alkyl radical intermediates A (Scheme 2.1) from the reaction of substrate 1a by [Co(P1)] 
in the absence of TEMPO could be directly detected by HRMS (C90H100CoN8O5+, m/z: 
calculated: 1431.7143, found: 1431.7125). The HRMS experiment was carried out in the 
absence of any additives such as formic acid, which commonly act as electron carriers for 
ionization, allowing for the detection of the molecular ion signals corresponding to Co(III)-
alkyl radical (C90H100CoN8O5·) by the loss of one electron.
Scheme 2.3| High Resolution Mass Spectroscopy (HRMS) Spectrum for Co(III)-
Supported Alkyl Radical Intermediate
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Besides the HR-MS experiment, the corresponding intermediate A (Scheme 2.1) 
was also trapped by spin trapping reagent phenyl N-tert-butylnitrone (PBN) to give the 
characteristic EPR signal. As shown in Scheme 2.4, the resulting EPR spectrum (in red), 
which is assigned to PBN-trapped Co(III)-supported alkyl radical intermediates, displays 
the characteristic triplet of doublet signal for alkyl radicals that are trapped by phenyl N-
tert-butylnitrone (PBN). The spectrum has been simulated (in blue) with with g = 2.006, 
AN = 14.6 G, AH = 2.6 G, which is consistent with the resulting O-centered radical with the 
hyperfine splitting by the neighboring N and H atoms. The values are consistent with those 
for similar species reported in litrature.7d
Scheme 2.4| Isotropic X-band EPR Spectrum of Phenyl N-tert-butylnitrone (PBN)-
Trapped Co(III)-Supported Alkyl Radical Intermediate
Furthermore, mono-deuterated sulfonylhydrazone 1a-D was synthesized to 
evaluate the intramolecular kinetic isotope effect (KIE) of the C–H activation process 
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(Scheme 2.5). Under the standard conditions by the achiral catalyst [Co(P1)], both C–H
(2a-H) and C–D (2a-D) alkylation products were formed in a combined yield of 78%. 1H-
NMR analysis of the product mixture revealed an intramolecular KIE ratio of kH/kD = 6.7/1. 
This significantly high level of primary KIE was in well accordance with the proposed 
direct C–H bond breaking via H-atom abstraction by α-Co(III)-benzyl radical intermediate 
A (Scheme 2.1). Together, these observed results including intramolecular KIE study and 
TEMPO-trapping experiment are well supportive for the postulated stepwise radical 
mechanism.
Scheme 2.5| Intramolecular Kinetic Isotope Effect for the Radical C–H Alkylation
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2.3 CONCLUSIONS
In summary, an asymmetric radical pathway for the synthesis of enantioenriched 2-
substituted dihydrobenzofuran derivatives is achieved via Co(II)-based enantioselective 
radical C–H alkylation. The Co(II) complex of D2-symmetric chiral amidoporphyrin 2,6-
DiMeO-ChenPhyrin, [Co(P3)], is identified as effective metalloradical catalyst to activate 
in situ-generated α-aryldiazomethanes for enantioselective intramolecular radical 
alkylation of C–H bonds that are adjacent to a variety of aromatic functional groups with 
varied electronic and steric properties. The corresponding 2-substituted 
dihydrobenzofurans are achieved in high yields with good enantioselectivities. This 
enantioselective radical process would offer a streamlined synthesis of chiral 2-substituted 
dihydrobenzofurans from readily available 2-alkoxylbenzaldehyde-derived 
sulfonylhydrazones.
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2.4 EXPERIMENTAL SECTION
2.4.1 General Considerations
1H NMR spectra were recorded on a Varian INOVA 400 (400 MHz), 500 (500 
MHz) or a 600 (600 MHz) spectrometer. Chemical shifts are internally referenced to 
residual CHCl3 signal (δ 7.26 ppm). Data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, hept = 
heptet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR spectra were 
recorded on a Varian INOVA 500 (125 MHz), or 600 (150 MHz) spectrometers with
complete proton decoupling. Chemical shifts are reported in ppm with residual CHCl3 as 
the internal standard (δ 77.0 ppm). High-resolution mass spectrometry was performed on 
a Micromass LCT ESI-MS and JEOL Accu TOF Dart at the Mass Spectrometry Facility, 
Boston College. The UV-Vis absorption spectra in the range 200-700 nm were measured 
with an Evolution 300 UV-VIS spectrophotometer using quartz cuvettes with 1.0 cm 
optical path length. HPLC measurements were carried out on a Shimadzu HPLC system 
with Chiralcel AD-H, ODH, OJH, and ChiralPak Immobilized columns: IA, and IB. 
Infrared (IR) spectra were recorded on a Termo Scientific Nicolet Is5 System. Frequencies 
are reported in wavenumbers (cm-1). HRMS data was obtained on an Agilent 6210 Time-
of-Flight LC/MS with ESI as the ion source. Optical rotations were measured on a Rudolph 
Research Analytical AUTOPOL® IV digital polarimeter. The X-ray diffraction data were 
collected using Bruker Kappa APEX DUO diffractometer and a Rigaku HighFlux Homelab 
diffractometer. X-band EPR spectra were recorded on a Bruker EMX-Plus spectrometer 
(Bruker BioSpin).
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Unless otherwise noted, all C–H alkylation reactions were performed in oven-dried 
glassware under dry N2 atmosphere with standard Schlenk vacuum line techniques.
Gastight syringes were used to transfer liquid reagents and solvents in catalytic reactions. 
Anhydrous solvents as well as other commercial reagents were purchased from Sigma-
Aldrich, Acros, Alfa Aesar, Strem, Oakwood Products Inc., TCI, or Matrix Scientific and 
used as received unless otherwise stated. Thin layer chromatography was performed on 
Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed with 
ICN silica gel (60 Å, 230-400 mesh, 32-63 μm).
2.4.2 Procedure for HRMS Experiment
To an oven-dried Schlenk tube, sulfonylhydrazone 1a (0.05 mmol) and Cs2CO3
(2.0 equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen 
for 3 times. The Teflon screw cap was replaced with a rubber septum, and CH3CN (0.5 
mL) was added via a gastight syringe. The mixture was then stirred at 60 oC for 0.5 h. The 
resulting light yellow solution was then passed through a short pad of Celite (to get rid of 
base and salt) under the flow of nitrogen and the filtrate was collected in a HPLC vial (vial 
A, degassed and backfilled with argon). During the time, [Co(P1)] (4 mol %) was charged 
into another HPLC vial (vial B, degassed and backfilled with argon) and dissolved in 
CH3CN (0.5 mL). After mixing equal amount of solutions from vial A (0.1 mL) and vial B 
(0.1 mL), the sample was further diluted with CH3CN and immediately injected into HRMS 
instrument. The HRMS experiment was carried out in the absence of any additives such as 
formic acid, which commonly act as electron carriers for ionization, allowing for the 
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detection of the molecular ion signals corresponding to Co(III)-alkyl radical 
(C90H100CoN8O5•) by the loss of one electron.
2.4.3 Procedure for EPR Experiment
To an oven-dried Schlenk tube A, sulfonylhydrazone 1a (0.05 mmol) and Cs2CO3
(2.0 equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen 
for 3 times. The Teflon screw cap was replaced with a rubber septum, and benzene (0.5 
mL) was added via a gastight syringe. The mixture was then stirred at 60 oC for 0.5 h.
During the time, [Co(P1)] (4 mol %) was charged into another oven-dried Schlenk tube B. 
The Schlenk tube B was then evacuated and backfilled with nitrogen for 3 times. After 0.5
h, the resulting light yellow solution from tube A was passed through a short pad of Celite 
(to get rid of base and salt) under the flow of nitrogen and transferred to Schlenk tube B. 
The mixture was stirred for 1 min, followed by the addition of phenyl N-tert-butylnitrone 
(PBN, 0.05 mmol). The reaction mixture was stirred for 3 min and transferred into a 
degassed EPR tube (filled with argon) through a gastight syringe. The sample was then 
carried out for EPR experiment at room temperature (EPR settings: T = 298 K; microwave 
frequency: 9.37762 GHz; power: 6.325 mW; modulation amplitude: 1.0 G).
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2.4.4 Synthetic Procedure for 2-(Benzyloxy)benzaldehyde Derivatives s2
To a solution of s1 (2 mmol) and Cs2CO3 (2.4 mmol) in MeCN (20 mL) was added 
alkyl bromide (2.4 mmol) at room temperature. The reaction was heated at 50 oC for 2 h. 
The resulting mixture was cooled down to room temperature and filtered through a short 
pad of silica. The combined organic mixture was concentrated under vacuum and purified 
by flash column chromatography.
2-(benzyloxy)benzaldehyde s2-a Yield: 99%. Hexanes/ethyl acetate = 
8/1. 1H NMR (500 MHz, CDCl3) δ 10.57 (s, 1H), 7.87 (dd, J = 7.7, 1.7 Hz, 1H), 7.57 –
7.51 (m, 1H), 7.45 (d, J = 7.1 Hz, 2H), 7.41 (dd, J = 9.9, 4.8 Hz, 2H), 7.36 (t, J = 7.1 Hz, 
1H), 7.05 (t, J = 8.0 Hz, 2H), 5.20 (s, 2H). 13C NMR (100MHz, CDCl3) δ 189.70, 161.02, 
136.05, 135.86, 128.71, 128.44, 128.25, 127.26, 125.19, 120.99, 113.01,70.46. IR (neat,
cm-1): 2870.51, 1726.84, 1682.48, 1598.14, 1510.54, 1221.15, 1156.32, 1104.94, 1011.07, 
823.10, 753.20, 649.21 601.86.
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2-((3-methoxybenzyl)oxy)benzaldehyde s2-b Yield: 98%.
Hexanes/ethyl acetate = 6/1. 1H NMR (500 MHz, CDCl3) δ 10.57 (s, 1H), 7.86 (dd, J =
7.9, 1.6 Hz, 1H), 7.58 – 7.49 (m, 1H), 7.32 (t, J = 7.9 Hz, 1H), 7.09 – 6.97 (m, 4H), 6.89 
(dd, J = 8.2, 2.4 Hz, 1H), 5.18 (s, 2H), 3.83 (s, 3H). 13C NMR (125MHz, CDCl3) δ 189.70, 
160.97, 159.89, 137.65, 135.88, 129.79, 128.49, 125.15, 121.02, 119.36, 113.59, 113.01, 
112.78, 70.30, 55.26. IR (neat, cm-1): 2864.32, 2834.06, 1682.62, 1597.87, 1584.20, 
1453.39, 1040.20, 846.51, 763.82, 687.94, 663.02,439.39. HRMS (EI) (M+) Calcd. for 
C15H14O3+: 242.0937, found 242.0943.
2-((2-methylbenzyl)oxy)benzaldehyde s2-c Yield: 98%.
Hexanes/ethyl acetate = 7/1. 1H NMR (600 MHz, CDCl3) δ 1H NMR (600 MHz, cdcl3) δ
10.52 (s, 1H), 7.86 (dd, J = 7.7, 1.7 Hz, 1H), 7.57 – 7.54 (m, 1H), 7.41 (d, J = 7.3 Hz, 1H), 
7.28 – 7.27 (m, 1H), 7.25 – 7.22 (m, 2H), 7.09 (d, J = 8.4 Hz, 1H), 7.05 (t, J = 7.5 Hz, 1H), 
5.16 (s, 2H), 2.39 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 189.61, 161.16, 136.50, 135.84, 
133.90, 130.53, 130.27, 128.55, 128.44, 126.12, 125.26, 120.98, 112.93, 69.12, 18.90. IR 
(neat, cm-1): 3033.82, 2853.31, 2760.02, 1683.47, 1595.89, 1486.13, 1452.50, 1401.09, 
1294.99, 1248.84, 1028.16, 739.78, 653.42. HRMS (EI) (M+) Calcd. for C15H14O2+:
226.0988, found 226.0982.
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2-((3,4-dichlorobenzyl)oxy)benzaldehyde s2-d Yield: 98%. 
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 9.71 (s, 1H), 7.84 (d, J = 7.6 
Hz, 1H), 7.57 (td, J = 7.7, 1.5 Hz, 1H), 7.41 (t, J = 7.5 Hz, 1H), 7.08 (d, J = 8.0 Hz, 3H), 
6.77 (d, J = 8.5 Hz, 2H), 4.89 and 4.75 (br, 2H), 3.76 (s, 3H), 3.63 (s, 3H). 13C NMR (150 
MHz, CDCl3) δ 189.57, 159.31, 156.07, 143.30, 134.75, 132.91, 130.34, 128.89, 128.60, 
128.44, 127.89, 113.92, 55.18, 54.51, 53.29. IR (neat, cm-1): 2955.10, 2837.50, 2758.23, 
1711.53, 1611.89, 1598.52, 1514.07, 1459.69, 1251.04, 1034.18. HRMS (ESI) (M+H+)
Calcd. for C17H18NO4+: 300.1230, found 300.1232.
2-((4-fluorobenzyl)oxy)benzaldehyde s2-e Yield: 99%. 
Hexanes/ethyl acetate = 8/1. 1H NMR (500 MHz, CDCl3) δ 10.53 (s, 1H), 7.86 (dd, J =
7.7, 1.8 Hz, 1H), 7.54 (ddd, J = 8.4, 7.4, 1.9 Hz, 1H), 7.45 – 7.39 (m, 2H), 7.12 – 7.02 (m, 
4H), 5.15 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 189.62, 162.62 (d, J = 247.0 Hz), 160.83,
135.91, 131.82 (d, J = 3.2 Hz), 129.21 (d, J = 8.2 Hz), 128.60, 125.17, 121.16, 115.69 (d, 
J = 21.5 Hz) 112.95, 69.83. IR (neat, cm-1): 2870.51, 1682.48, 1598.14, 1483.85, 1456.88, 
1221.15, 1156.32, 1104.94, 1011.77, 823.10, 753.2. HRMS (EI) (M+) Calcd. for 
C14H11FO2+: 230.0738, found 230.0729.
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2-((4-(trifluoromethyl)benzyl)oxy)benzaldehyde s2-f Yield: 
95%. Hexanes/ethyl acetate = 8/1. 1H NMR (500 MHz, CDCl3) δ 10.57 (s, 1H), 7.88 (dd, 
J = 7.7, 1.7 Hz, 1H), 7.67 (d, J = 8.2 Hz, 2H), 7.58 (d, J = 8.2 Hz, 2H), 7.55 (t, J = 8.4 Hz, 
1H), 7.08 (t, J = 7.5 Hz, 1H), 7.02 (d, J = 8.4 Hz, 1H), 5.26 (s, 2H). 13C NMR (100MHz, 
CDCl3) δ 189.36, 160.49, 140.09, 135.91, 130.46 (q, J = 32.4 Hz, 1C), 128.84, 127.23, 
125.69, 125.19, 123.95 (q, J = 270 Hz, 1C), 121.38, 112.79, 69.53. IR (neat, cm-1): 2910.54, 
2870.84, 1920.47, 1684.76, 1622.70, 1598.14, 1487.35, 1451.76, 1405.03, 1321.36, 
1302.01, 1103.66, 1067.67, 822.69, 747.90. HRMS (EI) (M+) Calcd. for C15H11F3O2+:
280.0706, found 280.0702.
2-(naphthalen-2-ylmethoxy)benzaldehyde s2-g Yield: 99%. 
Hexanes/ethyl acetate = 7/1. 1H NMR (600 MHz, CDCl3) δ 10.63 (s, 1H), 7.90 – 7.85 (m, 
5H), 7.56 – 7.50 (m, 4H), 7.10 (d, J = 8.4 Hz, 1H), 7.08 – 7.03 (m, 1H), 5.36 (s, 2H). 13C
NMR (150 MHz, CDCl3) δ 189.70, 161.04, 135.88, 133.51, 133.22, 133.13, 128.62, 
128.49, 127.92, 127.77, 126.44, 126.30, 126.26, 125.23, 124.88, 121.05, 113.09, 70.62. IR 
(neat, cm-1): 3078.80, 2852.31, 2761.05, 1684.99, 1595.92, 1482.09, 1456.78, 1303.00, 
1240.17, 1014.26, 824.59. HRMS (ESI) (M+H+) Calcd. for C18H15O2+: 263.1067, found
263.1069.
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2-(benzyloxy)-5-bromobenzaldehyde s2-h Yield: 95%. 
Hexanes/ethyl acetate = 7/1. 1H NMR (500 MHz, CDCl3) δ 10.46 (s, 1H), 7.95 (d, J = 2.6 
Hz, 1H), 7.61 (dd, J = 8.9, 2.6 Hz, 1H), 7.46 – 7.33 (m, 5H), 6.95 (d, J = 8.9 Hz, 1H), 5.18 
(s, 2H). 13C NMR (125MHz, CDCl3) δ 188.27, 159.87, 138.22, 135.50, 131.06, 128.81, 
128.48, 127.31, 126.44, 115.11, 113.83, 70.85. IR (neat, cm-1): 3074.35, 2922.97, 2865.62, 
2760.99, 1676.62, 1588.92, 1474.82, 1448.97, 1395.10, 1382.03, 1273.55, 1236.59, 
1183.89, 1123.23, 1022.57. HRMS (EI) (M+) Calcd. for C14H11BrO2+: 289.9937, found 
289.9925.
5-bromo-2-((4-(trifluoromethyl)benzyl)oxy)benzaldehyde 
s2-i Yield: 90%. Hexanes/ethyl acetate = 7/1. 1H NMR (500 MHz, CDCl3) δ 10.46 (s, 1H), 
7.96 (d, J = 2.6 Hz, 1H), 7.68 (d, J = 8.1 Hz, 2H), 7.62 (dd, J = 8.8, 2.6 Hz, 1H), 7.55 (d, J
= 8.1 Hz, 2H), 6.92 (d, J = 8.8 Hz, 1H), 5.24 (s, 2H). 13C NMR (100MHz, CDCl3) δ 187.87, 
159.36, 139.52, 138.27, 131.39, 130.68 (q, J = 32.5 Hz, 1C), 127.29, 126.44, 125.78,
123.88 (q, J = 270 Hz, 1C), 114.85, 114.22, 69.91. IR (neat, cm-1): 2915.71, 2874.21, 
1917.19, 1676.46, 1591.57, 1478.27, 1452.63, 1323.06, 1271.37, 1237.57, 1164.37, 
1165.57, 1106.09. HRMS (EI) (M+) Calcd. for C15H10BrF3O2+: 357.9811, found 357.9790.
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2-(benzyloxy)-3-methoxybenzaldehyde s2-j Yield: 98%. 
Hexanes/ethyl acetate = 6/1. 1H NMR (500 MHz, CDCl3)  δ 10.23 (s, 1H), 7.41 – 7.31 (m, 
6H), 7.20 – 7.12 (m, 2H), 5.18 (s, 2H), 3.95 (s, 3H). 13C NMR (125MHz, CDCl3) δ 190.23, 
153.02, 151.02, 136.32, 130.30, 128.65, 128.58, 128.52, 124.24, 119.01, 117.96, 76.33, 
56.08. IR (neat, cm-1): 3008.09, 2967.36, 2877.99, 2840.97, 1688.13, 1594.12, 1583.01, 
1478.28, 1454.55, 1438.21, 1365.78, 1060.52, 964.77, 750.64. HRMS (EI) (M+) Calcd. for 
C15H14O3+: 242.0937, found 242.0923.
3-methoxy-2-((3-methoxybenzyl)oxy)benzaldehyde s2-k
Yield: 97%. Hexanes/ethyl acetate = 4/1. 1H NMR (500 MHz, CDCl3) δ 10.26 (s, 1H), 7.39 
(dd, J = 7.5, 1.7 Hz, 1H), 7.28 (t, J = 7.8 Hz, 1H), 7.20 – 7.12 (m, 2H), 6.98 – 6.93 (m, 
2H), 6.88 (dd, J = 8.2, 2.4 Hz, 1H), 5.15 (s, 2H), 3.95 (s, 3H), 3.80 (s, 3H). 13C NMR 
(125MHz, CDCl3) δ 190.38, 159.73, 152.99, 151.04, 137.86, 130.29, 129.63, 124.25, 
120.77, 119.05, 117.97, 114.03, 113.99, 76.20, 56.09, 55.24. IR (neat, cm-1): 2939.71, 
2837.80, 1687.60, 1583.83, 1480.01, 1454.92, 1438.43, 1366.78, 1262.21, 1247.37,
781.63, 751.27. HRMS (EI) (M+) Calcd. for C16H16O4+: 272.1043, found 272.1044.
5-methoxy-2-((4-methoxybenzyl)oxy)benzaldehyde s2-
l15 Yield: 96%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 10.46 (s, 1H), 
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7.35 – 7.33 (m, 3H), 7.11 (dd, J = 9.0, 3.2 Hz, 1H), 7.02 (d, J = 9.1 Hz, 1H), 6.92 (d, J =
8.6 Hz, 2H), 5.08 (s, 2H), 3.82 (s, 3H), 3.80 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 159.64, 
155.93, 153.85, 129.16, 128.25, 125.62, 123.48, 115.36, 114.09, 110.16, 71.29, 55.80, 
55.30. IR (neat, cm-1): 2961.70, 2953.04, 2878.94, 1669.67, 1611.23, 1514.99, 1490.37, 
1279.57, 1212.22, 1027.74, 993.12, 880.06, 704.72.
2-(pyridin-2-ylmethoxy)benzaldehyde s2-m Yield: 90%. 
Hexanes/ethyl acetate = 4/1. 1H NMR (500 MHz, CDCl3) δ 10.61 (s, 1H), 8.61 (d, J = 4.8 
Hz, 1H), 7.86 (dd, J = 7.7, 1.8 Hz, 1H), 7.75 (td, J = 7.7, 1.7 Hz, 1H), 7.62 – 7.43 (m, 2H), 
7.26 (t, J = 7.3 Hz, 1H), 7.10 – 6.94 (m, 2H), 5.32 (s, 2H). 13C NMR (125MHz, CDCl3) δ 
189.51, 160.53, 156.27, 149.33, 137.00, 135.97, 128.80, 125.07, 122.92, 121.21, 112.96, 
71.02. IR (neat, cm-1): 3073.94, 2865.91, 2761.70, 1683.67, 1583.43, 1600.44, 1486.54, 
1434.36, 1282.46, 1194.79, 1171.88, 995.03, 850.81, 838.70, 750.54. HRMS (EI) (M+)
Calcd. for C13H11NO2+: 213.0784, found 213.0777.
2-(thiophen-3-ylmethoxy)benzaldehyde s2-n Yield: 90%. 
Hexanes/ethyl acetate = 5/1. 1H NMR (500 MHz, CDCl3) δ 10.53 (s, 1H), 7.86 (dd, J =
7.8, 1.8 Hz, 1H), 7.56 – 7.52 (m, 1H), 7.38 – 7.34 (m, 2H), 7.16 (dd, J = 4.9, 1.1 Hz, 1H), 
7.07 – 7.03 (m, 2H), 5.21 (s, 2H). 13C NMR (125MHz, CDCl3) δ 189.63, 160.91, 136.98, 
135.82, 128.50, 126.69, 126.61, 125.25, 123.26, 121.08, 112.98, 66.29. IR (neat, cm-1): 
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2918.48, 2849.49, 1686.70, 1598.53, 1482.60, 1457.32, 1286.20, 1239.14, 761.63. HRMS 
(EI) (M+) Calcd. for C12H11O2S+: 219.0474, found 219.0477.
2-(benzo[b]thiophen-3-ylmethoxy)benzaldehyde s2-o Yield: 
97%. Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 10.49 (s, 1H), 7.91 – 7.85 
(m, 3H), 7.59 – 7.57 (m, 1H), 7.53 (s, 1H), 7.44 – 7.39 (m, 2H), 7.16 (d, J = 8.4 Hz, 1H), 
7.07 (t, J = 7.5 Hz, 1H), 5.43 (s, 2H). 13C NMR (150MHz, CDCl3) δ 189.54, 160.84, 
140.59, 137.56, 135.84, 130.84, 128.58, 125.59, 125.33, 124.80, 124.51, 122.97, 121.73, 
121.22, 112.92, 65.36. IR (neat, cm-1): 2842.73, 2754.12, 1676.36, 1598.85, 1307.10, 
1244.51, 1053.45, 1010.87, 839.86, 779.96, 746.58. HRMS (EI) (M+) Calcd. for 
C16H13O2S+: 269.0631, found 269.0629.
2.4.5 The Synthetic Procedure for Triisopropyl Sulfonylhydrazone Derivatives 1
To a stirred solution of pure 2,4,6-triisopropylbenzenesulfonohydrazide 
(TrisNHNH2, 2 mmol) in THF (10.0 mL) at 0 oC, aldehyde s2 (1 equiv.) was added 
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dropwise (or portionwise if solid). The reaction was monitored by TLC. After the reaction 
was completed, the solvent was removed directly under reduced pressure, and the crude 
solid was further purified by flash column chromatography.
N'-(2-(benzyloxy)benzylidene)-2,4,6-triisopropylbenzene-
sulfonohydrazide 1-a Yield: 80%. Hexanes/ethyl acetate = 6/1. 1H NMR (500 MHz, 
CDCl3) δ  8.21 (s, 1H), 7.81 (dd, J = 8.0, 1.6 Hz, 1H), 7.41 – 7.32 (m, 4H), 7.29 (td, J =
8.2, 1.7 Hz, 1H), 7.17 (s, 2H), 6.92 (dd, J = 7.7, 6.4 Hz, 2H), 5.06 (s, 2H), 4.27 (hept, J =
6.7 Hz, 2H), 2.90 (hept, J = 6.8 Hz, 1H), 1.30 (d, J = 6.8 Hz, 12H), 1.25 (d, J = 6.9 Hz, 
6H). 13C NMR (125MHz, CDCl3) δ 156.95, 153.27, 151.31, 142.36, 136.38, 131.43, 
131.40, 128.63, 128.15, 127.40, 126.57, 123.80, 122.17, 120.97, 112.44, 70.37, 34.15, 
30.03, 24.85, 23.52. IR (neat, cm-1): 3146.18, 2958.54, 1597.71, 1451. 12, 1425.95, 
1293.54, 1259.37, 1153.52, 748.34, 544.27. HRMS (ESI) (M+H+) Calcd. for 
C29H37N2O3S+: 493.2519, found 493.2502.
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2,4,6-triisopropyl-N'-(2-((3-methoxybenzyl)oxy)benzylidene) 
benzenesulfonohydrazide 1-b Yield: 85%. Hexanes/ethyl acetate = 5/1. 1H NMR (500 
MHz, CDCl3) δ 8.21 (s, 1H), 7.80 (dd, J = 7.9, 1.5 Hz, 1H), 7.78 (s, 1H), 7.33 – 7.26 (m, 
2H), 7.17 (s, 2H), 6.97 – 6.86 (m, 5H), 5.03 (s, 2H), 4.26 (hept, J = 6.7 Hz, 2H), 3.81 (s, 
3H), 2.89 (hept, J = 6.9 Hz, 1H), 1.30 (d, J = 6.8 Hz, 13H), 1.25 (d, J = 6.9 Hz, 6H). 13C
NMR (125MHz, CDCl3) δ 159.81, 156.91, 153.27, 151.32, 142.27, 137.97, 131.43, 
131.41, 129.73, 126.57, 123.80, 122.15, 120.99, 119.58, 113.41, 113.09, 112.31, 70.28, 
55.24, 34.15, 30.04, 24.86, 23.52. IR (neat, cm-1): 3192.99, 2958.12, 1598.12, 1450.63, 
1427.93, 1316.48, 1247.70, 1147.74, 1036.04, 955.99, 848.71, 749.04, 669.94, 554.45. 
HRMS (ESI) (M+H+) Calcd. for C30H39N2O4S+: 523.2625, found 523.2645.
2,4,6-triisopropyl-N'-(2-((2-methylbenzyl)oxy)benzylidene)-
benzenesulfonohydrazide 1-c Yield: 88%. Hexanes/ethyl acetate = 6/1. 1H NMR (600 
MHz, CDCl3) δ 8.16 (s, 1H), 7.81 (dd, J = 7.7, 1.1 Hz, 1H), 7.74 (s, 1H), 7.34 – 7.27 (m, 
3H), 7.24 – 7.20 (m, 2H), 7.17 (s, 2H), 6.96 (d, J = 8.3 Hz, 1H), 6.93 (t, J = 7.5 Hz, 1H), 
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5.03 (s, 2H), 4.26 (hept, J = 6.7 Hz, 2H), 2.89 (hept, J = 6.9 Hz, 1H), 2.33 (s, 3H), 1.29 (d, 
J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 157.08, 153.28, 
151.32, 142.24, 136.69, 134.25, 131.47, 131.41, 130.50, 128.69, 128.54, 126.63, 126.10, 
123.80, 122.13, 120.99, 112.15, 68.98, 34.16, 30.03, 24.86, 23.52, 18.87. IR (neat, cm-1):
3185.38, 2960.41, 2926.86, 1598.05, 1450.78, 1319.23, 1250.20, 1150.49, 751.55, 666.68. 
HRMS (ESI) (M+H+) Calcd. for C30H39N2O3S+: 507.2676, found 507.2664.
N'-(2-((3,4-dichlorobenzyl)oxy)benzylidene)-2,4,6-triisopropyl-
benzenesulfonohydrazide 1-d Yield: 82%. Hexanes/ethyl acetate = 6/1. 1H NMR (500 
MHz, CDCl3) δ δ 8.17 (s, 1H), 7.82 (br, 1H), 7.81 (dd, J = 7.8, 1.5 Hz, 1H), 7.46 (d, J =
8.2 Hz, 2H), 7.31 – 7.22 (m, 1H), 7.21 (dd, J = 8.2, 1.8 Hz, 1H), 7.17 (s, 2H), 6.94 (t, J =
7.6 Hz, 1H), 6.85 (d, J = 8.3 Hz, 1H), 5.01 (s, 2H), 4.26 (hept, J = 6.8 Hz, 2H), 2.89 (hept, 
J = 6.9 Hz, 1H), 1.30 (d, J = 6.8 Hz, 12H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (100 MHz, 
CDCl3) δ 156.52, 153.39, 151.35, 142.05, 140.44, 131.47, 131.34, 130.50, 130.18, 127.30, 
126.79, 125.62, 123.85, 122.27, 121.34, 112.15, 69.45, 34.16, 30.06, 24.84, 23.50. IR (neat, 
cm-1): 3194.76, 2960.03, 1598.92, 1449.73, 1323.92, 1247.77, 1149.75, 1057.72, 957.72, 
749.98, 657.53, 538.48. HRMS (ESI) (M+H+) Calcd. for C29H35Cl2N2O3S+: 561.1740, 
found 561.1748.
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N'-(2-((4-fluorobenzyl)oxy)benzylidene)-2,4,6-triisopropyl-
benzenesulfonohydrazide 1-e Yield: 85%. Hexanes/ethyl acetate = 6/1. 1H NMR (500 
MHz, CDCl3) δ 8.18 (s, 1H), 7.82 (s, 1H), 7.80 (dd, J = 7.8, 1.6 Hz, 1H), 7.34 (dd, J = 8.5, 
5.4 Hz, 1H), 7.32 – 7.27 (m, 1H), 7.17 (s, 2H), 7.06 (t, J = 8.6 Hz, 2H), 6.94-6.89 (m, 1H), 
5.02 (s, 1H), 4.26 (hept, J = 6.8 Hz, 2H), 2.89 (hept, J = 6.8 Hz, 1H), 1.29 (d, J = 6.8 Hz, 
12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (100 MHz, cdcl3) δ 162.55 (d, J = 246.9 Hz), 
156.75, 153.30, 151.29, 142.21, 132.09 (d, J = 2.7 Hz), 131.43, 131.33, 129.28 (d, J = 8.2 
Hz), 129.24, 126.66, 123.79, 122.14, 121.10, 115.58 (d, J = 21.6 Hz), 112.21, 77.27, 76.95, 
76.63, 69.72, 34.13, 30.01, 24.81, 23.48. IR (neat, cm-1): 3145.65, 2961.27, 1599.14, 
1511.73, 1258.98, 1223.20, 1153.55, 1032.21, 927.12, 747.91, 532.61. HRMS (ESI) 
(M+H+) Calcd. for C29H36FN2O3S+: 511.2425, found 511.2428.
2,4,6-triisopropyl-N'-(2-((4-(trifluoromethyl)benzyl)oxy)-
benzylidene)benzenesulfonohydrazide 1-f Yield: 85%. Hexanes/ethyl acetate = 6/1. 1H
NMR (400 MHz, CDCl3) δ 8.25 (s, 1H), 8.07 (s, 1H), 7.82 (dd, J = 7.8, 1.7 Hz, 1H), 7.63 
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(d, J = 8.1 Hz, 2H), 7.50 (d, J = 8.0 Hz, 2H), 7.29 (ddd, J = 8.3, 7.4, 1.8 Hz, 1H), 6.94 (t, 
J = 7.6 Hz, 1H), 6.88 (d, J = 8.4 Hz, 1H), 5.13 (s, 2H), 4.29 (hept, J = 6.7 Hz, 2H), 2.93 
(hept, J = 6.8 Hz, 1H), 1.30 (d, J = 6.8 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR 
(100MHz, CDCl3) δ 156.52, 153.39, 151.35, 142.05, 140.44, 131.47, 131.34, 130.50, 
130.18, 127.30, 126.79, 125.62, 123.85, 122.27, 121.34, 112.15, 69.45, 34.16, 30.06, 
24.84, 23.50. IR (neat, cm-1): 3204.84, 2963.91, 1600.01, 1452.06, 1324.04, 1256.33, 
1152.94, 1116.15, 1066.06, 822.65, 749.70, 651.71, 532.26. HRMS (ESI) (M+H+) Calcd. 
for C30H35F3N2O3S+: 561.2393, found 561.2397.
2,4,6-triisopropyl-N'-(2-(naphthalen-2-ylmethoxy)benzyl-
idene)benzenesulfonohydrazide 1-g Yield: 80%. Hexanes/ethyl acetate = 5/1. 1H NMR 
(600 MHz, CDCl3) δ 8.25 (s, 1H), 7.87 – 7.82 (m, 6H), 7.52 – 7.47 (m, 3H), 7.31 – 7.28 
(m, 1H), 7.18 (s, 2H), 6.97 (d, J = 8.3 Hz, 1H), 6.92 (t, J = 7.6 Hz, 1H), 5.22 (s, 2H), 4.27 
(hept, J = 6.7 Hz, 2H), 2.90 (hept, J = 6.9 Hz, 1H), 1.30 (d, J = 6.7 Hz, 12H), 1.25 (d, J =
6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 157.02, 153.30, 151.34, 142.34, 133.83, 
133.22, 133.12, 131.48, 131.43, 128.56, 127.92, 127.77, 126.64, 126.48, 126.42, 126.29, 
125.16, 123.82, 122.21, 121.05, 112.39, 70.63, 34.17, 30.06, 24.87, 23.53. IR (neat, cm-1): 
3192.11, 2959.75, 2862.08, 1597.50, 1448.89, 1321.80, 1254.22, 1164.14, 1051.95, 
943.36, 808.77, 737.37, 664.50. HRMS (ESI) (M+H+) Calcd. for C33H39N2O3S+: 543.2676, 
found 543.2673.
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N'-(2-(benzyloxy)-5-bromobenzylidene)-2,4,6-triisopropyl-
benzenesulfonohydrazide 1-h Yield: 88%. Hexanes/ethyl acetate = 6/1. 1H NMR (500 
MHz, CDCl3) δ 8.09 (s, 1H), 7.91 (d, J = 2.3 Hz, 1H), 7.84 (s, 1H), 7.47 – 7.34 (m, 6H), 
7.19 (s, 2H), 6.79 (d, J = 8.8 Hz, 1H), 5.04 (s, 2H), 4.24 (hept, J = 6.5 Hz, 2H), 2.90 (hept, 
J = 6.8 Hz, 1H), 1.31 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (125MHz, 
CDCl3) δ 155.78, 153.49, 151.48, 140.47, 135.88, 133.70, 131.21, 129.08, 128.70, 128.33, 
127.40, 124.08, 123.89, 114.20, 113.70, 70.70, 34.17, 30.13, 24.89, 23.52. IR (neat, cm-1): 
3182.03, 2958.50, 1597.26, 1450.14, 1267.84, 1254.29, 1149.70, 750.46, 542.35. HRMS 
(ESI) (M+H+) Calcd. for C29H36BrN2O3S+: 571.1625, found 571.1623.
N'-(5-bromo-2-((4-(trifluoromethyl)benzyl)oxy)benzyl-
idene)-2,4,6-triisopropylbenzenesulfonohydrazide 1-i Yield: 82%. Hexanes/ethyl 
acetate = 5/1. 1H NMR (400 MHz, CDCl3) δ 8.10 (s, 1H), 7.93 (d, J = 2.5 Hz, 1H), 7.88 
(br, 1H), 7.65 (d, J = 8.1 Hz, 2H), 7.48 (d, J = 8.1 Hz, 2H), 7.37 (dd, J = 8.8, 2.6 Hz, 1H), 
7.19 (s, 2H), 6.75 (d, J = 8.9 Hz, 1H), 5.11 (s, 2H), 4.25 (hept, J = 6.8 Hz, 2H), 2.91 (hept, 
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J = 6.9 Hz, 1H), 1.31 (d, J = 6.8 Hz, 12H), 1.26 (d, J = 6.9 Hz, 6H).13C NMR (100MHz, 
CDCl3) δ 155.38, 153.60, 151.50, 140.09, 139.87, 133.81, 131.15, 129.37, 127.44, 125.74, 
124.08, 123.94, 114.14, 113.95, 77.32, 77.00, 76.68, 69.83, 34.20, 30.16, 24.90, 23.53. IR 
(neat, cm-1): 3137.24, 2969.07, 1596.83, 1425.26, 1325.83, 1255.19, 1154.23, 1121.32,
1067.12, 943.74, 537.75. HRMS (ESI) (M+H+) Calcd. for C30H35BrF3N2O3S+: 639.1498, 
found 639.1495.
N'-(2-(benzyloxy)-3-methoxybenzylidene)-2,4,6-triisopropyl-
benzenesulfonohydrazide 1-j Yield: 80%. Hexanes/ethyl acetate = 5/1. 1H NMR (400 
MHz, CDCl3) δ 7.87 (s, 1H), 7.65 (br, 1H), 7.36 – 7.33 (m, 6H), 7.16 (s, 2H), 7.00 (t, J =
8.0 Hz, 1H), 6.92 (dd, J = 8.2, 1.5 Hz, 1H), 4.99 (s, 2H), 4.28 – 4.17 (m, 2H), 3.88 (s, 3H), 
2.95 – 2.83 (m, 1H), 1.28 (d, J = 6.8 Hz, 12H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (125 
MHz, CDCl3) δ 153.32, 152.65, 151.30, 146.93, 142.37, 136.84, 131.33, 128.51, 128.45, 
128.35, 127.51, 124.09, 123.80, 117.92, 113.72, 75.83, 55.83, 34.16, 30.00, 24.85, 23.52.
IR (neat, cm-1): 3187.41, 2958.91, 1598.65, 1437.65, 1321.66, 1272.55, 1164.80, 1153.97, 
729.03, 578.67. HRMS (ESI) (M+H+) Calcd. for C30H39N2O4S+: 523.2625, found
523.2615.
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2,4,6-triisopropyl-N'-(3-methoxy-2-((3-methoxybenzyl)oxy) 
benzylidene)benzenesulfonohydrazide 1-k Yield: 85%. Hexanes/ethyl acetate = 5/1. 1H
NMR (500 MHz, CDCl3) δ 7.91 (s, 1H), 7.64 (s, 1H), 7.35 (dd, J = 7.9, 1.5 Hz, 1H), 7.28 
(t, J = 8.0 Hz, 1H), 7.16 (s, 2H), 7.00 (t, J = 8.0 Hz, 1H), 6.97 – 6.90 (m, 3H), 6.87 (ddd, J
= 8.3, 2.5, 1.0 Hz, 1H), 4.96 (s, 2H), 4.25 (hept, J = 6.8 Hz, 2H), 3.87 (s, 3H), 3.81 (s, 3H), 
2.90 (hept, J = 6.9 Hz, 1H), 1.28 (d, J = 6.8 Hz, 12H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR 
(100MHz, CDCl3) δ 159.88, 153.33, 152.64, 151.32, 147.00, 142.40, 138.44, 131.36, 
129.58, 127.51, 124.29, 123.81, 120.52, 117.97, 113.98, 113.77, 113.71, 75.72, 55.86, 
55.26, 34.17, 30.02, 24.86, 23.52. IR (neat, cm-1): 3126.64, 2968.93, 1597.92, 1572.65, 
1462.20, 1427.24, 1317.69, 1272.68, 1257.67, 1163.71, 1153.02, 1040.17, 1021.88, 
895.79, 785.66, 544.47. HRMS (ESI) (M+H+) Calcd. for C31H41N2O5S+: 553.2731, found 
553.2724.
2,4,6-triisopropyl-N'-(5-methoxy-2-((4-methoxy-
benzyl)oxy)benzylidene)benzenesulfonohydrazide 1-l Yield: 87%. Hexanes/ethyl 
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acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 8.13 (s, 1H), 7.84 (s, 1H), 7.30 – 7.26 (m, 3H), 
7.18 (s, 2H), 6.90 (d, J = 8.5 Hz, 2H), 6.86 (s, 2H), 4.92 (s, 2H), 4.27 (hept, J = 6.7 Hz, 
2H), 3.82 (s, 3H), 3.72 (s, 3H), 2.90 (hept, J = 6.9 Hz, 1H), 1.30 (d, J = 6.7 Hz, 12H), 1.25 
(d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 159.57, 153.82, 153.33, 151.65, 151.24, 
142.37, 131.32, 129.24, 128.60, 123.81, 122.85, 118.59, 114.52, 114.02, 109.51, 71.25, 
55.68, 55.29, 34.16, 29.97, 24.87, 23.51. IR (neat, cm-1): 3178.36, 2956.81, 1491.59, 
1511.53, 1319.37, 1245.12, 1033.26, 910.09, 550.63. HRMS (ESI) (M+H+) Calcd. for 
C31H41N2O5S+: 553.2731, found 553.2731.
2,4,6-triisopropyl-N'-(2-(pyridin-2-ylmethoxy)benzylidene)-
benzenesulfonohydrazide 1-m Yield: 80%. Hexanes/ethyl acetate = 4/1. 1H NMR (500 
MHz, DMSO-d6) δ 11.69 (s, 1H), 8.58 (d, J = 4.7 Hz, 1H), 8.43 (s, 1H), 7.84 (t, J = 7.7 Hz, 
1H), 7.61 (d, J = 7.7 Hz, 1H), 7.54 (d, J = 7.8 Hz, 1H), 7.39 – 7.29 (m, 2H), 7.23 (s, 2H), 
7.13 (d, J = 8.4 Hz, 1H), 6.94 (t, J = 7.5 Hz, 1H), 5.22 (s, 2H), 4.25 (hept, J = 6.7 Hz, 2H), 
2.89 (hept, J = 6.8 Hz, 1H), 1.21 (d, J = 6.8 Hz, 12H), 1.18 (d, J = 6.9 Hz, 6H). 13C NMR 
(125 MHz, DMSO-d6) δ 156.86, 156.66, 153.10, 150.86, 149.58, 141.13, 137.46, 133.02, 
131.80, 125.47, 124.05, 123.49, 122.71, 121.86, 121.46, 113.64, 70.99, 33.82, 29.67, 
25.18, 23.85. IR (neat, cm-1): 3024.22, 2998.62, 1603.03, 1496.39, 1157.29, 1048.03, 
931.01, 797.21, 696.10. HRMS (ESI) (M+H+) Calcd. for C28H36N3O3S+: 494.2472, found 
494.2462.
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2,4,6-triisopropyl-N'-(2-(thiophen-3-ylmethoxy)benzylidene)-
benzenesulfonohydrazide 1-n Yield: 90%. Hexanes/ethyl acetate = 4/1. 1H NMR (600 
MHz, CDCl3) δ 8.18 (s, 1H), 7.88 (br, 1H), 7.80 (d, J = 9.0 Hz, 1H), 7.33 – 7.27 (m, 3H), 
7.18 (s, 2H), 7.09 (d, J = 4.8 Hz, 1H), 6.93 – 6.91 (m, 2H), 5.07 (s, 2H), 4.29 – 4.25 (m, 
2H), 2.93 – 2.86 (m, 1H), 1.30 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR 
(150 MHz, CDCl3) δ 156.87, 153.29, 151.34, 142.36, 137.33, 131.43, 126.88, 126.62, 
126.48, 123.81, 123.26, 122.28, 121.09, 112.37, 66.10, 34.16, 30.05, 24.86, 23.52. IR (neat, 
cm-1): 3145.26, 2958.52, 2865.78, 1598.66, 1458.52, 1426.76, 1258.19, 1153.46, 774.63. 
HRMS (ESI) (M+H+) Calcd. for C27H35N2O3S2+: 499.2084, found 499.2072.
N'-(2-(benzo[b]thiophen-3-ylmethoxy)benzylidene)-2,4,6-
triisopropylbenzenesulfonohydrazide 1-o Yield: 93%. Hexanes/ethyl acetate = 4/1. 1H
NMR (600 MHz, CDCl3) δ 8.11 (s, 1H), 7.90 – 7.77 (m, 4H), 7.45 (s, 1H), 7.40 – 7.37 (m, 
2H), 7.35 – 7.32 (m, 1H), 7.17 (s, 2H), 7.03 (d, J = 8.3 Hz, 1H), 6.95 (t, J = 7.6 Hz, 1H), 
5.29 (s, 2H), 4.24 (hept, J = 6.7 Hz, 2H), 2.90 (hept, J = 6.8 Hz, 1H), 1.28 (d, J = 6.8 Hz, 
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12H), 1.26 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 156.87, 153.29, 151.34, 
142.36, 137.33, 131.43, 126.88, 126.62, 126.48, 123.81, 123.26, 122.28, 121.09, 112.37, 
66.10, 34.16, 30.05, 24.86, 23.52. IR (neat, cm-1): 3203.90, 3139.50, 2956.61, 2867.26, 
1601.39, 1455.55, 1252.70, 1149.64, 786.69. HRMS (ESI) (M+H+) Calcd. for 
C31H37N2O3S2+: 549.2240, found 549.2245.
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2.4.6 General Procedure for [Co(P6)]-Catalyzed Enantioselective Radical C–H
Alkylation
An oven-dried Schlenk tube was charged with sulfonyl hydrazone 1 (0.1 mmol), 
[Co(P3)] (2 mol %) and Cs2CO3 (0.2 mmol). The Schlenk tube was then evacuated and 
back filled with nitrogen for 3 times. The Teflon screw cap was replaced with a rubber 
septum, methanol (1.0 mL) was added via a gastight syringe. The Schlenk tube was then 
purged with nitrogen for 30 s and the rubber septum was replaced with a Teflon screw cap. 
The mixture was then stirred at RT. After 24 h, the reaction mixture was filtrated through 
a short pad of silica gel, concentrated under vacuum and purified by flash column 
chromatography. The fractions containing product were collected and concentrated under 
vacuum to afford the desired compound 2.
(S)-2-phenyl-2,3-dihydrobenzofuran 2a16 Yield: 77%. 92:8 er.
Hexanes/ethyl acetate = 10/1, Rf = 0.70. 1H NMR (500 MHz, CDCl3) δ 7.44 – 7.40 (m, 
2H), 7.40 – 7.35 (m, 2H), 7.35 – 7.29 (m, 1H), 7.23 – 7.13 (m, 2H), 6.95 – 6.82 (m, 2H), 
5.77 (t, J = 8.9 Hz, 1H), 3.64 (dd, J = 15.6, 9.5 Hz, 1H), 3.23 (dd, J = 15.6, 8.2 Hz, 1H). 
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13C NMR (125MHz, CDCl3) δ 153.24, 142.38, 129.36, 128.55, 127.66, 127.56, 127.33, 
123.97, 118.13, 107.19, 72.18, 39.47, 34.26. HPLC analysis: ADH (100% hexanes, 0.8 
mL/min): tmajor = 17.68 min, tminor = 22.33 min. [α]20 D =-56.14 (c=0.5, CHCl3).
(S)-2-(3-methoxyphenyl)-2,3-dihydrobenzofuran 2b Yield: 
80%. 95.4:4.5 er. Hexanes/ethyl acetate = 8/1, Rf = 0.65. 1H NMR (500 MHz, CDCl3) δ 
7.29 (t, J = 7.9 Hz, 1H), 7.24 – 7.10 (m, 2H), 7.01 – 6.93 (m, 2H), 6.93 – 6.79 (m, 3H), 
5.74 (t, J = 8.8 Hz, 1H), 3.81 (s, 3H), 3.63 (dd, J = 15.6, 9.5 Hz, 1H), 3.22 (dd, J = 15.6, 
8.2 Hz, 1H). 13C NMR (125MHz, CDCl3) δ 159.82, 159.56, 143.58, 129.71, 128.17, 
126.42, 124.83, 120.65, 118.00, 113.44, 111.24, 109.37, 83.86, 55.25, 38.40. HPLC 
analysis: ADH (99% hexanes, 1.0 mL/min): tmajor = 13.46 min, tminor = 17.40 min. [α]20 D
=-59.02 (c=0.5, CHCl3) HRMS (EI) (M+) Calcd. for C15H14O2+: 226.0988, found
226.0981.
(S)-2-(o-tolyl)-2,3-dihydrobenzofuran 2c16 Yield: 78%. 90:10 er.
Hexanes/ethyl acetate = 10/1, Rf = 0.67. 1H NMR (600 MHz, CDCl3) δ 7.47 – 7.46 (m, 
1H), 7.23 – 7.17 (m, 5H), 6.92 – 6.88 (m, 2H), 6.00 – 5.93 (m, 1H), 3.67 (dd, J = 15.5, 9.6 
Hz, 1H), 3.10 (dd, J = 15.5, 8.2 Hz, 1H), 2.38 (s, 3H). 13C NMR (150 MHz, CDCl3) δ
159.69, 140.23, 134.18, 130.49, 128.19, 127.60, 126.31, 126.25, 124.95, 124.92, 120.62, 
109.37, 81.52, 37.44, 19.22. HPLC analysis: IA (99.8% hexanes, 0.8 mL/min): tmajor =
11.58 min, tminor = 10.19 min. [α]20 D = -56.14 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for 
C15H14O+: 210.1039, found 210.1042.
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(S)-2-(3,4-dichlorophenyl)-2,3-dihydrobenzofuran 2d Yield: 
80%. 90:10 er. Hexanes/ethyl acetate = 9/1, Rf = 0.68. 1H NMR (500 MHz, CDCl3) δ 7.50 
(d, J = 2.0 Hz, 1H), 7.44 (d, J = 8.3 Hz, 1H), 7.23 (dd, J = 8.3, 1.9 Hz, 1H), 7.18 (t, J = 6.9 
Hz, 2H), 6.97 – 6.82 (m, 2H), 5.71 (dd, J = 9.4, 8.1 Hz, 1H), 3.65 (dd, J = 15.6, 9.6 Hz, 
1H), 3.15 (dd, J = 15.6, 7.9 Hz, 1H). 13C NMR (125MHz, CDCl3) δ 159.20, 142.37, 132.74, 
131.85, 130.63, 128.41, 127.71, 125.69, 124.99, 124.92, 121.05, 109.48, 82.38, 38.37.
HPLC analysis: OJH (99% hexanes, 1.0 mL/min): tmajor = 24.31 min, tminor =22.28 min. 
[α]20 D = -71.66 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C14H10Cl2O+: 264.0103, found
264.0094.
(S)-2-(4-fluorophenyl)-2,3-dihydrobenzofuran 2e16 Yield: 70%. 
90:10 er. Hexanes/ethyl acetate = 10/1, Rf = 0.70. 1H NMR (500 MHz, CDCl3) δ 7.42 –
7.35 (m, 2H), 7.23 – 7.13 (m, 2H), 7.11 – 7.01 (m, 2H), 6.90 (td, J = 7.5, 0.9 Hz, 1H), 6.87 
(d, J = 8.0 Hz, 1H), 5.77 – 5.70 (m, 1H), 3.63 (dd, J = 15.6, 9.4 Hz, 1H), 3.19 (dd, J = 15.6, 
8.2 Hz, 1H). 13C NMR (125MHz, CDCl3) δ 163.43, 161.47, 159.40, 137.73, 137.71, 
128.27, 127.58, 127.52, 126.24, 124.85, 120.77, 115.58, 115.41, 109.37, 83.37, 38.43.
HPLC analysis: ODH (100% hexanes, 0.8 mL/min): tmajor = 29.86 min, tminor = 34.90 min. 
[α]20 D = -41.40 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C14H11FO+: 214.0788, found
214.0776.
(S)-2-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzofuran 
2f16 Yield: 70%. 90:10 er. Hexanes/ethyl acetate = 10/1, Rf = 0.70. 1H NMR (500 MHz, 
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CDCl3) δ 7.63 (d, J = 8.1 Hz, 2H), 7.52 (d, J = 8.1 Hz, 2H), 7.25 – 7.13 (m, 2H), 7.00 –
6.84 (m, 2H), 5.81 (t, J = 8.8 Hz, 1H), 3.70 (dd, J = 15.6, 9.6 Hz, 1H), 3.17 (dd, J = 15.6, 
7.9 Hz, 1H). 13C NMR (125MHz, CDCl3) δ 159.38, 146.14, 128.41, 125.92, 125.82, 
125.68, 125.65, 125.62, 125.58, 124.95, 121.03, 109.48, 82.99, 38.48. HPLC analysis: 
ODH (99% hexanes, 1 mL/min): tmajor = 21.09 min, tminor = 11.82 min. [α]20 D = -86.52 
(c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C15H11F3O+: 264.0757, found 264.0748.
(S)-2-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzofuran 2g
Yield: 70%. 90:10 er. Hexanes/ethyl acetate = 10/1, Rf = 0.70. 1H NMR (600 MHz, CDCl3)
δ 7.88 – 7.84 (m, 4H), 7.53 – 7.48 (m, 3H), 7.22 (dd, J = 13.2, 7.3 Hz, 2H), 6.93 (dd, J =
15.2, 7.7 Hz, 2H), 5.94 (t, J = 8.9 Hz, 1H), 3.71 (dd, J = 15.6, 9.5 Hz, 1H), 3.31 (dd, J =
15.6, 8.2 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 159.68, 139.22, 133.18, 133.10, 128.65, 
128.24, 128.01, 127.69, 126.45, 126.27, 126.05, 124.89, 124.68, 123.57, 120.70, 109.42, 
84.01, 38.41. HPLC analysis: IB (99.5% hexanes, 0.8 mL/min): tmajor = 20.94 min, tminor =
22.76 min. [α]20 D = -56.82 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C18H14O+:
246.1039, found 246.1042.
(S)-5-bromo-2-phenyl-2,3-dihydrobenzofuran 2h Yield: 82%. 
93:7 er. Hexanes/ethyl acetate = 9/1, Rf = 0.70. 1H NMR (500 MHz, CDCl3) δ 7.38 (d, J =
4.4 Hz, 4H), 7.36 – 7.31 (m, 1H), 7.31 – 7.24 (m, 2H), 6.75 (d, J = 8.4 Hz, 1H), 5.78 (dd, 
J = 9.3, 8.2 Hz, 1H), 3.63 (dd, J = 15.9, 9.5 Hz, 1H), 3.21 (dd, J = 15.9, 8.1 Hz, 1H). 13C
NMR (125 MHz, CDCl3) δ 158.78, 141.33, 130.96, 128.97, 128.70, 128.22, 127.79,
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125.68, 112.37, 110.86, 84.70, 38.15. HPLC analysis: ADH (99% hexanes, 1.0 mL/min):
tmajor = 13.78 min, tminor = 10.80 min. [α]20 D = 26.70 (c=0.5, CHCl3). HRMS (EI) (M+)
Calcd. for C14H11BrO+: 273.9988, found 273.9978.
(S)-5-bromo-2-(4-(trifluoromethyl)phenyl)-2,3-
dihydrobenzo- furan 2i Yield: 77%. 90:10 er. Hexanes/ethyl acetate = 9/1, Rf = 0.70. 1H
NMR (500 MHz, CDCl3) δ 7.38 (d, J = 4.4 Hz, 4H), 7.36 – 7.31 (m, 1H), 7.31 – 7.24 (m, 
2H), 6.75 (d, J = 8.4 Hz, 1H), 5.78 (dd, J = 9.3, 8.2 Hz, 1H), 3.63 (dd, J = 15.9, 9.5 Hz, 
1H), 3.21 (dd, J = 15.9, 8.1 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 158.57, 145.47, 
131.20, 130.35 (q, J = 32.4 Hz, 1C), 128.33, 127.91, 125.84, 125.72, 125.69, 112.79, 
110.98, 83.56, 38.21. HPLC analysis: OJH (99% hexanes, 1.0 mL/min): tmajor = 65.36 min, 
tminor = 44.72 min. [α]20 D = 4.16 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for 
C15H10BrF3O+: 341.9862, found 341.9853.
(S)-7-methoxy-2-phenyl-2,3-dihydrobenzofuran 2j Yield: 90%. 
94.5:5.5 er. Hexanes/ethyl acetate = 7/1, Rf = 0.60. 1H NMR (500 MHz, CDCl3) δ 7.48 –
7.40 (m, 2H), 7.40 – 7.33 (m, 2H), 7.33 – 7.27 (m, 1H), 6.89 – 6.78 (m, 3H), 5.81 (t, J =
9.0 Hz, 1H), 3.90 (s, 3H), 3.64 (dd, J = 15.5, 9.5 Hz, 1H), 3.26 (dd, J = 15.5, 8.5 Hz, 1H). 
13C NMR (125MHz, CDCl3) δ 147.91, 144.39, 141.61, 128.51, 127.98, 127.64, 125.98, 
121.21, 117.01, 111.38, 84.80, 77.25, 55.98, 38.83. HPLC analysis: ADH (99% hexanes, 
1.0 mL/min): tmajor = 20.64 min, tminor = 16.26 min. [α]20 D = -109.66 (c=0.5, CHCl3) HRMS 
(EI) (M+) Calcd. for C15H14O2+: 226.0988, found 226.0984.
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(S)-7-methoxy-2-(3-methoxyphenyl)-2,3-dihydrobenzofuran 
2k Yield: 89%. 94.5:5.5 er. Hexanes/ethyl acetate = 7/1, Rf = 0.60. 1H NMR (500 MHz, 
CDCl3) δ 7.27 (t, J = 7.5 Hz, 1H), 7.06 – 6.94 (m, 2H), 6.93 – 6.73 (m, 4H), 5.78 (t, J = 9.0 
Hz, 1H), 3.90 (s, 3H), 3.80 (s, 3H), 3.63 (dd, J = 15.5, 9.5 Hz, 1H), 3.26 (dd, J = 15.5, 8.6 
Hz, 1H). 13C NMR (125MHz, CDCl3) δ 159.73, 147.89, 144.40, 143.23, 129.58, 127.61, 
121.23, 118.25, 117.00, 113.47, 111.46, 111.40, 84.66, 55.98, 55.24, 38.83. HPLC 
analysis: OJH (98% hexanes, 1.0 mL/min): tmajor = 55.82 min, tminor = 43.22 min. [α]20 D =
-108.36 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C16H16O3+: 256.1094, found 
256.1102.
(S)-7-methoxy-2-(3-methoxyphenyl)-2,3-
dihydrobenzofuran 2l Yield: 82%. 91:9 er. Hexanes/ethyl acetate = 6/1, Rf = 0.60. 1H
NMR (600 MHz, CDCl3) δ 7.34 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 6.79 (br, 
1H), 6.75 (d, J = 8.6 Hz, 1H), 6.70 (dd, J = 8.6, 2.4 Hz, 1H), 5.69 (t, J = 8.8 Hz, 1H), 3.81 
(s, 3H), 3.77 (s, 3H), 3.55 (dd, J = 15.7, 9.2 Hz, 1H), 3.20 (dd, J = 15.7, 8.4 Hz, 1H). 13C
NMR (150 MHz, CDCl3) δ 159.43, 154.20, 153.70, 133.90, 127.68, 127.26, 113.97, 
112.94, 111.16, 109.14, 84.15, 56.01, 55.29, 38.69. HPLC analysis: IB (99% hexanes, 0.8 
mL/min): tmajor = 26.98 min, tminor = 30.61 min. [α]20 D =-50.180 (c=0.5, CHCl3). HRMS 
(EI) (M+) Calcd. for C16H16O3+: 256.1099, found 256.1102.
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(S)-2-(2,3-dihydrobenzofuran-2-yl)pyridine 2m16 Yield: 88%. 94:6 
er. Hexanes/ethyl acetate = 5/1, Rf = 0.56. 1H NMR (500 MHz, CDCl3) δ 8.60 (d, J = 4.8 
Hz, 1H), 7.68 (td, J = 7.7, 1.7 Hz, 1H), 7.51 (d, J = 7.9 Hz, 1H), 7.25 – 7.12 (m, 3H), 6.92 
(d, J = 8.0 Hz, 1H), 6.89 (t, J = 7.4 Hz, 1H), 5.87 (dd, J = 9.9, 7.0 Hz, 1H), 3.74 (dd, J =
15.8, 9.9 Hz, 1H), 3.39 (dd, J = 15.8, 7.0 Hz, 1H). 13C NMR (125MHz, CDCl3) δ 161.25, 
159.42, 149.31, 136.82, 128.10, 126.11, 125.03, 122.60, 120.89, 119.97, 109.42, 83.87, 
36.74. HPLC analysis: OJH (97% hexanes, 1.0 mL/min): tmajor = 12.17 min, tminor = 22.97 
min. [α]20 D = 139.82 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C13H11NO+: 197.0841, 
found 197.0843.
(S)-2-(thiophen-3-yl)-2,3-dihydrobenzofuran 2n Yield: 82%. 
88.5:11.5 er. Hexanes/ethyl acetate = 6/1, Rf = 0.60. 1H NMR (600 MHz, CDCl3) δ 7.34 –
7.32 (m, 1H), 7.32 (s, 1H), 7.20 (d, J = 7.2 Hz, 1H), 7.16 (t, J = 7.7 Hz, 1H), 7.12 (d, J =
4.8 Hz, 1H), 6.89 (t, J = 7.4 Hz, 1H), 6.85 (d, J = 8.0 Hz, 1H), 5.83 (t, J = 8.6 Hz, 1H), 
3.59 (dd, J = 15.4, 9.3 Hz, 1H), 3.27 (dd, J = 15.4, 7.9 Hz, 1H). 13C NMR (150 MHz, 
CDCl3) δ 159.29, 142.75, 128.18, 126.63, 126.41, 125.51, 124.84, 121.83, 120.62, 109.46, 
80.36, 37.45. HPLC analysis: ID (99.5% hexanes, 0.8 mL/min): tmajor = 15.11 min, tminor =
16.23 min. [α]20 D = 59.18 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C12H10OS+:
202.0447, found 202.0448.
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(S)-2-(benzo[b]thiophen-3-yl)-2,3-dihydrobenzofuran 2o Yield: 
83%. 96:4 er. Hexanes/ethyl acetate = 7/1, Rf = 0.60. 1H NMR (600 MHz, CDCl3) δ 7.88 
– 7.85 (m, 1H), 7.76 – 7.73 (m, 1H), 7.45 (s, 1H), 7.38 – 7.35 (m, 2H), 7.24 – 7.17 (m, 2H), 
6.91 (t, J = 7.0 Hz, 2H), 6.09 (t, J = 8.9 Hz, 1H), 3.68 (dd, J = 15.5, 9.6 Hz, 1H), 3.40 (dd, 
J = 15.5, 8.2 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 159.39, 141.10, 136.82, 136.20, 
128.30, 126.32, 124.98, 124.56, 124.24, 123.08, 123.06, 122.08, 120.78, 109.57, 80.00, 
36.31. HPLC analysis: ee = 92%. ID (99.5% hexanes, 0.8 mL/min): tmajor = 17.62 min, tminor
= 19.92 min. [α]20 D = 69.90 (c=0.5, CHCl3). HRMS (EI) (M+) Calcd. for C13H11NO+:
197.0841, found 197.0843.
2.4.7 General Procedure for TEMPO Trapping Reactions
An oven-dried Schlenk tube was charged with 1.0 equivalent of sulfonyl hydrazone 
1d (0.1 mmol), [Co(P1)] (4 mol %) and Cs2CO3 (0.2 mmol). The Schlenk tube was then 
evacuated and back filled with nitrogen for 3 times. The Teflon screw cap was replaced 
with a rubber septum, TEMPO (2.5 equiv.) was added under nitrogen flow and methanol 
(1.0 mL) was added via a gastight syringe. The Schlenk tube was then purged with nitrogen 
for 10 s and the rubber septum was replaced with a Teflon screw cap. The mixture was 
then stirred at RT. After 24 h, the reaction mixture was filtrated through a short pad of 
silica, concentrated under vacuum and purified by flash column chromatography. The 
fractions containing product were collected and concentrated under vacuum to afford the 
desired compound.
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2,2,6,6-tetramethyl-1-((2-(phenyl((2,2,6,6-tetramethylpiperidin
-1-yl)oxy)methoxy)benzyl)oxy)piperidine 3d Yield: 53%.1H NMR (600 MHz, CDCl3) δ 
7.59 (d, J = 1.6 Hz, 1H), 7.44 (d, J = 7.3 Hz, 1H), 7.37 (d, J = 8.3 Hz, 1H), 7.31 (dd, J =
8.3, 1.7 Hz, 1H), 7.25 (d, J = 8.3 Hz, 1H), 7.17 (t, J = 7.3 Hz, 1H), 6.96 (t, J = 7.4 Hz, 1H), 
6.38 (s, 1H), 4.78 (d, J = 12.1 Hz, 1H), 4.71 (d, J = 12.1 Hz, 1H), 1.64 – 1.56 (m, 4H), 1.49 
– 1.48 (m, 4H), 1.38 – 1.33 (m, 2H), 1.23 – 1.11 (m, 26H). 4.75 (dd, J = 41.1, 12.1 Hz,
2H), 1.64 – 1.56 (m, 4H), 1.49 – 1.48 (m, 4H), 1.38 – 1.33 (m, 2H), 1.23 – 1.11 (m, 
26H).13C NMR (150 MHz, CDCl3) δ 153.47, 138.70, 132.28, 130.11, 128.66, 128.53, 
128.29, 127.61, 125.96, 121.34, 115.72, 105.86, 73.53, 61.07, 59.82, 59.79, 59.76, 40.32, 
39.97, 39.64, 39.62, 33.13, 32.96, 32.86, 32.77, 20.69, 20.47, 20.28, 20.19, 17.05, 17.03.
HRMS (ESI) (M+H+) Calcd. for C32H46Cl2N2O3+: 577.2958, found 577.2963.
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CHAPTER 3                    
ENANTIOSELECTIVE RADICAL PROCESS FOR SYNTHESIS OF CHIRAL 
INDOLINES BY CO(II)-BASED METALLORADICAL ALKYLATION OF 
DIVERSE C(SP3)–H BONDS
3.1 INTRODUCTION
Recent years have witnessed intense research efforts in exploring the unique 
features of radical reactions for organic synthesis.1 Among the diverse types of radical 
reactions, hydrogen atom abstraction (HAA) has been recognized as a general and 
straightforward pathway to activate C(sp3)–H bonds, offering a potentially powerful 
approach for C–C bond formation via direct radical C–H alkylation.2 In addition to the 
prerequisite for controlled generation of the incoming radicals, development of HAA-
based radical C–H alkylation, however, faces formidable challenges associated with 
governing the reactivity and selectivity of the outgoing alkyl radicals for ensuing C–C bond 
formation. In particular, control of enantioselectivity of radical reactions is typically 
difficult, in part due to the lack of general strategies to exert adequate catalyst-substrate 
interaction that is essential for asymmetric induction.1,2e Among recent developments,3
metalloradical catalysis (MRC), which involves the use of metal-centered radicals for 
catalytic generation of metal-stabilized organic radicals while controlling the subsequent 
radical reactions, has emerged as a conceptually new approach for the development of 
stereoselective radical processes.4,5
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Scheme 3.1| Working Proposal for Construction of 2-Substituted Indolines by Radical 
C–H Alkylation via Co(II)-MRC
As stable metalloradicals, Co(II) complexes of D2-symmetric chiral 
amidoporphyrins [Co(D2-Por*)] exhibit the unusual capability of homolytically activating 
diazo compounds as radical precursors to generate α-Co(III)-alkyl radicals (also known as 
Co(III)-carbene radicals), a fundamentally new class of metal-supported organic radicals.6
These Co-stabilized C-centered radicals, which are confined inside the pocket-like 
environment of the chiral porphyrin ligands, can serve as key catalytic intermediates for an 
array of asymmetric radical transformations.7
Recently, the applications of Co(II)-based MRC were further extended to the use 
of in situ generated donor-substituted diazo compounds such as aryldiazomethanes as 
radical precursors.8 It was shown that, upon metalloradical activation, the resulting α-
Co(III)-benzyl radical intermediates underwent radical addition to C=C bonds and 
succeeding radical substitution for stereoselective radical cyclopropanation.8c
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Besides radical addition, we were interested in exploring the potential ability of 
these α-Co(III)-benzyl radicals for HAA that might lead to radical alkylation of C–H bonds. 
Particularly, we were attracted to the case of aryldiazomethane 1’ with ortho-amino 
functionality on the basis of the hypothesis that the corresponding α-Co(III)-benzyl radical 
intermediate A would favor intramolecular HAA from the C–H bonds at the distal 5-
position to form ε-Co(III)-aminoalkyl radical B, where the C-centered radical would be 
considerably stabilized by the lone pair of the adjacent nitrogen (Scheme 3.1). If the 
pendant α-aminoalkyl radical in B could subsequently proceed 5-exo-tet radical cyclization 
at the α-carbon center for C–C bond formation in an asymmetric fashion, it would lead to 
a new catalytic system for enantioselective radical C–H alkylation to construct optically 
active 2-substituted indolines, which exist ubiquitously in both natural and synthetic 
compounds with interesting biological properties (Figure 3.1).9
Figure 3.1| Examples of Natural Products and Biologically Active Compounds 
Containing Indoline Moiety
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Tremendous efforts have been devoted to develop catalytic systems for asymmetric 
synthesis of 2-substituted indolines due to their biological importance.10 Among others,11
existing methods have explored strategies that are based on asymmetric hydrogenation of 
C2=C3 bond,11a,11b asymmetric alkylation at C2 position,11c asymmetric formation of C3–
C3a bond,11d,11e as well as asymmetric formation of N1–C7a11f-h and N1-C2 bonds (Scheme 
3.1).11i However, stereoselective construction of chiral 2-substituted indolines that is based 
on asymmetric formation of C2–C3 bond via C–H alkylation has been much less 
developed.12 This underdevelopment may be attributed to the inherent challenge for 
enantioselective formation of C–C bonds between two sp3-carbon centers. Recently, Wirth 
and coworkers reported asymmetric synthesis of 2,3-disubstituted indolines by Rh2-
catalyzed C–H insertion of donor/acceptor-type diazo compounds in 33%-94% ee.12c To 
the best of our knowledge, there is no previous report on asymmetric construction of 2-
substituted indolines through C2(sp3)–C3(sp3) bond formation via stereoselective C(sp3)–
H alkylation using donor-type diazo compounds. As a new synthetic application of Co(II)-
based MRC, we have developed the first catalytic system for asymmetric synthesis of 2-
substituted indolines via enantioselective radical C–H alkylation of aryldiazomethanes,
which can be generated in situ from readily accessible aryl aldehyde-derived hydrazone 
precursors. Through the design of a new D2-symmetric chiral amidoporphyrin as the 
supporting ligand, the Co(II)-catalyzed radical process can effectively alkylate diverse 
types of C–H bonds at room temperature, offering a streamlined synthesis of optically 
active 2-substituted indoline derivatives. We also describe our detailed mechanistic studies 
that shed light on the stepwise radical pathway of this new catalytic C–H alkylation 
process.
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3.2 RESULTS AND DISCUSSION
3.2.1 Condition Optimization of Co(II)-Based Catalytic System for Enantioselec-
tive Radical C–H Alkylation of Aryldiazomethanes
At the outset of this study, o-aminobenzaldehyde-derived hydrazone 1a was 
selected as the model substrate to examine the feasibility of Co(II)-catalyzed radical C–H
alkylation (Table 3.1). We were gratified to find that Co(II) complex of D2h-symmetric 
achiral amidoporphyrin [Co(P1)] (P1 = 3,5-DitBu-IbuPhyrin)13 was an effective 
metalloradical catalyst for the reaction, delivering the desired 2-phenylindoline 2a in 81% 
yield using 2 mol % catalyst loading even at room temperature (entry 1). The high product 
yield implies that the in situ generation of the corresponding aryldiazomethane from 
hydrazone 1a was facile and properly matched with the rate of its metalloradical activation 
by the catalyst toward the desired C–H alkylation without the accumulation of the unstable 
donor-substituted diazo compound.
To achieve enantioselectivity, the initial use of the first-generation catalyst 
[Co(P2)] (P2 = 3,5-DitBu-ChenPhyrin),7a which is known for asymmetric radical 
cyclopropanation, resulted in the formation of 2a in a similar yield with a low but 
significant enantioselectivity (entry 2). The asymmetric induction was improved without 
negatively affecting the product yield when [Co(P3)] (P3 = 2,6-DiMeO-ChenPhyrin) was 
used as the catalyst where the ligand has a sterically more demanding environment as a 
result of the non-chiral meso-aryl substituents (entry 3). This positive ligand buttressing 
effect prompted us to evaluate the activity of the second-generation catalyst [Co(P4)] (P4
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= 3,5-DitBu-QingPhyrin),7c which consists of more sterically hindered chiral amides with 
two stereogenic centers. 
Table 3.1| Ligand Effect of Co(II)-Based Catalytic System for Enantioselective 
Radical C–H Alkylation of Aryldiazomethanes
a Carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2.0 equiv.) by [Co(Por)] (2 mol 
%) in Toluene (1.0 mL); Tris = 2,4,6-triisopropylphenyl sulfonyl; b Isolated yields; c
Determined by chiral HPLC.
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As expected, both the reactivity and enantioselectivity were significantly enhanced 
(Table 3.1, entry 4). In a similar trend, when sterically more encumbered [Co(P5)] (P5 =
2,6-DiMeO-QingPhyrin) was used, improvement in asymmetric induction continued (entry 
5). To amplify such effect, we synthesized the new catalyst [Co(P6)] (P6 = 2,6-DiPhO-
QingPhyrin) by replacing the methoxy groups at the 2,6-positions of the meso-aryl 
substituents in P5 with phenoxy groups. It was satisfying to find that [Co(P6)] could 
catalyze the formation of 2a in 82% yield with 66% ee (entry 6).
Table 3.2| Protecting Group and Solvent Effect of Co(II)-Based Catalytic System for 
Enantioselective Radical C–H Alkylation of Aryldiazomethanes
a Carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2.0 equiv.) by [Co(P6)] (2 mol 
%) in solvent (1.0 mL); Tris = 2,4,6-triisopropylphenyl sulfonyl; PhCH3 = toluene; PhH = 
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benzene; PhCl = Chlorobenzene; DCE = 1,2-Dichloroethene; DCM = Dichloromethane;
THF = Tetrahydrofuran; TBME = Methyl tert-butyl ether; DME = Dimethoxyethane;
MeOH = Methanol; Et2O = Diethyl ether; DMF = Dimethylformamide. b Isolated yields; c
Determined by chiral HPLC.
Figure 3.2| Molecular Modeling of Proposed ε-Co(III)-Aminoalkyl Radical 
Intermediates Showing Potential Hydrogen-bonding Interactions
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With [Co(P6)] in hand, we then examined the effect of different N-substituents of 
substrate 1 on the catalytic reaction (Table 3.2). It was shown that changes from t-butyl 
(1a) to ethyl (1b) to methyl (1c) carbamates led to a successive increase in both yield and
enantioselectivity, achieving almost quantitative yield and 86% ee in the case of substrate 
1c (entries 1–3). This outcome is possibly attributed to the potential hydrogen-bonding 
interaction between the carbonyl group of the carbamate and the amido group of the chiral 
catalyst, which strengthens upon the decrease in steric hinderance as indicated in the 
Spartan model (Figure 3.2).
Further investigation of the different solvent effect revealed that except for DMF, 
both polar and non-polar solvents were suitable for this asymmetric radical process,
delivering the desired product with different yields and enantioselectivities (Table 3.2, 
entries 3–14). Interestingly, when methanol was employed as the solvent, it afforded 2-
phenylindoline 2c at room temperature in 92% yield with 94% ee (entry 12).
Like Tris-protected hydrazones (Table 3.3, entry 1), catalytic reactions of Ts-
protected hydrazones could also proceed at room temperature (entry 2), affording the 
desired indoline with the equally high enantioselectivity but in a much lower yield (47%).
The same enantioselectivity observed is consistent with the proposed mechanism in 
Scheme 3.1 where the hydrazones are not directly involved in the catalytic cycle, and the 
lower yield is contributed to the slower generation of the corresponding diazo compounds 
from Ts-protected hydrazones at room temperature. At elevated temperatures such as 40 
ºC and 60 ºC, the catalytic reactions of simple Ts-protected hydrazones could produce the 
desired indolines in the similarly high yields but with relatively lower enantioselectivities
(Table 3.3, entries 3-4).
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Table 3.3| The Effect of Different R Groups on Enantioselective Radical C–H 
Alkylation of Aryldiazomethanesa
 a Carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2.0 equiv.) by [Co(P6)] (2 mol 
%) in solvent (1.0 mL); Yield refers to isolated yield; ee was determined by chiral HPLC; 
Tris = 2,4,6-triisopropylphenyl sulfonyl.
3.2.2 Enantioselective Radical C–H Alkylation for Construction of Chiral 2-
Substituted Indolines with Various C(sp3)–H Bonds
Under the optimized conditions, the scope of [Co(P6)]-catalyzed radical alkylation 
was evaluated by employing different C–H substrates, and the results were summarized in 
Table 3.4.
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Table 3.4| [Co(P6)]-Catalyzed Enantioselective Radical C–H Alkylation for 
Construction of Chiral 2-Substituted Indolinesa
a Carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2.0 equiv.) in MeOH (1.0 mL); 
Yields refer to isolated yields; ee was determined by chiral HPLC; b At 60 oC; c At 40 oC.
Tris = 2,4,6-triisopropyl phenylsulfonyl.
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As demonstrated with substrates 1c–1k, benzylic C–H bonds having varied 
electronic and steric properties could be effectively alkylated at room temperature in a 
highly enantioselective fashion, affording chiral 2-arylindoline derivatives 2c–2k in 
excellent yields (entries 1–9). The absolute configurations of both 2e and 2g were 
established by X-ray crystal structural analysis as (R). The availability of halogenated 
products such as 2g and 2h in high enantiopurity may allow for further transformations via 
metal-catalyzed couplings and related reactions (entries 5 and 6).
It is noteworthy to mention that even the highly electron-deficient 
pentafluorobenzylic C–H bond in substrate 1k could successfully undergo radical 
alkylation, forming 2-perfluorophenylindoline (2k) in 90% yield with 95% ee (entry 9). 
The catalytic system could also efficiently alkylate C–H bonds adjacent to other aryl groups 
as shown with the successful reaction of the 2-naphthyl-based substrate 1l (entry 10). 
Besides -NO2 and -CN functionalities (entries 7 and 8), the C–H alkylation was shown to 
tolerate both alkenyl and alkynyl groups, as demonstrated by the stereoselective formation 
of indolines 2m and 2n without complications from potential reactions with the C=C and 
C C bonds, respectively (entries 11 and 12). 
Notably, this system was equally effective for alkylation of C–H bonds next to 
heteroaryl groups, such as pyridine (1o), thiophene (1p), and benzothiophene (1q), 
providing 2-heteroarylindolines 2o–2q in high yields with high enantioselectivities (entries 
13–15). Given that both heteroarene and indoline are prevalent as key structural elements 
in many bioactive natural and synthetic compounds, the easy access of these linked 
biheterocyclic compounds in high enantiopurity may find applications in pharmaceutical 
research and development.
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Furthermore, non-activated C–H bonds could also be alkylated by the system, as 
exemplified by the regioselective radical 1,5-alkylation of substrate 1r, forming 2-
propylindoline (2r) in 65% yield with 87% ee although 60 oC was needed (entry 16). The 
alkylation was further highlighted by its applicability to even C–H bonds that are directly 
attached to electron-withdrawing groups. For example, electron-poor C–H bonds that are 
adjacent to ester (1s) and amide (1t) groups were smoothly alkylated at 40 oC to furnish 
the 2-ester- (2s) and 2-amido- (2t) indolines in varied yields and enantioselectivities 
(entries 17 and 18). These results clearly manifested the low sensitivity of the Co(II)-based 
metalloradical alkylation to the electronic properties of C–H bonds, which are consistent 
with its underlying radical mechanism.
3.2.3 Mechanistic Studies on Co(II)-Catalyzed Intramolecular Radical C–H
Alkylation of o-Aminoaryldiazomethanes
To gain insight into the underlying mechanism of this Co(II)-catalyzed C–H
alkylation, a set of mechanistic experiments were conducted. We first examined the effect 
of the radical scavenger TEMPO on the process under the standard conditions (Scheme 
3.2). Addition of TEMPO (2.5 equiv.) to the reaction of benzyl C–H substrate 1c by achiral 
catalyst [Co(P1)] resulted in complete inhibition of the C–H alkylation without observation 
of 2c. Instead, compound (±)-3c was isolated in 70% yield, whose structure was confirmed 
by X-ray analysis to contain two TEMPO units at the 1- and 5-positions, respectively. The 
formation of (±)-3c is indicative of the formation of the initial α-Co(III)-benzyl radical (1c-
A) as well as the resulting ε-Co(III)-aminoalkyl radical (1c-B) from 1,5-HAA, which was 
presumably capped subsequently by one molecule of TEMPO at the ε-position through 
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radical recombination to generate intermediate 1c-C and then followed by radical 
substitution with the second molecule of TEMPO at the α-position to break the weak 
Co(III)–C bond for final production of (±)-3c.
Scheme 3.2| Mechanistic Studies on Co(II)-Catalyzed Intramolecular Radical C–H 
Alkylation of o-Aminoaryldiazomethanes: Effect of TEMPO on Benzylic C–H 
Reaction
To gain information on stereochemistry, the same reaction was performed with 
chiral catalyst [Co(P6)] (Scheme 3.2). The same bis-TEMPO-capped compound (-)-3c was 
also generated, but in a much higher yield of 90% and, remarkably, with 93% ee. The fact 
that the enantioselectivity for the C–O bond formation (93% ee) of the TEMPO-capped 
product (-)-3c was almost identical to the one observed for the C–C bond formation (94% 
ee) of the C–H alkylation product 2c in the absence of TEMPO (Table 3.4, entry 1) implies 
that the prochiral α-aminoalkyl radical in 1c-B was confined inside the chiral pocket of 
[Co(P6)] to adapt a stable, well-defined configuration.
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Scheme 3.3| High Resolution Mass Spectroscopy (HRMS) Spectrum for Co(III)-
Supported Alkyl Radical Intermediate
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In addition, the resulting Co(III)-supported alkyl radical intermediates from the 
reaction of substrate 1c by [Co(P1)] in the absence of TEMPO could be directly detected 
by HRMS (C92H103CoN9O6+, m/z: calculated: 1488.7358, found: 1488.7350) (Scheme 3.3).
The HRMS experiment was carried out in the absence of any additives such as formic acid, 
which commonly act as electron carriers for ionization, allowing for the detection of the 
molecular ion signals corresponding to Co(III)-alkyl radical (C92H103CoN9O6·) by the loss 
of one electron.
Scheme 3.4| Isotropic X-band EPR Spectrum of Phenyl N-tert-butylnitrone (PBN)-
Trapped Co(III)-Supported Alkyl Radical Intermediate
Besides the HRMS experiment, the corresponding alkyl radical intermediate was 
also trapped by spin trapping reagent phenyl N-tert-butylnitrone (PBN) to give the 
characteristic EPR signal. As shown in Scheme 3.4, the resulting EPR spectrum (in red), 
which is assigned to PBN-trapped Co(III)-supported alkyl radical intermediates, displays 
the characteristic triplet of doublet signal for alkyl radicals that are trapped by phenyl N-
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tert-butylnitrone (PBN). The spectrum has been simulated (in blue) with g = 2.006, AN = 
14.6 G, AH = 2.6 G, which is consistent with the resulting O-centered radical with the 
hyperfine splitting by the neighboring N and H atoms. The values are consistent with those 
for similar species reported in litrature.8b
To gather further evidence to support the stepwise radical mechanism of the 
catalytic process, we also designed specific substrates as radical probes to shed more light 
on the nature of ε-Co(III)-aminoalkyl radical intermediates.
Scheme 3.5| Mechanistic Studies on Co(II)-Catalyzed Intramolecular Radical C–H
Alkylation of o-Aminoaryldiazomethanes: Effect of TEMPO on Allylic C–H
Reaction-Olefin Isomerization
First, allylic C–H substrate 1u was prepared as a radical resonance probe to evaluate 
potential olefin isomerization via the resulting allylic radical intermediate after 1,5-HAA 
(Scheme 3.5). Under the standard conditions, the catalytic reaction of 1u by [Co(P1)] was 
carried out in the presence of TEMPO (2.5 equiv.) at 40 oC. As observed for the benzylic 
C–H substrate 1c (Scheme 3.2), a similar type of bis-TEMPO-capped compound 3u was 
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isolated in 72% yield without formation of the corresponding C–H alkylation product 
(Scheme 3.5). Characterizations of 3u revealed that the C=C double bond was isomerized 
from the terminal to internal position. Clearly, the resulting ε-Co(III)-aminoalkyl radical, 
which can be represented by its two resonance forms 1u-A and 1u-B as an allylic radical, 
was captured by TEMPO to give intermediate 1u-C and then underwent further radical 
substitution with another molecule of TEMPO to deliver the final product 3u. The 
predominant production of 3u is presumably a result of the much faster capping rate of 
resonance form 1u-B (a primary allylic radical) than resonance form 1u-A (a secondary 
allylic radical) by the sterically demanding TEMPO radical.
Scheme 3.6| Mechanistic Studies on Co(II)-Catalyzed Intramolecular Radical C–H
Alkylation of o-Aminoaryldiazomethanes: Effect of TEMPO on Cyclopropylmethyl 
C–H Reaction-Ring Opening
Second, substrate 1v bearing a cyclopropyl ring was synthesized as a radical clock 
to examine possible ring-opening of the cyclopropylmethyl radical generated from 1,5-
HAA (Scheme 3.6). Interestingly, the catalytic reaction of 1v under similar conditions by 
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[Co(P1)] in the presence of TEMPO (2.5 equiv.) resulted in the formation of bis-TEMPO-
capped compound 3v in 40% yield as well as the C–H alkylation product 2v in 30% yield. 
Obviously, the corresponding ε-Co(III)-aminoalkyl radical intermediate 1v-A underwent 
two competitive pathways during the catalytic process. While its radical substitution 
resulted in the formation of the 2-cyclopropylindoline 2v, the cyclopropylcarbinyl radical 
in 1v-A also proceeded ring-opening competitively to generate homoallylic alkyl radical 
1v-B, which was transformed to the final enamine 3v upon two sequential capture reactions 
by TEMPO via intermediate 1v-C. The fact that 2v and 3v were produced in similar yields 
indicated that the forming rate of C2–C3 bond via radical substitution to construct the 
indoline ring was fast, considering that the rate constant of ring-opening of the parent 
cyclopropylmethyl radical is 8.6x107 s–1.14
Collectively, all these experimental observations strongly support the proposed 
stepwise radical mechanism of the Co(II)-based C–H alkylation with N-arylsulfonyl 
hydrazones.
3.3 CONCLUSIONS
In summary, we have developed the new Co(II)-based metalloradical system for 
asymmetric C–C bond formation via enantioselective radical alkylation of C(sp3)–H bonds. 
The enantioselective radical process has been demonstrated for stereoselective synthesis of 
chiral indolines through asymmetric C2–C3 bond formation. With the design of the new 
chiral ligand 2,6-DiPhO-QingPhyrin, this Co(II)-catalyzed system can effectively activate 
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ortho-aminoaryldiazomethanes at room temperature, which are readily generated in situ
from hydrazone precursors, for highly stereoselective radical alkylation of different types 
of C(sp3)–H bonds with varied electronic and steric properties. In addition to the attributes 
of chemoselectivity and regioselectivity, this catalytic radical system features a high level 
of functional group tolerance as well as good compatibility with heteroaryl units. Detailed 
mechanistic studies also provided insight into the underlying stepwise radical pathway.
This enantioselective radical process represents a new synthetic application of Co(II)-based 
MRC and offers a streamlined construction of chiral 2-substituted indolines from readily 
available starting materials.
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3.4 EXPERIMENTAL SECTION
3.4.1 General Considerations
1H NMR spectra were recorded on a Varian INOVA 400 (400 MHz), 500 (500 
MHz) or a 600 (600 MHz) spectrometer. Chemical shifts are internally referenced to 
residual CHCl3 signal (δ 7.26 ppm). Data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, hept = 
heptet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR spectra were 
recorded on a Varian INOVA 500 (125 MHz), or 600 (150 MHz) spectrometers with
complete proton decoupling. Chemical shifts are reported in ppm with residual CHCl3 as 
the internal standard (δ 77.0 ppm). High-resolution mass spectrometry was performed on 
a Micromass LCT ESI-MS and JEOL Accu TOF Dart at the Mass Spectrometry Facility, 
Boston College. The UV-Vis absorption spectra in the range 200-700 nm were measured 
with an Evolution 300 UV-VIS spectrophotometer using quartz cuvettes with 1.0 cm 
optical path length. HPLC measurements were carried out on a Shimadzu HPLC system 
with ChiralPak Immobilized columns: IA, IB and IC. Infrared (IR) spectra were recorded 
on a Termo Scientific Nicolet Is5 System. Frequencies are reported in wavenumbers (cm-
1). HRMS data was obtained on an Agilent 6210 Time-of-Flight LC/MS with ESI as the 
ion source. Optical rotations were measured on a Rudolph Research Analytical 
AUTOPOL® IV digital polarimeter. The X-ray diffraction data were collected using 
Bruker Kappa APEX DUO diffractometer and a Rigaku HighFlux Homelab 
diffractometer. X-band EPR spectra were recorded on a Bruker EMX-Plus spectrometer 
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(Bruker BioSpin). Spartan modelling was performed using Spartan’14 software from 
Wavefunction, Inc.
Unless otherwise noted, all C–H alkylation reactions were performed in oven-dried 
glassware under dry N2 atmosphere with standard vacuum line techniques. Gastight 
syringes were used to transfer liquid reagents and solvents in catalytic reactions. 
Anhydrous solvents as well as other commercial reagents were purchased from Sigma-
Aldrich, Acros, Alfa Aesar, Strem, Oakwood Products Inc., TCI, or Matrix Scientific and 
used as received unless otherwise stated. Thin layer chromatography was performed on 
Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed with 
ICN silica gel (60 Å, 230-400 mesh, 32-63 μm).
3.4.2 Procedure for HRMS Experiment
To an oven-dried Schlenk tube, sulfonylhydrazone 1c (0.05 mmol) and Cs2CO3 (2.0
equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen for 
3 times. The Teflon screw cap was replaced with a rubber septum, and CH3CN (0.5 mL) 
was added via a gastight syringe. The mixture was then stirred at 60 oC for 0.5 h. The 
resulting light yellow solution was then passed through a short pad of Celite (to get rid of 
base and salt) under the flow of nitrogen and the filtrate was collected in a HPLC vial (vial 
A, degassed and backfilled with argon). During the time, [Co(P1)] (2 mol %) was charged 
into another HPLC vial (vial B, degassed and backfilled with argon) and dissolved in 
CH3CN (0.5 mL). After mixing equal amount of solutions from vial A (0.1 mL) and vial B 
(0.1 mL), the sample was further diluted with CH3CN and immediately injected into HRMS 
instrument. The HRMS experiment was carried out in the absence of any additives such as 
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formic acid, which commonly act as electron carriers for ionization, allowing for the 
detection of the molecular ion signals corresponding to Co(III)-alkyl radical 
(C92H103CoN9O6·) by the loss of one electron.
3.4.3 Procedure for EPR Experiment
To an oven-dried Schlenk tube A, sulfonylhydrazone 1c (0.05 mmol) and Cs2CO3
(2.0 equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen 
for 3 times. The Teflon screw cap was replaced with a rubber septum, and benzene (0.5 
mL) was added via a gastight syringe. The mixture was then stirred at 60 oC for 0.5 h. 
During the time, [Co(P1)] (4 mol %) was charged into another oven-dried Schlenk tube B. 
The Schlenk tube B was then evacuated and backfilled with nitrogen for 3 times. After 0.5 
h, the resulting light yellow solution from tube A was passed through a short pad of Celite 
(to get rid of base and salt) under the flow of nitrogen and transferred to Schlenk tube B. 
The mixture was stirred for 1 min, followed by the addition of phenyl N-tert-butylnitrone 
(PBN, 0.05 mmol). The reaction mixture was stirred for 3 min and transferred into a 
degassed EPR tube (filled with argon) through a gastight syringe. The sample was then 
carried out for EPR experiment at room temperature (EPR settings: T = 298 K; microwave 
frequency: 9.37762 GHz; power: 6.325 mW; modulation amplitude: 1.0 G).
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3.4.4 Procedure for Synthesis of Catalyst [Co(P5)]
[H2(P5)] was synthesized according to our previous reported procedure7a with 58% 
yield. The 5,15-bis(2,6-dibromophenyl)-10,20-bis(2,6-dimethoxyphenyl)porphyrin (0.2 
mmol), (1R, 2R)-2-methyl-2-phenylcyclopropane-1-carboxamide7c (3.2 mmol), Pd(OAc)2
(0.08 mmol), Xantphos (0.16 mmol), and Cs2CO3 (3.2 mmol) were placed in an oven-dried, 
resealable Schlenk tube. The tube was capped with a Teflon screwcap, evacuated, and 
backfilled with nitrogen. The screwcap was replaced with a rubber septum, and dioxane 
(10 mL) was added via a gastight syringe. The tube was purged with nitrogen for 2 minutes, 
and then the septum was replaced with the Teflon screwcap. The tube was sealed and stirred 
at 100 oC for 72 h. The resulting mixture was cooled down to room temperature, diluted in 
ethyl acetate, filtrated through a silica pad and concentrated under vacuum. The pure 
compound was obtained as a purple solid after purification by flash column 
chromatography (hexanes/DCM/ethyl acetate: 10/10/2 to 10/10/3). 1H NMR (500 MHz, 
CDCl3) δ 8.88 (s, 8H), 8.48 (d, J = 5.9 Hz, 4H), 7.89 (t, J = 8.3 Hz, 2H), 7.69 (t, J = 8.5 
Hz, 2H), 6.90 (d, J = 8.6 Hz, 4H), 6.68 (s, 4H), 5.98 (s, 4H), 5.31 (br, 16H), 2.96 (s, 12H), 
0.99 – 0.96 (m, 16H), 0.56 (br, 4H), 0.18 (br, 4H), -2.12 (s, 2H). 13C NMR (125 MHz, 
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CDCl3) δ 168.60, 160.36, 144.50, 139.05, 132.77, 130.79, 130.28, 130.01, 126.81, 125.94, 
124.97, 121.46, 117.81, 117.15, 114.78, 106.81, 103.80, 55.07, 30.01, 29.92, 19.42, 17.71. 
IR (neat, cm-1): 3409.14, 3313.83, 2928.10, 2836.12, 1690.30, 1586.35, 1464.60, 1249.90, 
1108.38, 731.66. HRMS (ESI) (M+H+) Calcd. for C92H83N8O8+: 1427.6328, found 
1427.6301. UV–vis (CH2Cl2), λmax nm (log ε): 421(5.43), 514(4.23), 588(3.74), 643(3.34).
[Co(P5)] was synthesized according to our previous reported procedure7a with 92% 
yield. Free base porphyrin [H2(P5)] and anhydrous CoCl2 (8 equiv.) were placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen. The screwcap was then replaced with a rubber 
septum, 2,6-lutidine (4 equiv.) and anhydrous THF were added via a gastight syringe. The 
tube was purged with nitrogen for 2 minutes, and then the septum was replaced with the 
Teflon screwcap. The reaction was conducted at 80 oC for 12 h. The resulting mixture was 
cooled down to room temperature, diluted with ethyl acetate, and transferred to a separatory 
funnel. The reaction mixture was washed with water 3 times and concentrated under 
vacuum. The target compound [Co(P5)] was isolated as a purple solid after purification by 
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flash column chromatography with hexanes/ethyl acetate (2/1) as eluent. IR (neat, cm-1):
3405.77, 2930.13, 1691.39, 1584.23, 1464.43, 1249.49, 1107.50, 997.65, 762.32. HRMS 
(ESI) (M*+) Calcd. for C92H80CoN8O8+: 1483.5426, found 1483.5488. UV–vis (CH2Cl2), 
λmax nm (log ε): 413(4.90), 532(3.77).
3.4.5 Procedure for Synthesis of Catalyst [Co(P6)]
2, 6-diphenoxybenzaldehyde was synthesized according to previous reported 
procedure.15 To a stirred solution of 1,3-diphenoxybenzene (10 mmol) in dry THF (60 mL) 
at 0 °C, n-BuLi (8 mL, 1.5 M in hexanes) was added dropwise for 1 h. Then the mixture 
was stirred at room temperature for 2 h and followed by the slow addition of DMF (1.83
g, 25 mmol). After 2 h, the mixture was poured into ice water. The organic phase was 
separated and the aqueous phase was extracted with ether (3×30 mL). The combined 
organic layer was dried over anhydrous Na2SO4. After the removal of solvent under 
vacuum, the product was purified by column chromatography with hexanes/ethyl acetate 
(9:1 to 6:1) as eluent to afford 2, 6-diphenoxybenzaldehyde as a white solid in 70% yield.
1H NMR (600 MHz, CDCl3) δ 10.61 (s, 1H), 7.39 (t, J = 7.9 Hz, 4H), 7.32 (t, J = 8.4 Hz, 
1H), 7.18 (t, J = 7.4 Hz, 2H), 7.10 – 7.08 (m, 4H), 6.58 (d, J = 8.4 Hz, 2H).13C NMR (150 
MHz, CDCl3) δ 188.15, 159.85, 156.13, 135.09, 129.95, 124.31, 119.61, 118.47, 112.72. 
IR (neat, cm-1): 2774.28, 1688.49, 1598.71, 1570.31, 1487.76, 1454.31, 1409.35, 1204.09, 
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1030.85, 772.93, 717.85, 685.53. HRMS (ESI) (M+H+) Calcd. for C19H15O3+: 291.1021, 
found 291.1034.
5,15-bis(2,6-dibromophenyl)-10,20-bis(2,6-diphenoxyphenyl)porphyrin was 
synthesized according to our previous reported procedure7a with 60% yield. A mixture of 
meso-(2,6-dibromophenyl)dipyrromethane (5 mmol), 2, 6-diphenoxybenzaldehyde (5 
mmol) in chloroform (500 mL) was purged with nitrogen for 10 min. The flask was 
wrapped with aluminum foil to shield it from light. Then boron trifluoride diethyl etherate 
was added dropwise via a syringe. After the solution was stirred under the nitrogen 
atmosphere at room temperature for 3 h, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
(DDQ) (7.5 mmol) was added at one time. After 1 h, triethylamine (10 mL) was added. 
The reaction solution was then directly poured into a silica gel column that was rinsed with 
dichloromethane. The column was eluted with dichloromethane. The fractions containing 
the product were collected and concentrated under vacuum. The residue was washed 
several times with methanol to afford the pure compound. 1H NMR (600 MHz, CD2Cl2) δ 
9.00 (s, 4H), 8.62 (s, 4H), 8.06 (d, J = 7.7 Hz, 4H), 7.68 (t, J = 7.7 Hz, 2H), 7.57 (t, J = 7.5 
Hz, 2H), 7.11 (d, J = 8.0 Hz, 4H), 6.89 (d, J = 5.8 Hz, 8H), 6.70 (d, J = 6.5 Hz, 12H), -2.73 
(s, 2H). 13C NMR (150 MHz, CD2Cl2) δ 159.40, 156.70, 143.47, 131.93, 131.61, 130.68, 
129.58, 128.78, 124.59, 123.70, 119.58, 118.31, 113.27, 111.14. IR (neat, cm-1): 3311.65, 
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1570.06, 1487.58, 1449.43, 1230.13, 1209.38, 1023.02, 1012.10, 979.66, 796.47, 721.44. 
HRMS (ESI) (M+H+) Calcd. for C68H43Br4N4O4+: 1295.0012, found 1295.0050. UV–vis
(CH2Cl2), λmax nm (log ε): 422(5.63), 516(4.37), 592(3.87), 646(3.11).
[H2(P6)] was synthesized according to our previous reported procedure7a with 61% 
yield. The 5,15-bis(2,6-dibromophenyl)-10,20-bis(2,6-diphenoxyphenyl)porphyrin (0.2 
mmol), (1R, 2R)-2-methyl-2-phenylcyclopropane-1-carboxamide7c (3.2 mmol), Pd(OAc)2
(0.08 mmol), Xantphos (0.16 mmol), and Cs2CO3 (3.2 mmol) were placed in an oven-dried, 
resealable Schlenk tube. The tube was capped with a Teflon screwcap, evacuated, and 
backfilled with nitrogen. The screwcap was replaced with a rubber septum, and dioxane 
(10 mL) was added via a gastight syringe. The tube was purged with nitrogen for 2 minutes, 
and then the septum was replaced with the Teflon screwcap. The tube was sealed and stirred 
at 100 oC for 72 h. The resulting mixture was cooled down to room temperature, diluted in 
ethyl acetate, filtrated through a silica pad and concentrated under vacuum. The pure 
compound was obtained as a purple solid after purification by flash column 
chromatography (hexanes/ethyl acetate: 3/1 to 2/1). 1H NMR (600 MHz, CDCl3) δ 9.18 (d, 
J = 4.4 Hz, 4H), 8.92 (d, J = 4.4 Hz, 4H), 8.49 (br, 4H), 7.89 (t, J = 8.3 Hz, 2H), 7.52 (t, J
= 8.6 Hz, 2H), 6.87 (t, J = 7.9 Hz, 8H), 6.82 (d, J = 8.5 Hz, 4H), 6.74 (t, J = 7.3 Hz, 4H), 
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6.58 (br, 4H), 6.52 (d, J = 7.9 Hz, 8H), 6.04 (br, 4H), 5.60 (br, 8H), 5.44 (br, 8H), 0.77 (s, 
12H), 0.60 (br, 4H), 0.22 (br, 4H), 0.09 (br, 4H), -2.27(s, 2H). 13C NMR (150 MHz, CDCl3)
δ 168.77, 159.50, 155.55, 144.27, 139.06, 132.58, 130.48, 130.35, 129.21, 126.92, 125.71, 
125.07, 123.63, 121.64, 121.44, 119.90, 117.38, 113.00, 110.70, 107.55, 30.13, 29.36, 
19.10, 18.31. IR (neat, cm-1): 3409.85, 3009.75, 1686.60, 1686.60, 1488.40, 1450.74, 
1208.39, 1160.10, 978.20, 749.56, 692.35. HRMS (ESI) (M+H+) Calcd. for C112H91N8O8+:
1675.6954, found 1675.6960. UV–vis (CH2Cl2), λmax nm (log ε): 422(5.46), 515(4.25), 
591(3.75), 645(3.12).
[Co(P6)] was synthesized according to our previous reported procedure7a with 92% 
yield. Free base porphyrin [H2(P6)] and anhydrous CoCl2 (8 equiv.) were placed in an 
oven-dried, resealable Schlenk tube. The tube was capped with a Teflon screwcap, 
evacuated, and backfilled with nitrogen. The screwcap was then replaced with a rubber 
septum, 2,6-lutidine (4 equiv.) and anhydrous THF were added via a gastight syringe. The 
tube was purged with nitrogen for 2 minutes, and then the septum was replaced with the 
Teflon screwcap. The reaction was conducted at 80 oC for 12 h. The resulting mixture was 
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cooled down to room temperature, diluted with ethyl acetate, and transferred to a separatory 
funnel. The reaction mixture was washed with water for 3 times and concentrated under 
vacuum. The target compound [Co(P6)] was isolated as a purple solid after purification by 
flash column chromatography with hexanes/ethyl acetate (2/1) as eluent. IR (neat, cm-1):
3407.80, 1692.64, 1488.16, 1449.06, 1206.20, 1159.67, 998.09, 759.70, 690.98. HRMS 
(ESI) (M*+) Calcd. for C112H88CoN8O8+: 1731.6057, found 1731.6057. UV–vis (CH2Cl2), 
λmax nm (log ε): 414(4.84), 534(3.67).
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3.4.6 Synthetic Procedure for (2-(Hydroxymethyl)phenyl)carbamates s1
The compound s1 was synthesized according to the previous reported procedure.16
To a solution of 2-aminobenzyl alcohol (20 mmol) and pyridine (26 mmol) in DCM (80.0 
mL) at 0 oC, methyl chloroformate (or ethyl chloroformate) (22 mmol) was added 
dropwise. The reaction was then stirred at 0 oC for 4 h. After that, the reaction was 
quenched by the addition of 0.1 M HCl and extracted with DCM (80 mL) for 3 times. The 
combined organic layers were then dried over anhydrous Na2SO4 and concentrated under 
vacuum. The mixture was then purified by flash column chromatography.
methyl (2-(hydroxymethyl)phenyl)carbamate s1-a White solid. Yield:
81%. Hexanes/ethyl acetate = 3/1. 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 7.6 Hz, 1H), 
7.90 (s, 1H), 7.34 (td, J = 8.0, 1.6 Hz, 1H), 7.17 (dd, J = 7.5, 1.6 Hz, 1H), 7.04 (td, J = 7.5, 
1.1 Hz, 1H), 4.72 (d, J = 5.8 Hz, 2H), 3.78 (s, 3H), 1.96 (t, J = 5.8 Hz, 1H).13C NMR (125 
MHz, CDCl3) δ 154.57, 137.61, 129.17, 128.89, 128.78, 123.42, 120.98, 64.22, 52.29. IR 
(neat, cm-1): 3288.39, 1697.47, 1528.92, 1455.34, 1294.08, 1247.81, 1024.00, 664.01. 
HRMS (ESI) (M+H+) Calcd. for C9H12NO3+: 182.0812, found 182.0810.
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ethyl (2-(hydroxymethyl)phenyl)carbamate s1-b, known compound.17
White solid. Yield: 77%. Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3) δ 7.93 
– 7.86 (m, 2H), 7.32 (t, J = 7.8 Hz, 1H), 7.16 (d, J = 7.1 Hz, 1H), 7.03 (t, J = 7.5 Hz, 1H), 
4.69 (d, J = 5.7 Hz, 2H), 4.21 (q, J = 7.1 Hz, 2H), 2.25 (t, J = 5.7 Hz, 1H), 1.31 (t, J = 7.1 
Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 154.16, 137.74, 129.21, 128.83, 123.31, 120.98, 
64.29, 61.21, 14.52.
3.4.7 Synthetic Procedure for (2-Formylphenyl)carbamates s2
The compound s2 was synthesized according to the previous reported procedure.18
To a solution of carbamate s1 (15 mmol) in 150 mL of DCM was added pyridinium 
chlorochromate (PCC, 30 mmol) and Al2O3 (use same amount as PCC in order to ease the 
separation of the desired product from the PCC residue). The reaction mixture was stirred 
at room temperature for 2 h and then filtered through a pad of silica. The filtrate was 
concentrated under reduced pressure and purified by flash column chromatography with 
hexanes/ethyl acetate (4/1) as eluent.
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methyl (2-formylphenyl)carbamate s2-a White solid. Yield: 90%. 1H
NMR (500 MHz, CDCl3) δ 10.61 (s, 1H), 9.90 (s, 1H), 8.45 (d, J = 8.5 Hz, 1H), 7.64 (d, J
= 7.7 Hz, 1H), 7.59 (t, J = 7.9 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H), 3.80 (s, 3H). 13C NMR 
(125 MHz, CDCl3) δ 195.03, 154.09, 141.22, 135.99, 135.97, 121.92, 121.31, 118.24, 
52.39. IR (neat, cm-1): 3277.15, 3023.56, 2957.46, 2843.22, 2764.22, 1731.62, 1522.48, 
1455.43, 1214.36, 1058.89, 1044.52, 769.03, 695.17. HRMS (ESI) (M+H+) Calcd. for 
C9H10NO3+: 180.0661, found 180.0666.
ethyl (2-formylphenyl)carbamate s2-b White solid. Yield: 85%. 1H
NMR (600 MHz, CDCl3) δ 10.56 (s, 1H), 9.91 (s, 1H), 8.46 (d, J = 8.5 Hz, 1H), 7.64 (dd, 
J = 7.6, 1.4 Hz, 1H), 7.61 – 7.58 (m, 1H), 7.16 (td, J = 7.6, 0.9 Hz, 1H), 4.24 (q, J = 7.1 
Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 195.03, 153.70, 141.37,
135.99, 121.80, 121.28, 118.27, 61.39, 14.46. IR (neat, cm-1): 3278.69, 2985.48, 1729.45, 
1654.96, 1585.28, 1522.65, 1451.42, 1242.86, 1191.63, 1058.03, 1042.13, 871.07, 764.43. 
HRMS (ESI) (M+H+) Calcd. for C10H12NO3+: 194.0812, found 194.0809.
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3.4.8 Synthetic Procedure for Benzyl(2-formylphenyl)carbamate Derivatives s3
To a solution of s2 (2 mmol) and Cs2CO3 (2.4 mmol) in MeCN (20 mL) was added 
alkyl bromide (2.4 mmol) at room temperature. The reaction was heated at 50 oC for 2 h. 
The resulting mixture was cooled down to room temperature and filtered through a short 
pad of silica. The combined organic mixture was concentrated under vacuum and purified 
by flash column chromatography.
tert-butyl benzyl(2-formylphenyl)carbamate s3-a Yield: 95%.
Hexanes/ethyl acetate = 10/1. 1H NMR (500 MHz, CDCl3) δ 9.75 (s, 1H), 7.82 (d, J = 6.5 
Hz, 1H), 7.57 – 7.54 (m, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.25 – 7.14 (m, 6H), 4.99 and 4.78 
(br, 2H), 1.33 (br, 9H). 13C NMR (150 MHz, CDCl3) δ 189.80, 154.58, 144.27, 136.99, 
134.59, 132.88, 128.73, 128.55, 128.37, 128.15, 127.76, 127.36, 81.36, 54.29, 28.12. IR 
(neat, cm-1): 2978.49, 2873.61, 1682.42, 1595.02, 1484.35, 1445.89, 1367.81, 1152.81, 
1016.51, 861.22, 740.86. HRMS (ESI) (M+H+) Calcd. for C19H22NO3+: 312.1594, found 
312.1596.
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ethyl benzyl(2-formylphenyl)carbamate s3-b Yield: 94%.
Hexanes/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 9.72 (br, 1H), 7.84 (d, J = 7.2 
Hz, 1H), 7.56 (td, J = 7.7, 1.6 Hz, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.26 – 7.25 (m, 3H), 7.18 
– 7.13 (m, 3H), 4.96 and 4.82 (br, 2H), 4.18 and 4.07 (br, 2H), 1.09 (br, 3H). 13C NMR 
(150 MHz, CDCl3) δ 189.58, 155.64, 143.50, 136.48, 134.71, 132.87, 128.91, 128.59, 
127.93, 127.77, 62.28, 54.92, 14.45. IR (neat, cm-1): 2917.25, 2848.98, 1709.73, 1598.20, 
1455.24, 1378.29, 1216.68, 1019.37, 701.86. HRMS (ESI) (M+H+) Calcd. for C17H18NO3
+: 284.1289, found 284.1287.
methyl benzyl(2-formylphenyl)carbamate s3-c Yield: 99%. 
Hexanes/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 9.72 (s, 1H), 7.84 (d, J = 7.6 
Hz, 1H), 7.58 – 7.55 (m, 1H), 7.43 – 7.39 (m, 1H), 7.28 – 7.23 (m, 3H), 7.17 (d, J = 3.3 
Hz, 2H), 7.12 (d, J = 7.8 Hz, 1H), 4.92 and 4.84 (br, 2H), 3.65 (br, 3H). 13C NMR (150 
MHz, CDCl3) δ 189.55, 156.13, 143.26, 134.78, 132.85, 129.16, 129.00, 128.80, 128.62, 
128.00, 127.95, 127.76, 55.12, 53.38. IR (neat, cm-1): 3030.97, 2954.16, 2855.87, 1713.47, 
1598.69, 1454.69, 1382.03, 1270.69, 734.74. HRMS (ESI) (M+H+) Calcd. for C16H16NO3+:
270.1125, found 270.1126.
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methyl (2-formylphenyl)(4-methoxybenzyl)carbamate s3-d
Yield: 98%. Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 9.71 (s, 1H), 7.84 
(d, J = 7.6 Hz, 1H), 7.57 (td, J = 7.7, 1.5 Hz, 1H), 7.41 (t, J = 7.5 Hz, 1H), 7.08 (d, J = 8.0 
Hz, 3H), 6.77 (d, J = 8.5 Hz, 2H), 4.89 and 4.75 (br, 2H), 3.76 (s, 3H), 3.63 (s, 3H). 13C
NMR (150 MHz, CDCl3) δ 189.57, 159.31, 156.07, 143.30, 134.75, 132.91, 130.34, 
128.89, 128.60, 128.44, 127.89, 113.92, 55.18, 54.51, 53.29. IR (neat, cm-1): 2955.10, 
2837.50, 2758.23, 1711.53, 1611.89, 1598.52, 1514.07, 1459.69, 1251.04, 1034.18. 
HRMS (ESI) (M+H+) Calcd. for C17H18NO4+: 300.1230, found 300.1232.
methyl (2-formylphenyl)(3-methoxybenzyl)carbamate s3-e
Yield: 99%. Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 9.76 (s, 1H), 7.85 
(d, J = 7.5 Hz, 1H), 7.59 – 7.54 (m, 1H), 7.41 (t, J = 7.5 Hz, 1H), 7.17 (t, J = 7.8 Hz, 1H), 
7.14 (d, J = 7.5 Hz, 1H), 6.80 (dd, J = 8.3, 2.5 Hz, 1H), 6.75 (d, J = 7.6 Hz, 1H), 6.73 (s, 
1H), 4.88 and 4.82 (br, 2H), 3.73 (s, 3H), 3.83 and 3.64 (br, 3H).13C NMR (150 MHz, 
CDCl3) δ 189.59, 159.70, 156.11, 143.25, 137.85, 134.75, 132.85, 129.63, 129.20, 128.72, 
127.92, 121.20, 114.43, 113.50, 55.17, 55.02, 53.37. IR (neat, cm-1): 3002.67, 2953.35, 
2836.31, 1692.94, 1597.51, 1488.11, 1445.75, 1377.15, 1299.06, 1264.77, 1192.76, 
1051.67, 769.19, 740.54. HRMS (ESI) (M+H+) Calcd. for C17H18NO4+: 300.1230, found 
300.1236.
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methyl (2-formylphenyl)(2-methylbenzyl)carbamate s3-f Yield: 
99%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.74 (s, 1H), 7.82 (d, J =
7.6 Hz, 1H), 7.55 – 7.53 (m, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.16 – 7.15 (m, 1H), 7.10 (t, J =
8.0 Hz, 2H), 7.05 (br, 2H), 4.98 and 4.90 (br, 2H), 3.66 (s, 3H), 2.13 (s, 3H). 13C NMR 
(150 MHz, CDCl3) δ 189.42, 156.06, 143.11, 136.59, 134.70, 134.24, 133.06, 130.54, 
130.12, 129.23, 128.89, 128.06, 127.98, 126.07, 53.39, 52.16, 19.02. IR (neat, cm-1):
3022.23, 2953.91, 2860.00, 1711.08, 1598.43, 1486.9, 1457.43, 1377.82, 1304.30, 
1272.43, 1194.06, 743.36. HRMS (ESI) (M+H+) Calcd. for C17H18NO3+: 284.1281, found
284.1284.
methyl (2-chlorobenzyl)(2-formylphenyl)carbamate s3-g Yield: 
99%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.88 (s, 1H), 7.83 (d, J =
7.6 Hz, 1H), 7.55 (td, J = 7.8, 1.4 Hz, 1H), 7.41 (t, J = 7.5 Hz, 2H), 7.29 – 7.27 (m, 1H), 
7.21 – 7.18 (m, 2H), 7.16 (d, J = 7.8 Hz, 1H), 5.05 (br, 2H), 3.79 and 3.67 (s, 3H). 13C
NMR (150 MHz, CDCl3) δ 189.61, 156.12, 143.00, 134.68, 134.04, 132.89, 131.34, 
129.63, 129.31, 128.55, 127.96, 127.56, 127.02, 126.85, 53.47, 51.90. IR (neat, cm-1):
3004.63, 2953.62, 2360.00, 1712.93, 1598.56, 1444.12, 1379.73, 1302.25, 1277.42, 
765.24, 742.13. HRMS (ESI) (M+H+) Calcd. for C16H15ClNO3+: 304.0735, found 
304.0739.
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methyl (3,4-dichlorobenzyl)(2-formylphenyl)carbamate s3-h
Yield: 98%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.87 (s, 1H), 7.88 
(dd, J = 7.7, 1.5 Hz, 1H), 7.59 (td, J = 7.7, 1.7 Hz, 1H), 7.46 (t, J = 7.5 Hz, 1H), 7.35 (d, J
= 8.2 Hz, 1H), 7.32 (s, 1H), 7.06 (t, J = 8.3 Hz, 2H), 4.91 and 4.70 (br, 2H), 3.66 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ 189.46, 156.08, 142.69, 142.52, 136.88, 134.87, 134.69, 
132.63, 132.46, 132.08, 130.75, 130.57, 128.82, 128.24, 53.94, 53.51. IR (neat, cm-1):
3002.67, 2953.42, 2860.35, 2746.50, 1712.18, 1598.16, 1447.29, 1374.56, 1297.34, 
1216.67, 1032.47, 738.51. HRMS (ESI) (M+H+) Calcd. for C16H14Cl2NO3+: 338.0345, 
found 338.0347.
methyl (2-formylphenyl)(4-nitrobenzyl)carbamate s3-i Yield: 
80%. Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3) δ 9.87 (s, 1H), 8.14 (d, J =
8.2 Hz, 2H), 7.87 (d, J = 7.5 Hz, 1H), 7.58 (t, J = 7.6 Hz, 1H), 7.47 (t, J = 7.5 Hz, 1H), 
7.41 (d, J = 8.1 Hz, 2H), 7.09 (d, J = 5.9 Hz, 1H), 5.05 and 4.83 (br, 2H), 3.66 (s, 3H).13C
NMR (150 MHz, CDCl3) δ 189.44, 156.12, 147.57, 143.97, 142.31, 134.91, 132.37, 
131.10, 129.60, 128.72, 128.33, 123.83, 54.33, 53.58. IR (neat, cm-1): 3077.25, 2955.54, 
2857.16, 2756.27, 1691.77, 1597.46, 1518.47, 1445.74, 1344.17, 1307.21, 1267.61, 
1192.18, 732.85. HRMS (ESI) (M+H+) Calcd. for C16H15N2O5+: 315.0975, found 
315.0977.
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methyl (4-cyanobenzyl)(2-formylphenyl)carbamate s3-j Yield: 
98%. Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3) δ 9.85 (s, 1H), 7.86 (d, J =
7.6 Hz, 1H), 7.59 – 7.56 (m, 3H), 7.46 (t, J = 7.5 Hz, 1H), 7.34 (d, J = 7.9 Hz, 2H), 7.07 
(d, J = 7.4 Hz, 1H), 4.99 and 4.80 (br, 2H), 3.65 (br, 3H).13C NMR (125 MHz, CDCl3) δ
189.40, 156.10, 142.41, 141.95, 134.88, 134.72, 132.39, 130.85, 129.44, 128.68, 128.27, 
118.45, 111.86, 54.62, 53.53. IR (neat, cm-1): 2954.98, 2851.81, 2751.36, 2228.37, 
1708.46, 1598.31, 1456.80, 1379.91, 1316.36, 1269.35, 1193.78, 778.53, 735.44, HRMS 
(ESI) (M+H+) Calcd. for C17H15N2O3+: 295.1077, found 295.1079.
methyl (2-formylphenyl)((perfluorophenyl)methyl)carbamate 
s3-k Yield: 97%. Hexanes/ethyl acetate = 4/1. 1H NMR (500 MHz, CDCl3) δ 9.94 (s, 1H), 
7.87 (dd, J = 7.7, 1.4 Hz, 1H), 7.61 (td, J = 7.7, 1.6 Hz, 1H), 7.49 (t, J = 7.6 Hz, 1H), 7.18 
(d, J = 7.8 Hz, 1H), 5.02 (br, 2H), 3.64 (br, 3H). 13C NMR (150 MHz, CDCl3) δ 189.48,
155.50, 145.45 (md, J = 250.0 Hz), 141.50, 141.12 (md, J = 255.3 Hz), 137.31 (md, J =
252.6 Hz), 134.82, 132.69, 131.10, 129.04, 128.53, 109.95, 53.58, 41.88. IR (neat, cm-1):
2957.90, 2838.25, 2751.54, 1706.21, 1526.90, 1503.64, 1456.77, 1439.58, 1383.57, 
1278.56, 966.81, 945.34, 760.50. HRMS (ESI) (M+H+) Calcd. for C16H11F5NO3+:
360.0654, found 360.0657.
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methyl (2-formylphenyl)(naphthalen-2-ylmethyl)carbamate 
s3-l Yield: 99%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.83 (s, 1H), 
7.84 – 7.70 (m, 3H), 7.73 – 7.72 (m, 1H), 7.57 (s, 1H), 7.53 (td, J = 7.7, 1.5 Hz, 1H), 7.47 
– 7.44 (m, 2H), 7.41-7.38 (m, 2H), 7.11 (br, 1H), 5.08 and 5.02 (br, 2H), 3.67 (br, 3H). 13C
NMR (150 MHz, CDCl3) δ 189.58, 156.26, 143.16, 134.73, 133.93, 133.15, 132.87, 
132.72, 129.46, 129.42, 128.81, 128.52, 127.94, 127.81, 127.67, 126.63, 126.22, 126.11, 
55.20, 53.42. IR (neat, cm-1): 3015.95, 2952.55, 2856.83, 2752.36, 1708.72, 1597.93, 
1446.53, 1365.74, 755.23. HRMS (ESI) (M+H+) Calcd. for C20H18NO3+: 320.1281, found 
320.1282.
methyl (2-formylphenyl)(4-vinylbenzyl)carbamate s3-m Yield: 
80%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.78 (s, 1H), 7.85 (d, J =
7.5 Hz, 1H), 7.56 (td, J = 7.6, 1.6 Hz, 1H), 7.40 – 7.43 (m, 1H), 7.30 (d, J = 8.0 Hz, 2H), 
7.17 – 7.07 (m, 3H), 6.66 (dd, J = 17.6, 10.9 Hz, 1H), 5.71 (d, J = 17.6 Hz, 1H), 5.23 (d, J
= 10.9 Hz, 1H), 4.86 (s, 2H), 3.65 (br, 3H).13C NMR (150 MHz, CDCl3) δ 189.56, 156.13, 
137.26, 136.26, 135.90, 134.75, 132.78, 129.33, 129.14, 128.79, 127.93, 126.42, 114.17, 
54.80, 53.36. IR (neat, cm-1): 2953.28, 2855.09, 2754.32, 1707.44, 1597.93, 1446.39, 
1379.05, 1269.78, 1193.14, 990.30, 910.56, 779.90. HRMS (ESI) (M+H+) Calcd. for 
C18H18NO3+: 296.1281, found 296.1282.
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methyl (2-formylphenyl)(3-phenylprop-2-yn-1-yl)carbamate 
s3-n Yield: 95%. Hexanes/ethyl acetate = 5/1. 1H NMR (400 MHz, CDCl3) δ 10.21 (s, 1H), 
7.97 (dd, J = 7.7, 1.7 Hz, 1H), 7.70 – 7.66 (m, 1H), 7.50 (t, J = 7.5 Hz, 1H), 7.43 (d, J =
7.6 Hz, 1H), 7.31 – 7.27 (m, 5H), 4.85 and 4.67 (br, 2H), 3.67 (br, 3H). 13C NMR (150 
MHz, CDCl3) δ 189.77, 155.48, 142.56, 134.87, 133.24, 131.45, 129.18, 128.84, 128.44, 
128.38, 128.19, 122.12, 85.46, 83.36, 53.51, 41.33. IR (neat, cm-1): 2955.69, 2861.87, 
1698.24, 1597.94, 1489.13, 1375.69, 1443.87, 1271.73, 758.84. HRMS (ESI) (M+H+)
Calcd. for C18H16NO3+: 294.1125, found 294.1126.
methyl (2-formylphenyl)(pyridin-2-ylmethyl)carbamate s3-o Yield: 
50%. Hexanes/ethyl acetate = 1/1. 1H NMR (600 MHz, CDCl3) δ 10.03 (s, 1H), 8.49 (s, 
1H), 7.85 (d, J = 7.5 Hz, 1H), 7.63 (td, J = 7.7, 1.7 Hz, 1H), 7.57 (t, J = 7.8 Hz, 1H), 7.41 
– 7.37 (m, 2H), 7.31 (d, J = 7.7 Hz, 1H), 7.17 – 7.15 (m, 1H), 5.03 and 5.00 (br, 2H), 3.65 
(br, 3H). 13C NMR (150 MHz, CDCl3) δ 190.08, 156.50, 156.12, 149.36, 143.70, 136.64, 
134.73, 132.67, 129.34, 128.23, 127.77, 122.95, 122.57, 56.45, 53.40. IR (neat, cm-1):
2955.07, 2854.05, 2359.77, 2343.66, 1711.48, 1598.24, 1486.57, 1459.02, 1310.65, 
1271.14, 1193.08, 779.37. HRMS (ESI) (M+H+) Calcd. for C15H15N2O3+: 271.1077, found 
271.1081.
Chapter 3. Enantioselective Radical C–H Alkylation for 2-Substituted Indoline Synthesis 
methyl (2-formylphenyl)(thiophen-3-ylmethyl)carbamate s3-p
Yield: 99%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.69 (s, 1H), 7.86 
(d, J = 7.6 Hz, 1H), 7.59 (td, J = 7.7, 1.4 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 7.25 – 7.24 (m, 
1H), 7.13 (d, J = 7.7 Hz, 1H), 7.00 (d, J = 1.5 Hz, 1H), 6.97 (d, J = 2.2 Hz, 1H), 4.94 and 
4.79 (br, 2H), 3.63 (br, 3H).13C NMR (150 MHz, CDCl3) δ 189.41, 155.90, 143.20, 136.85, 
134.81, 132.96, 129.05, 128.82, 128.02, 126.42, 124.39, 53.32, 49.64. IR (neat, cm-1):
2953.44, 2852.10, 2360.47, 2339.74, 1713.03, 1598.52, 1458.39, 1374.07, 1270.54, 
1193.41, 738.61. HRMS (ESI) (M+H+) Calcd. for C14H14NO3S+: 276.0689, found 
276.0691.
methyl (benzo[b]thiophen-3-ylmethyl)(2-formylphenyl)-
carbamate s3-q Yield: 80%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 
9.63 (s, 1H), 7.83 – 7.80 (m, 3H), 7.53 (td, J = 7.5, 1.3 Hz, 1H), 7.41 (t, J = 7.4 Hz, 1H), 
7.37 – 7.33 (m, 2H), 7.05 (s, 2H), 5.19 and 5.11 (br, 2H), 3.67 (s, 3H). 13C NMR (150 
MHz, CDCl3) δ 189.30, 156.02, 142.75, 140.34, 137.86, 134.70, 133.09, 131.19, 129.39, 
129.01, 128.12, 126.74, 124.62, 124.45, 122.87, 122.04, 53.48, 48.07. IR (neat, cm-1):
2952.77, 2852.10, 1692.59, 1597.84, 1446.29, 1268.88, 1193.07, 768.87, 734.65. HRMS 
(ESI) (M+Na+) Calcd. for C18H15NNaO3S+: 348.0665, found 348.0666.
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methyl butyl(2-formylphenyl)carbamate s3-r Yield: 50%. 
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 10.10 (s, 1H), 7.92 (d, J = 7.7 
Hz, 1H), 7.63 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.5 Hz, 1H), 7.25 (s, 1H), 3.70 and 3.61 (br, 
5H), 1.55 – 1.52 (m, 2H), 1.34 – 1.27 (m, 2H), 0.89 (t, J = 7.4 Hz, 3H). 13C NMR (150 
MHz, CDCl3) δ 189.82, 155.81, 143.92, 134.83, 132.79, 129.22, 128.63, 127.72, 53.12, 
51.21, 30.13, 19.98, 13.70. IR (neat, cm-1): 2958.28, 2934.23, 2863.57, 1715.49, 1599.16, 
1459.51, 1388.38, 1305.41, 1193.94, 772.69, 739.25. HRMS (ESI) (M+H+) Calcd. for 
C13H18NO3+: 236.1281, found 236.1283.
methyl N-(2-formylphenyl)-N-(methoxycarbonyl)glycinate s3-s
Yield: 63%. Hexanes/ethyl acetate = 2/1. 1H NMR (600 MHz, CDCl3) δ 10.27 (s, 1H), 
7.92 (d, J = 7.8 Hz, 1H), 7.62 (t, J = 7.7, 1H), 7.47 – 7.43 (m, 2H), 4.53 (d, J = 17.6 Hz, 
1H), 4.32 (d, J = 17.6 Hz, 1H), 3.75 (s, 3H), 3.81 and 3.67 (s, 3H). 13C NMR (125 MHz, 
CDCl3) δ 190.20, 169.60, 155.86, 143.16, 134.86, 132.55, 130.12, 129.51, 128.18, 53.65, 
52.32, 52.22. IR (neat, cm-1): 2955.86, 2854.05, 1749.40, 1714.17, 1694.29, 1599.00, 
1486.45, 1447.36, 1375.33, 1271.26, 1214.81, 776.76. HRMS (ESI) (M+H+) Calcd. for 
C12H14NO5+: 252.0866, found 252.0868.
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methyl (2-(diethylamino)-2-oxoethyl)(2-formylphenyl)-
carbamate s3-t Yield: 78%. Hexanes/ethyl acetate = 2/1. 1H NMR (500 MHz, CDCl3) δ 
10.30 (s, 1H), 7.87 (d, J = 7.5 Hz, 1H), 7.60 – 7.59 (m, 2H), 7.42 – 7.39 (m, 1H), 4.67 (d, 
J = 16.2 Hz, 1H), 4.21 (d, J = 16.2 Hz, 1H), 3.63 (s, 3H), 3.43 – 3.33 (br, m, 2H), 3.32 –
3.24 (br, m, 2H), 1.21 (t, J = 7.1 Hz, 3H), 1.10 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 190.61, 166.65, 155.98, 143.86, 134.67, 132.48, 129.23, 128.56, 127.70, 53.39, 
52.20, 41.18, 40.63, 14.14, 12.97. IR (neat, cm-1): 2975.98, 2934.23, 1712.52, 1693.54, 
1654.68, 1485.49, 1459.82, 1379.82, 1265.69, 1195.86, 760.72. HRMS (ESI) (M+H+)
Calcd. for C15H21N2O4+: 293.1496, found 293.1498.
methyl allyl(2-formylphenyl)carbamate s3-u Yield: 99%.
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 10.06 (s, 1H), 7.88 (dd, J =
7.7, 1.6 Hz, 1H), 7.60 (t, J = 7.7, 1H), 7.42 (t, J = 7.5 Hz, 1H), 7.26 – 7.24 (m, 1H), 5.89 
(ddt, J = 16.8, 10.2, 6.6 Hz, 1H), 5.12 – 5.07 (m, 2H), 4.28 (br, 2H), 3.61 (br, 3H). 13C
NMR (150 MHz, CDCl3) δ 189.84, 155.72, 143.38, 134.78, 132.67, 132.49, 129.44, 
128.67, 127.86, 119.14, 54.01, 53.26. IR (neat, cm-1): 2969.80, 1721.22, 1599.12, 1456.18, 
1375.60, 1229.57. HRMS (ESI) (M+H+) Calcd. for C12H14NO3+: 220.0968, found 
220.0974.
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tert-butyl (cyclopropylmethyl)(2-formylphenyl)carbamate s3-v Yield: 
45%. Hexanes/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 10.22 (s, 1H), 7.91 (d, J
= 7.5 Hz, 1H), 7.62 – 7.60 (m, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.26 (br, 1H), 3.81 (s, 1H), 
3.38 (s, 1H), 1.59 – 1.31 (m, 9H), 0.97 (br, 1H), 0.43 (br, 2H), 0.15 (s, 1H), 0.03 (s, 1H). 
13C NMR (150 MHz, CDCl3) major rotamer: δ 190.46, 154.43, 145.09, 134.70, 133.27, 
129.82, 128.31, 127.31, 80.94, 54.87, 29.70, 28.15, 9.96, 3.73. IR (neat, cm-1): 2979.07, 
2929.87, 2855.13, 2760.04, 1684.56, 1596.35, 1429.78, 1369.43, 1291.66, 1149.82, 
1129.13, 974.20, 760.89. HRMS (ESI) (M+Na+) Calcd. for C16H21NNaO3+: 298.1414, 
found 298.1413.
3.4.9 Synthetic Procedure for Triisopropyl Sulfonylhydrazone Derivatives 1
To a stirred solution of pure 2,4,6-triisopropylbenzenesulfonohydrazide 
(TPSNHNH2, 2 mmol) in THF (10.0 mL) at 0 oC, aldehyde s3 (1 equiv.) was added 
dropwise (or portionwise if solid). The reaction was monitored by TLC. After the reaction 
was completed, the solvent was removed directly under reduced pressure, and the crude 
solid was further purified by flash column chromatography.
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tert-butyl benzyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)-
hydrazono)methyl)phenyl)carbamate 1-a Yield: 70%. Hexanes/ethyl acetate = 6/1. 1H
NMR (500 MHz, CDCl3) δ 7.98 (s, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.47 (s, 1H), 7.33 (br, 
1H), 7.24 – 7.14 (m, 8H), 6.89 (s, 1H), 4.76 (d, J = 14.7 Hz, 1H), 4.57 (d, J = 14.7 Hz, 1H), 
4.26 (hept, J = 6.7 Hz, 2H), 2.90 (hept, J = 6.9 Hz, 1H), 1.33 – 1.25 (m, 27H).13C NMR 
(125 MHz, CDCl3) δ 154.82, 153.38, 151.36, 142.47, 141.10, 137.24, 131.38, 131.01, 
130.54, 128.84, 128.48, 127.75, 127.49, 127.27, 126.38, 123.82, 80.86, 54.10, 34.17, 
30.01, 28.20, 24.89, 23.53. IR (neat, cm-1): 3178.54, 2963.62, 1669.48, 1600.75, 1399.42, 
1315.89, 1157.20, 1071.86, 855.44, 757.16, 731.40. HRMS (ESI) (M+H+) Calcd. for 
C34H46N3O4S+: 592.3249, found 592.3274.
ethyl benzyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono) 
methyl) phenyl)carbamate 1-b Yield: 86%. Hexanes/ethyl acetate = 4/1. 1H NMR (500 
MHz, CDCl3) δ 8.10 (s, 1H), 7.82 (dd, J = 7.8, 1.4 Hz, 1H), 7.45 (s, 1H), 7.29 – 7.20 (m, 
5H), 7.17 – 7.14 (m, 4H), 6.91 (s, 1H), 4.79 and 4.76 (br, 1H), 4.63 and 4.61 (br, 1H), 4.25 
(hept, J = 6.7 Hz, 2H), 4.03 (br, 2H), 2.89 (hept, J = 6.9 Hz, 1H), 1.30 – 1.27 (m, 12H), 
1.25 (d, J = 6.9 Hz, 6H), 0.99 (br, 3H). 13C NMR (150 MHz, CDCl3) δ 155.87, 153.38, 
151.34, 141.87, 140.22, 136.72, 131.42, 131.14, 130.62, 129.05, 128.53, 127.94, 127.66, 
126.52, 123.99, 123.81, 62.12, 54.74, 34.17, 30.00, 24.88, 23.52, 14.46. IR (neat, cm-1):
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2960.77, 2869.70, 1673.95, 1600.11, 1455.15, 1319.36, 1297.65, 1166.56, 1037.84, 
942.18, 743.78, 657.99. HRMS (ESI) (M+H+) Calcd. for C32H42N3O4S+: 564.2891, found 
564.2876.
methyl benzyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)-
hydrazono)methyl)phenyl) carbamate 1-c Yield: 90%. Hexanes/ethyl acetate = 4/1. 1H
NMR (600 MHz, CDCl3) δ 8.13 (s, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.46 (s, 1H), 7.28 (td, J
= 7.6, 1.4 Hz, 1H), 7.25 – 7.22 (m, 4H), 7.18 (s, 2H), 7.15 (br, 2H), 6.91 (d, J = 6.5 Hz, 
1H), 4.75 (d, J = 14.5 Hz, 1H), 4.65 (d, J = 14.5 Hz, 1H), 4.24 (hept, J = 6.7 Hz, 2H), 3.54 
(s, 3H), 2.90 (hept, J = 6.9 Hz, 1H), 1.30 – 1.28 (m, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C
NMR (150 MHz, CDCl3) δ 156.31, 153.41, 151.33, 141.80, 140.04, 136.54, 131.36, 
131.18, 130.71, 129.12, 128.67, 128.56, 128.03, 127.83, 126.58, 123.82, 54.93, 53.26, 
34.17, 30.00, 24.87, 23.52. IR (neat, cm-1): 3213.94, 2958.2, 2869.64, 1696.82, 1601.14, 
1321.40, 1166.54, 1152.04. HRMS (ESI) (M+H+) Calcd. for C31H40N3O4S+: 550.2734, 
found 550.2740.
methyl (4-methoxybenzyl)(2-((2-((2,4,6-triisopropylphenyl) 
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-d Yield: 87%. Hexanes/ethyl acetate = 
3/1. 1H NMR (600 MHz, CDCl3) δ 8.24 (s, 1H), 7.82 (d, J = 7.8 Hz, 1H), 7.51 (s, 1H), 
7.31 – 7.27 (m, 1H), 7.24 – 7.20 (m, 1H), 7.18 (s, 2H), 7.07 (d, J = 7.5 Hz, 2H), 6.90 – 6.86
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(m, 1H), 6.78 (d, J = 8.5 Hz, 2H), 4.75 (d, J = 14.3 Hz, 1H), 4.51 (d, J = 14.3 Hz, 1H), 4.25 
(hept, J = 6.7 Hz, 2H), 3.77 (s, 3H), 3.52 (s, 3H), 2.89 (hept, J = 6.9 Hz, 1H), 1.29 (d, J =
6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 159.30, 156.29, 
153.38, 151.33, 141.79, 140.01, 131.38, 131.15, 130.61, 130.44, 128.82, 128.64, 127.77, 
126.52, 123.80, 113.87, 55.19, 54.29, 53.20, 34.16, 29.99, 24.85, 23.52. IR (neat, cm-1):
3161.77, 2957.90, 2868.98, 2359.85, 2342.17, 1704.86, 1681.69, 1456.72. HRMS (ESI) 
(M+H+) Calcd. for C32H42N3O5S+: 580.2840, found 580.2839.
methyl (3-methoxybenzyl)(2-((2-((2,4,6-triisopropylphenyl) 
sulfonyl) hydrazono)methyl)phenyl)carbamate 1-e Yield: 94%. Hexanes/ethyl acetate 
= 4/1. 1H NMR (600 MHz, CDCl3) δ 8.18 (s, 1H), 7.82 (dd, J = 7.8, 1.5 Hz, 1H), 7.50 (s, 
1H), 7.27 (ddd, J = 5.8, 4.9, 1.6 Hz, 1H), 7.23 (td, J = 7.6, 0.9 Hz, 1H), 7.18 – 7.15 (m, 
3H), 6.91 (br, 1H), 6.79 (dd, J = 8.2, 2.3 Hz, 1H), 6.73 (d, J = 7.0 Hz, 1H), 6.69 (s, 1H), 
4.76 (d, J = 14.5 Hz, 1H), 4.56 (d, J = 14.5 Hz, 1H), 4.24 (hept, J = 6.7 Hz, 2H), 3.72 (s, 
3H), 3.53 (s, 3H), 2.90 (hept, J = 6.9 Hz, 1H), 1.28 (d, J = 6.7 Hz, 12H), 1.24 (d, J = 6.9 
Hz, 6H). 13C NMR (125MHz, CDCl3) δ 159.62, 156.32, 153.40, 151.33, 141.80, 140.03, 
138.04, 131.40, 131.17, 130.67, 129.58, 128.68, 127.84, 126.56, 123.81, 121.30, 114.79, 
113.31, 55.19, 54.85, 53.27, 34.17, 30.00, 24.86, 23.52. IR (neat, cm-1): 3182.56, 2958.18, 
2932.27, 2869.32, 2359.69, 2343.66, 1706.33, 1679.61, 1454.13, 1263.22, 1153.49, 
735.74. HRMS (ESI) (M+H+) Calcd. for C32H42N3O5S+: 580.2840, found 580.2839.
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methyl (2-methylbenzyl)(2-((2-((2,4,6-triisopropylphenyl)sulfonyl) 
hydrazono)methyl)phenyl)carbamate 1-f Yield: 94%. Hexanes/ethyl acetate = 5/1. 1H
NMR (500 MHz, CDCl3) δ 8.06 (br, 1H), 7.80 (dd, J = 7.4, 2.0 Hz, 1H), 7.47 (s, 1H), 7.23 
(td, J = 7.6, 1.5 Hz, 2H), 7.18 (s, 2H), 7.10 (t, J = 7.3 Hz, 2H), 7.04 (t, J = 7.6 Hz, 2H), 
6.87 (br, 1H), 4.87 (d, J = 14.4 Hz, 1H), 4.69 (d, J = 14.4 Hz, 1H), 4.24 (hept, J = 6.7 Hz, 
2H), 3.56 (br, 3H), 2.90 (hept, J = 6.9 Hz, 1H), 2.01 (s, 3H), 1.28 (br, 12H), 1.25 (d, J =
6.9 Hz, 6H). 13C NMR (125 MHz, CDCl3) δ 158.95, 156.05, 153.99, 144.33, 142.49, 
139.24, 137.15, 134.05, 133.29, 133.11, 132.80, 131.38, 130.74, 130.50, 129.21, 128.72, 
126.66, 126.48, 55.95, 54.43, 36.83, 32.66, 27.53, 26.19, 21.59. IR (neat, cm-1): 3184.54, 
2957.29, 2868.69, 2360.21, 2342.60, 1706.76, 1676.98, 1456.36, 1152.06, 746.98, 658.54. 
HRMS (ESI) (M+H+) Calcd. for C32H42N3O4S+: 564.2891, found 564.2895.
methyl (2-chlorobenzyl)(2-((2-((2,4,6-triisopropylphenyl)sulfonyl) 
hydrazono)methyl)phenyl)carbamate 1-g Yield: 85%. Hexanes/ethyl acetate = 5/1. 1H
NMR (600 MHz, CDCl3) δ 7.96 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.60 (s, 1H), 7.28 – 7.25
(m, 1H), 7.21 (t, J = 6.9 Hz, 3H), 7.17 (s, 2H), 7.13 – 7.10 (m, 2H), 6.98 (br, 1H), 4.90 and 
4.88 (br, 2H), 4.23 (hept, J = 6.6 Hz, 2H), 3.57 (s, 3H), 2.90 (hept, J = 6.7 Hz, 1H), 1.29 
(br, 12H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 156.27, 153.36, 151.31, 
141.58, 139.60, 133.99, 133.80, 131.44, 131.40, 131.24, 130.55, 129.54, 129.36, 128.31, 
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127.84, 126.88, 126.53, 123.82, 53.41, 51.72, 34.17, 30.00, 24.86, 23.52. IR (neat, cm-1):
3162.51, 2958.56, 2929.17, 2868.95, 2360.16, 2342.85, 1684.03, 1599.56, 1456.61, 
1383.67, 1166.61, 739.94. HRMS (ESI) (M+H+) Calcd. for C31H39ClN3O4S+: 584.2344, 
found 584.2347.
methyl (3,4-dichlorobenzyl)(2-((2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-h Yield: 85%. Hexanes/ethyl acetate = 
4/1. 1H NMR (600 MHz, CDCl3) δ 7.99 (s, 1H), 7.83 (d, J = 7.0 Hz, 1H), 7.62 (s, 1H), 
7.32 (d, J = 8.2 Hz, 1H), 7.30 – 7.27 (m, 3H), 7.19 (s, 2H), 6.98 (d, J = 7.0 Hz, 1H), 6.82 
(br, 1H), 4.92 (d, J = 14.3 Hz, 1H), 4.38 – 4.22 (m, 3H), 3.56 (br, 3H), 2.90 (hept, J = 6.9 
Hz, 1H), 1.29 (d, J = 6.5 Hz, 12H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (125MHz, CDCl3)
δ 156.38, 153.53, 151.35, 141.26, 139.61, 136.89, 132.58, 132.10, 131.28, 130.83, 130.69, 
130.53, 128.72, 128.21, 128.12, 127.11, 123.87, 53.69, 53.45, 34.18, 30.03, 24.85, 23.51. 
IR (neat, cm-1): 3182.21, 2959.02, 2869.36, 1708.61, 1680.94, 1455.62, 1374.93, 1151.17, 
1033.78. HRMS (ESI) (M+H+) Calcd. for C31H38Cl2N3O4S+: 618.1955, found 618.1960.
methyl (4-nitrobenzyl)(2-((2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-i Yield: 50%. Hexanes/ethyl acetate = 
4/1. 1H NMR (600 MHz, CDCl3) δ 8.46 (s, 1H), 8.12 (d, J = 8.5 Hz, 2H), 7.83 (br, 1H), 
7.72 (s, 1H), 7.35 (d, J = 8.0 Hz, 2H), 7.27 – 7.25 (m, 2H), 7.19 (s, 2H), 6.80 (s, 1H), 5.10 
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(d, J = 14.4 Hz, 1H), 4.39 (d, J = 14.4 Hz, 1H), 4.25 (hept, J = 6.7 Hz, 2H), 3.58 (br, 3H), 
2.90 (hept, J = 6.9 Hz, 1H), 1.29 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR 
(150 MHz, CDCl3) δ 156.38, 153.63, 151.34, 147.57, 143.91, 141.15, 139.57, 131.17, 
130.77, 130.75, 129.68, 128.59, 128.21, 127.23, 123.89, 123.80, 54.07, 53.53, 34.18, 
30.02, 24.83, 23.51. IR (neat, cm-1): 3218.81, 2960.23, 2359.80, 1670.43, 1519.94, 
1346.84, 738.21. HRMS (ESI) (M+H+) Calcd. for C31H39N4O6S+: 595.2585, found 
595.2587.
methyl (4-cyanobenzyl)(2-((2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-j Yield: 80%. Hexanes/ethyl acetate = 
3/1. 1H NMR (600 MHz, CDCl3) 8.44 (br, 1H), 7.82 (br, 1H), 7.71 (s, 1H), 7.55 (d, J =
8.3 Hz, 2H), 7.29 – 7.24 (m, 4H), 7.19 (s, 2H), 6.79 (br, 1H), 5.05 (d, J = 14.6 Hz, 1H), 
4.35 (d, J = 14.6 Hz, 1H), 4.26 (hept, J = 6.7 Hz, 2H), 3.57 (br, 3H), 2.91 (hept, J = 6.9 Hz, 
1H), 1.30 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ
156.42, 153.60, 151.34, 141.92, 141.17, 139.60, 132.37, 131.23, 130.81, 130.68, 129.51, 
128.56, 128.15, 127.17, 123.88, 118.44, 111.87, 54.37, 53.50, 34.17, 30.02, 24.85, 23.51.
IR (neat, cm-1): 3190.41, 2959.79, 2870.26, 2360.11, 2343.40, 1706.75, 1684.15, 1265.40, 
742.06. HRMS (ESI) (M+H+) Calcd. for C32H39N4O4S+: 575.2687, found 575.2691.
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methyl ((perfluorophenyl)methyl)(2-((2-((2,4,6-triisopropyl-
phenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-k Yield: 92%. Hexanes/ethyl 
acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 8.28 (s, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.71 
(s, 1H), 7.31 (td, J = 7.6, 1.4 Hz, 1H), 7.27 – 7.25 (m, 1H), 7.18 (s, 2H), 6.98 (d, J = 7.8 
Hz, 1H), 4.96 (d, J = 14.3 Hz, 1H), 4.84 (d, J = 14.3 Hz, 1H), 4.24 (hept, J = 6.7 Hz, 2H), 
3.58 (br, 3H), 2.90 (hept, J = 6.9 Hz, 1H), 1.29 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 
6H). 13C NMR (150 MHz, CDCl3) δ 155.78, 153.51, 151.36, 145.39 (md, J = 253.0 Hz), 
141.12 (md, J = 251.6 Hz), 140.78, 138.56, 137.31 (md, J = 253.7 Hz), 131.32, 131.22, 
130.73, 128.35, 128.04, 127.05, 123.85, 109.61, 53.61, 41.62, 34.18, 30.02, 24.80, 23.50. 
IR (neat, cm-1): 3170.74, 2959.60, 2869.98, 1714.25, 1687.55, 1504.90, 1036.45, 738.86. 
HRMS (ESI) (M+H+) Calcd. for C31H35F5N3O4S+: 640.2263, found 640.2264.
methyl (naphthalen-2-ylmethyl)(2-((2-((2,4,6-triisopropyl-
phenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-l Yield: 96%. Hexanes/ethyl 
acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 8.04 (br, 1H), 7.83 – 7.82 (m, 1H), 7.80 –
7.79 (m, 1H), 7.76 (d, J = 8.4 Hz, 1H), 7.73 – 7.71 (m, 1H), 7.61 (s, 1H), 7.55 (s, 1H), 7.45 
(p, J = 7.6 Hz, 2H), 7.34 (d, J = 7.5 Hz, 1H), 7.24 – 7.20 (m, 2H), 7.17 (s, 2H), 6.84 (br, 
1H), 5.09 (d, J = 14.6 Hz, 1H), 4.59 (d, J = 14.6 Hz, 1H), 4.23 (hept, J = 6.6 Hz, 2H), 3.55 
(br, 3H), 2.89 (hept, J = 6.9 Hz, 1H), 1.27 (d, J = 6.6 Hz, 12H), 1.24 (d, J = 6.9 Hz, 6H).13C
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NMR (150 MHz, CDCl3) δ 156.53, 153.38, 151.32, 141.58, 139.98, 134.01, 133.12, 
132.83, 131.40, 131.00, 130.56, 128.77, 128.40, 128.03, 127.84, 127.66, 126.66, 126.25, 
126.14, 123.81, 54.99, 53.34, 34.16, 29.99, 24.84, 23.52. IR (neat, cm-1): 3169.11, 2956.97, 
2867.76, 2359.96, 1679.88, 1600.27, 1152.06, 751.50. HRMS (ESI) (M+H+) Calcd. for 
C35H42N3O4S+: 600.2891, found 600.2891.
methyl (2-((2-((2,4,6-triisopropylphenyl)sulfonyl)-
hydrazono)methyl)phenyl)(4-vinylbenzyl)carbamate 1-m Yield: 85%. Hexanes/ethyl 
acetate = 4/1. 1H NMR (500 MHz, CDCl3) δ 7.90 (s, 1H), 7.82 (dd, J = 7.7, 1.7 Hz, 1H), 
7.50 (s, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.27 – 7.22 (m, 2H), 7.17 (s, 2H), 7.11 (d, J = 7.7 
Hz, 2H), 6.88 (d, J = 7.5 Hz, 1H), 6.67 (dd, J = 17.6, 10.9 Hz, 1H), 5.72 (d, J = 17.6 Hz, 
1H), 5.25 (d, J = 10.9 Hz, 1H), 4.82 (d, J = 14.5 Hz, 1H), 4.51 (d, J = 14.5 Hz, 1H), 4.23 
(hept, J = 6.7 Hz, 2H), 3.53 (br, 3H), 2.89 (hept, J = 6.9 Hz, 1H), 1.28 (d, J = 6.7 Hz, 12H), 
1.24 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 156.37, 153.40, 151.79, 151.33, 
141.65, 139.99, 137.26, 136.20, 131.37, 131.03, 130.60, 129.23, 128.73, 126.66, 126.37, 
123.99, 123.81, 114.27, 54.58, 53.28, 34.16, 29.99, 24.85, 23.52. IR (neat, cm-1): 3182.58, 
2959.56, 2869.56, 1682.03, 1456.25, 1384.34, 1265.36, 742.69. HRMS (ESI) (M+H+)
Calcd. for C33H42N3O4S+: 576.2891, found 576.2895.
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methyl (3-phenylprop-2-yn-1-yl)(2-((2-((2,4,6-triisopropyl-
phenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-n Yield: 76%. Hexanes/ethyl 
acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 8.50 (s, 1H), 7.99 (s, 1H), 7.94 (d, J = 7.4 Hz, 
1H), 7.40 (t, J = 7.5 Hz, 1H), 7.33 – 7.28 (m, 5H), 7.23 (d, J = 6.5 Hz, 2H), 7.18 (s, 2H), 
4.60 (s, 2H), 4.27 (hept, J = 6.7 Hz, 2H), 3.56 (s, 3H), 2.91 (hept, J = 6.9 Hz, 1H), 1.29 (d, 
J = 6.7 Hz, 12H), 1.26 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 155.83, 153.36, 
151.34, 141.74, 139.40, 131.70, 131.51, 130.78, 128.48, 128.39, 128.32, 128.27, 126.54, 
123.83, 122.16, 85.33, 83.48, 53.52, 41.22, 34.18, 30.02, 24.82, 23.53. IR (neat, cm-1):
3188.68, 2960.16, 2868.25, 1682.88, 1600.66, 1454.10, 1280.56, 1167.12, 755.85. HRMS 
(ESI) (M+H+) Calcd. for C33H40N3O4S+: 574.2734, found 574.2732.
methyl (pyridin-2-ylmethyl)(2-((2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-o Yield: 76%. Hexanes/ethyl acetate = 
2/1. 1H NMR (600 MHz, CDCl3) δ 8.48 (s, 1H), 8.33 (s, 1H), 7.89 (s, 1H), 7.81 (d, J = 7.8 
Hz, 1H), 7.57 (td, J = 7.7, 1.4 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.21 (t, J = 7.6 Hz, 2H), 
7.17 (s, 2H), 7.13 – 7.08 (m, 2H), 4.86 (br, 2H), 4.27 (hept, J = 6.7 Hz, 2H), 3.55 (s, 3H), 
2.89 (hept, J = 6.9 Hz, 1H), 1.29 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR 
(150 MHz, CDCl3) δ 156.30, 153.31, 151.31, 149.35, 142.27, 140.43, 136.62, 131.53, 
131.26, 130.63, 128.09, 127.73, 126.56, 123.80, 123.68, 122.98, 122.65, 56.27, 53.34, 
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34.17, 30.00, 24.88, 23.53. IR (neat, cm-1): 3208.37, 2957.41, 2867.81, 2359.66, 2341.70, 
1683.12, 1596.95, 1445.71, 1375.62, 1164.31, 737.28. HRMS (ESI) (M+H+) Calcd. for 
C30H39N4O4S+: 551.2687, found 551.2693.
methyl (thiophen-3-ylmethyl)(2-((2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-p Yield: 85%. Hexanes/ethyl acetate = 
4/1. 1H NMR (600 MHz, CDCl3) δ 8.04 (s, 1H), 7.84 (d, J = 7.7 Hz, 1H), 7.39 (s, 1H), 
7.31 (td, J = 7.6, 1.3 Hz, 1H), 7.26 – 7.24 (m, 1H), 7.21 – 7.20 (m, 1H), 7.18 (s, 2H), 7.00 
– 6.92 (m, 3H), 4.73 – 4.65 (m, 2H), 4.25 (hept, J = 6.7 Hz, 2H), 3.53 (s, 3H), 2.90 (hept, 
J = 6.9 Hz, 1H), 1.29 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, 
CDCl3) δ 156.12, 153.42, 151.35, 141.73, 139.99, 137.08, 131.39, 131.30, 130.75, 128.60, 
128.30, 127.90, 126.53, 126.25, 124.57, 123.83, 53.24, 49.37, 34.18, 30.02, 24.89, 23.53. 
IR (neat, cm-1): 3196.36, 2957.33, 2868.55, 1681.89, 1454.44, 1374.11, 1153.88, 768.53, 
588.75. HRMS (ESI) (M+H+) Calcd. for C29H38N3O4S2+: 556.2298, found 556.2301.
methyl (benzo[b]thiophen-3-ylmethyl)(2-((2-((2,4,6-
triisopropyl phenyl) sulfonyl)hydrazono)methyl)phenyl)carbamate 1-q Yield: 80%. 
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 7.91 (br, 1H), 7.87 – 7.86 (m, 
1H), 7.72 (d, J = 7.8 Hz, 1H), 7.40 (p, J = 6.5 Hz, 2H), 7.29 – 7.26 (m, 1H), 7.22 (t, J = 7.5 
Hz, 1H), 7.15 (s, 2H), 7.08 (br, 2H), 6.94 (s, 1H), 6.91 (d, J = 7.3 Hz, 1H), 5.21 (d, J =
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14.7Hz, 1H), 4.82 (d, J = 14.7 Hz, 1H), 4.14 (hept, J = 6.7 Hz, 2H), 3.54 (br, 3H), 2.88 
(hept, J = 6.9 Hz, 1H), 1.28 – 1.23 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 156.25,
153.32, 151.27, 141.60, 140.33, 139.41, 138.01, 131.55, 131.36, 131.01, 130.62, 128.67, 
127.94, 127.09, 126.35, 124.58, 124.41, 123.75, 123.11, 122.07, 53.35, 47.86, 34.13, 
29.93, 24.85, 23.50. IR (neat, cm-1): 3170.74, 2959.60, 2869.98, 1714.25, 1687.55, 
1521.47, 1504.90, 1122.65, 944.15, 738.86. HRMS (ESI) (M+H+) Calcd. for 
C33H40N3O4S2+: 606.2455, found 606.2456.
methyl butyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)-
hydrazono)methyl)phenyl)carbamate 1-r Yield: 67%. Hexanes/ethyl acetate = 5/1. 1H
NMR (600 MHz, CDCl3) δ 8.91 (s, 1H), 7.90 (d, J = 8.0 Hz, 1H), 7.88 (s, 1H), 7.37 – 7.35
(m, 1H), 7.28 – 7.26 (m, 1H), 7.18 (s, 2H), 7.10 (d, J = 7.8 Hz, 1H), 4.30 (hept, J = 6.7 Hz, 
2H), 3.67 (br, 1H), 3.54 (s, 3H), 3.41 (br, 1H), 2.90 (hept, J = 6.9 Hz, 1H), 1.48 – 1.43 (m, 
2H), 1.30 (d, J = 6.7 Hz, 12H), 1.29 – 1.27 (m, 2H), 1.25 (d, J = 6.9 Hz, 6H), 0.84 (t, J =
7.4 Hz, 3H). 13C NMR (150 MHz, CDCl3) δ 156.18, 153.30, 151.27, 141.28, 140.26, 
131.56, 131.18, 130.61, 128.50, 127.69, 126.48, 123.79, 53.14, 51.01, 34.17, 29.98, 29.78, 
24.87, 23.52, 19.92, 13.68. IR (neat, cm-1): 3155.25, 2956.43, 2868.74, 2359.98, 2342.85, 
1682.72, 1601.37, 1456.82, 1315.52, 1152.59, 555.64. HRMS (ESI) (M+H+) Calcd. for 
C28H42N3O4S+: 516.2891, found 516.2898.
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methyl N-(methoxycarbonyl)-N-(2-((2-((2,4,6-triisopropylphenyl) 
sulfonyl) hydrazono)methyl)phenyl)glycinate 1-s Yield: 90%. Hexanes/ethyl acetate = 
3/1. 1H NMR (600 MHz, CDCl3) δ 8.34(s, 1H), 8.17 (s, 1H), 7.88 (d, J = 7.8 Hz, 1H), 7.35 
(td, J = 7.5, 1.1 Hz, 1H), 7.28 – 7.24 (m, 2H), 7.18 (s, 2H), 4.31 – 4.18 (m, 3H), 3.78 (d, J
= 11.2 Hz, 1H), 3.70 (s, 3H), 3.56 (s, 3H), 2.89 (hept, J = 6.9 Hz, 1H), 1.30 (d, J = 6.7 Hz, 
12H), 1.24 (d, J = 6.9 Hz, 6H). 13C NMR (150 MHz, CDCl3) δ 169.56, 156.15, 153.32, 
151.30, 142.46, 140.38, 131.52, 131.32, 130.83, 128.07, 127.84, 126.70, 123.80, 53.57, 
52.28, 52.24, 34.16, 30.00, 24.85, 23.52. IR (neat, cm-1): 3176.72, 3057.43, 2958.72, 
1752.67, 1692.37, 1599.82, 1264.81, 1165.49, 734.33, 703.22. HRMS (ESI) (M+H+)
Calcd. for C27H38N3O6S+: 532.2476, found 532.2479.
methyl (2-(diethylamino)-2-oxoethyl)(2-((2-((2,4,6-triisopropyl-
phenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-t Yield: 78%. Hexanes/ethyl 
acetate = 1/1. 1H NMR (600 MHz, CDCl3) δ 8.46 (s, 1H), 8.38 (s, 1H), 7.87 (d, J = 7.8 Hz, 
1H), 7.38 – 7.32 (m, 2H), 7.24 – 7.23 (m, 1H), 7.17 (s, 2H), 4.36 – 4.28 (m, 4H), 3.52 (s, 
3H), 3.38 – 3.30 (m, 2H), 3.26 – 3.18 (m, 2H), 2.89 (hept, J = 6.9 Hz, 1H), 1.30 (t, J = 6.7 
Hz, 12H), 1.24 (d, J = 6.9 Hz, 6H), 1.16 (t, J = 7.1 Hz, 3H), 1.08 (t, J = 7.1 Hz, 3H). 13C
NMR (150 MHz, CDCl3) δ 166.43, 156.25, 153.19, 151.29, 143.43, 141.16, 131.68, 
131.51, 130.64, 128.11, 127.67, 126.48, 123.76, 53.40, 52.33, 41.12, 40.67, 34.15, 29.98, 
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24.88, 23.52, 14.10, 12.99. IR (neat, cm-1): 3159.61, 2958.54, 2869.40, 1694.41, 1651.06, 
1455.46, 1153.45, 1036.92, 944.22, 757.98. HRMS (ESI) (M+H+) Calcd. for 
C30H45N4O5S+: 573.3105, found 573.3108.
methyl allyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono)-
methyl)phenyl)carbamate 1-u Yield: 90%. Hexanes/ethyl acetate = 5/1. 1H NMR (500 
MHz, CDCl3) δ 8.07 (br, 1H), 7.87 (d, J = 7.9 Hz, 1H), 7.76 (s, 1H), 7.35 (td, J = 7.7, 1.6 
Hz, 1H), 7.28 – 7.25 (m, 1H), 7.18 (s, 2H), 7.09 (d, J = 7.9 Hz, 1H), 5.80 (ddt, J = 16.8, 
10.1, 6.6 Hz, 1H), 5.08 – 5.02 (m, 2H), 4.30 – 4.21 (m, 3H), 4.02 (br, 1H), 3.54 (br, 3H), 
2.90 (hept, J = 6.9 Hz, 1H), 1.30 (d, J = 6.7 Hz, 12H), 1.25 (d, J = 6.9 Hz, 6H). 13C NMR 
(125 MHz, CDCl3) δ 156.04, 153.37, 151.31, 141.63, 132.18, 131.48, 131.17, 130.64, 
128.51, 127.82, 126.60, 124.00, 123.81, 119.20, 53.83, 53.23, 34.18, 30.00, 24.86, 23.52. 
IR (neat, cm-1): 3146.27, 2959.08, 2869.15, 1675.25, 1601.09, 1455.41, 1376.42, 1278.58, 
1058.74, 1038.32, 937.35, 751.55. HRMS (ESI) (M+H+) Calcd. for C27H38N3O4S+:
500.2578, found 500.2583.
tert-butyl (cyclopropylmethyl)(2-((2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-v Yield: 83%. Hexanes/ethyl acetate = 
5/1. 1H NMR (600 MHz, CDCl3) δ 8.01 (s, 1H), 7.88 (s, 1H), 7.86 (d, J = 7.9 Hz, 1H), 
7.34 (t, J = 7.3 Hz, 1H), 7.22 (t, J = 7.6 Hz, 1H), 7.17 (s, 2H), 7.12 (s, 1H), 4.31 – 4.25 (m, 
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2H), 3.37 – 3.34 (m, 2H), 2.93 – 2.86 (m, 1H), 1.48 (br, 2H), 1.30 – 1.24 (m, 25H), 0.86 
(s, 1H), 0.35 and 0.29 (br, 2H), 0.10 – 0.03 (m, 1H), 0.01 – -0.05 (m, 1H). 13C NMR (150 
MHz, CDCl3) δ 154.74, 153.32, 151.34, 142.51, 141.47, 131.43, 131.29, 130.41, 128.46, 
127.12, 126.18, 123.78, 80.47, 54.69, 34.16, 29.99, 28.20, 24.87, 23.52, 9.90, 3.76, 3.44. 
IR (neat, cm-1): 3163.62, 2961.96, 2867.56, 2359.83, 1670.21, 1601.26, 1154.31, 757.50, 
590.96. HRMS (ESI) (M+Na+) Calcd. for C31H45N3NaO4S+: 578.3023, found 578.3021.
3.4.10 Procedure for [Co(P6)]-Catalyzed Enantioselective Radical C–H Alkylation
An oven-dried Schlenk tube was charged with sulfonyl hydrazone 1 (0.1 mmol), 
[Co(P6)] (2 mol %) and Cs2CO3 (0.2 mmol). The Schlenk tube was then evacuated and 
back filled with nitrogen for 3 times. The Teflon screw cap was replaced with a rubber 
septum, methanol (1.0 mL) was added via a gastight syringe. The Schlenk tube was then 
purged with nitrogen for 30 s and the rubber septum was replaced with a Teflon screw cap. 
The mixture was then stirred at RT. After 24 h, the reaction mixture was filtrated through 
a short pad of silica gel, concentrated under vacuum and purified by flash column 
chromatography. The fractions containing product were collected and concentrated under 
vacuum to afford the desired compound 2.
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tert-butyl (R)-2-phenylindoline-1-carboxylate 2a Yield: 82%. ee:
66%. Hexanes/ethyl acetate = 9/1, Rf = 0.50. 1H NMR (600 MHz, CDCl3) δ 7.93 (s, 1H), 
7.28 – 7.17 (m, 6H), 7.11 (d, J = 7.3 Hz, 1H), 6.97 (t, J = 7.4 Hz, 1H), 5.36 (br, 1H), 3.66 
(dd, J = 16.2, 10.7 Hz, 1H), 2.95 (d, J = 16.2 Hz, 1H), 1.30 (br, 9H). 13C NMR (150 MHz, 
CDCl3) δ 152.34, 144.60, 143.00, 129.10, 128.47, 127.58, 127.10, 125.24, 124.75, 122.52, 
114.62, 80.73, 62.58, 37.76, 28.13. IR (neat, cm-1): 2977.25, 2929.13, 1693.35, 1482.59, 
1387.15, 1139.31, 1015.13, 760.13, 701.62. HPLC analysis: ee = 66%. IA (99.7% hexanes: 
0.3% isopropanol, 0.8 mL/min): tmajor = 17.03 min, tminor = 14.45 min. [α]20 D = 29.6 (c =
0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C19H22NO2+: 296.1645, found 296.1648.
ethyl (R)-2-phenylindoline-1-carboxylate 2b Yield: 92%. ee: 86%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.55. 1H NMR (600 MHz, CDCl3) δ 7.91 (s, 1H), 7.28 –
7.18 (m, 6H), 7.14 (d, J = 7.3 Hz, 1H), 7.00 (t, J = 7.4 Hz, 1H), 5.43 (br, 1H), 4.13 (br, 
2H), 3.70 (dd, J = 16.2, 10.6 Hz, 1H), 2.99 (d, J = 16.2 Hz, 1H), 1.08 (br, 3H). 13C NMR 
(150 MHz, CDCl3) δ 153.28, 143.98, 129.25, 128.54, 127.67, 127.27, 125.36, 124.82, 
122.88, 114.85, 62.36, 61.36, 37.84, 14.32. IR (neat, cm-1): 2979.21, 2928.36, 1709.64, 
1486.22, 1407.35, 1382.31, 1274.04, 1055.34, 755.99. HPLC analysis: ee = 86%. IA (99% 
hexanes: 1% isopropanol, 0.8 mL/min): tmajor = 17.07 min, tminor = 12.02 min. [α]20 D = 50.8
(c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C17H18NO2+: 268.1338, found 268.1342.
Chapter 3. Enantioselective Radical C–H Alkylation for 2-Substituted Indoline Synthesis 
methyl (R)-2-phenylindoline-1-carboxylate 2c Yield: 92%. ee: 94%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.50. 1H NMR (600 MHz, CDCl3) δ 7.92 (s, 1H), 7.29 –
7.18 (m, 6H), 7.14 (d, J = 7.3 Hz, 1H), 7.00 (t, J = 7.4 Hz, 1H), 5.46 and 5.44 (br, 1H), 
3.71 (dd, J = 16.2, 10.5 Hz, 1H), 3.70 (br, 3H), 2.98 (dd, J = 16.2, 2.7 Hz, 1H). 13C NMR 
(125 MHz, CDCl3) δ 153.72, 143.74, 142.55, 129.42, 128.60, 127.42, 127.30, 125.23, 
124.86, 123.00, 114.88, 62.30, 52.51, 37.92. IR (neat, cm-1): 2952.64, 2920.54, 1705.53, 
1483.87, 1440.85, 1386.08, 1274.07, 1055.93, 753.68. HPLC analysis: ee = 94%. IA 
(99.5% hexanes: 0.5% isopropanol, 0.8 mL/min): tmajor = 26.13 min, tminor = 19.12 min. 
[α]20 D = 52.8 (c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C16H16NO2+: 254.1176, 
found 254.1181.
methyl (R)-2-(4-methoxyphenyl)indoline-1-carboxylate 2d 
Yield: 98%. ee: 94%. Hexanes/ethyl acetate = 5/1, Rf = 0.48. 1H NMR (600 MHz, CDCl3)
δ 7.89 (s, 1H), 7.24 (t, J = 7.7 Hz, 1H), 7.16 – 7.12 (m, 3H), 7.01 (t, J = 7.4 Hz, 1H), 6.81 
(d, J = 8.5 Hz, 2H), 5.42 and 5.40 (br, 1H), 3.77 (s, 3H), 3.71 (br, 3H), 3.69 (dd, J = 16.2, 
10.4 Hz, 1H), 2.97 (dd, J = 16.2, 2.1 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 158.81, 
153.76, 142.51, 135.98, 129.91, 127.64, 126.56, 124.85, 122.95, 114.92, 113.92, 61.84, 
55.21, 52.52, 37.93. IR (neat, cm-1): 2951.72, 1704.02, 1612.04, 1512.83, 1459.71, 
1247.99, 1051.36, 1025.76, 846.10, 742.09. HPLC analysis: ee = 94%. IA (99% hexanes:
1% isopropanol, 1.0 mL/min): tmajor = 24.97 min, tminor = 19.37 min. [α]20 D = 72.8 (c = 0.5,
CHCl3). HRMS (ESI) (M+H+) Calcd. for C17H18NO3+: 284.1281, found 284.1278.
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methyl (R)-2-(3-methoxyphenyl)indoline-1-carboxylate 2e 
Yield: 98%. ee: 90%. Hexanes/ethyl acetate = 5/1, Rf = 0.45. 1H NMR (600 MHz, CDCl3)
δ 7.91 (s, 1H), 7.26 – 7.23 (m, 1H), 7.20 (t, J = 7.9 Hz, 1H), 7.13 (d, J = 7.3 Hz, 1H), 7.00 
(t, J = 7.4 Hz, 1H), 6.78 – 6.76 (m, 2H), 6.73 (s, 1H), 5.43 and 5.42 (br, 1H), 3.75 – 3.68 
(m, 7H), 2.97 (dd, J = 16.2, 2.7 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 159.77, 153.74, 
145.48, 129.73, 127.69, 124.88, 123.03, 117.70, 117.48, 114.90, 113.20, 112.26, 111.26,
62.27, 55.14, 52.59, 37.93. IR (neat, cm-1): 2955.13, 1701.26, 1599.57, 1483.93, 1440.81, 
1385.47, 1264.11, 1134.70, 1056.34, 733.23. HPLC analysis: ee = 90%. IA (99% hexanes:
1% isopropanol, 1.0 mL/min): tmajor = 24.61 min, tminor = 15.78 min. [α]20 D = 47.2 (c = 0.5,
CHCl3). HRMS (ESI) (M+H+) Calcd. for C17H18NO3+: 284.1281, found 284.1282.
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methyl (R)-2-(o-tolyl)indoline-1-carboxylate 2f Yield: 96%. ee:
94%. Hexanes/ethyl acetate = 6/1, Rf = 0.5. 1H NMR (600 MHz, CDCl3) δ 7.99 (s, 1H), 
7.27 – 7.25 (m, 1H), 7.17 (d, J = 7.4 Hz, 1H), 7.14 – 7.10 (m, 2H), 7.06 (t, J = 7.5 Hz, 1H), 
7.01 – 6.99 (m, 2H), 5.67 and 5.66 (br, 1H), 3.73 (dd, J = 16.0, 10.6 Hz, 1H), 3.67 (br, 3H), 
2.84 (dd, J = 16.0, 3.0 Hz, 1H), 2.42 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 153.74, 142.81, 
141.90, 133.67, 130.50, 129.33, 127.71, 126.97, 126.38, 125.07, 123.53, 123.03, 114.87, 
59.16, 52.63, 37.03, 19.28. IR (neat, cm-1): 2954.05, 1702.15, 1599.16, 1485.45, 1440.67, 
1265.75, 1191.94, 1054.33, 737.90. HPLC analysis: ee = 94%. IA (99.5% hexanes: 0.5% 
isopropanol, 0.8 mL/min): tmajor = 25.25 min, tminor = 18.29 min. [α]20 D = 167.2 (c = 0.5,
CHCl3). HRMS (ESI) (M+H+) Calcd. for C17H18NO2+: 268.1332, found 268.1336.
methyl (R)-2-(2-chlorophenyl)indoline-1-carboxylate 2g Yield: 
92%. ee: 93%. Hexanes/ethyl acetate = 6/1, Rf = 0.55. 1H NMR (600 MHz, CDCl3) δ 7.99 
(s, 1H), 7.39 (d, J = 7.8 Hz, 1H), 7.28 – 7.25 (m, 1H), 7.17 (t, J = 7.4 Hz, 1H), 7.15 – 7.11 
(m, 2H), 7.06 (d, J = 7.6 Hz, 1H), 7.01 (t, J = 7.4 Hz, 1H), 5.86 and 5.84 (br, 1H), 3.79 (dd, 
J = 16.3, 10.5 Hz, 1H), 3.69 (s, 3H), 2.89 (dd, J = 16.3, 2.3 Hz, 1H). 13C NMR (150 MHz, 
CDCl3) δ 153.60, 142.64, 140.88, 131.50, 129.73, 129.00, 128.22, 127.75, 127.10, 125.29, 
125.08, 123.23, 114.93, 59.53, 52.70, 36.92. IR (neat, cm-1): 2954.71, 1701.97, 1601.19, 
1484.01, 1439.31, 1385.42, 1056.01, 744.34, 628.11. HPLC analysis: ee = 93%. IA (99% 
hexanes: 1% isopropanol, 0.8 mL/min): tmajor = 15.71 min, tminor = 12.04 min. [α]20 D = 77.6
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(c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C16H15ClNO2+: 288.0786, found 
288.0792.
methyl (R)-2-(3,4-dichlorophenyl)indoline-1-carboxylate 2h
Yield: 85%. ee: 96%. Hexanes/ethyl acetate = 6/1, Rf = 0.55. 1H NMR (600 MHz, CDCl3)
δ 7.91 (s, 1H), 7.35 (d, J = 8.3 Hz, 1H), 7.29 – 7.25 (m, 2H), 7.15 (d, J = 7.3 Hz, 1H), 7.03 
(t, J = 7.4 Hz, 2H), 5.40 and 5.38 (br, 1H), 3.73 (dd, J = 16.3, 10.6 Hz, 1H), 3.71 (br, 3H), 
2.93 (dd, J = 16.3, 3.0 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 153.44, 143.98, 132.69, 
131.36, 130.72, 127.98, 127.46, 124.98, 124.71, 123.36, 115.00, 61.38, 52.77, 37.73. IR 
(neat, cm-1): 2953.91, 1705.31, 1601.07, 1484.60, 1441.48, 1383.34, 1274.30, 1057.23, 
1030.58, 738.80. HPLC analysis: ee = 96%. IB (99.5% hexanes: 0.5% isopropanol, 0.8 
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mL/min): tmajor = 18.57 min, tminor = 23.24 min. [α]20 D = 58.0 (c = 0.5, CHCl3). HRMS 
(ESI) (M+H+) Calcd. for C16H14Cl2NO2+: 322.0396, found 322.0393.
methyl (R)-2-(4-nitrophenyl)indoline-1-carboxylate 2i Yield: 
96%. ee: 87%. Hexanes/ethyl acetate = 4/1, Rf = 0.38. 1H NMR (600 MHz, CDCl3) δ 8.16
(d, J = 8.6 Hz, 2H), 7.95 (br, 1H), 7.37 (d, J = 7.8 Hz, 2H), 7.28 (t, J = 7.8 Hz, 1H), 7.16 
(d, J = 7.3 Hz, 1H), 7.04 (t, J = 7.5 Hz, 1H), 5.55 and 5.53 (br, 1H), 3.77 (dd, J = 16.3, 10.7 
Hz, 1H), 3.71 (br, 3H), 2.95 (dd, J = 16.3, 3.0 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ
150.86, 147.28, 128.10, 126.20, 125.03, 124.13, 123.49, 115.00, 61.78, 52.82, 37.60. IR 
(neat, cm-1): 2961.51, 2940.10, 1714.04, 1595.41, 1509.88, 1483.70, 1382.51, 1141.76, 
1055.66, 762.06. HPLC analysis: ee = 87%. IA (98% hexanes: 2% isopropanol, 1.0 
mL/min): tmajor = 27.95 min, tminor = 34.67 min. [α]20 D = 43.2 (c = 0.5, CHCl3). HRMS 
(ESI) (M+H+) Calcd. for C16H15N2O4+: 299.1026, found 299.1026.
methyl (R)-2-(4-cyanophenyl)indoline-1-carboxylate 2j Yield: 
97%. ee: 94%. Hexanes/ethyl acetate = 4/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 7.94 
(s, 1H), 7.59 (d, J = 8.2 Hz, 2H), 7.31 – 7.25 (m, 3H), 7.15 (d, J = 7.3 Hz, 1H), 7.03 (t, J =
7.4 Hz, 1H), 5.49 and 5.48 (br, 1H), 3.75 (dd, J = 16.3, 10.7 Hz, 1H), 3.71 (br, 3H), 2.93 
(dd, J = 16.3, 3.0 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 153.47, 148.89, 132.64, 128.57, 
128.03, 126.09, 125.00, 123.42, 118.63, 114.96, 111.34, 61.96, 52.77, 37.63. IR (neat, cm-
1): 2954.50, 2228.06, 1701.14, 1607.61, 1483.90, 1463.55, 1384.31, 1272.02, 1055.25, 
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749.31. HPLC analysis: ee = 94%. IA (98% hexanes: 2% isopropanol, 1.0 mL/min): tmajor
= 28.18 min, tminor = 32.55 min. [α]20 D = 114.4 (c = 0.5, CHCl3). HRMS (ESI) (M+H+)
Calcd. for C17H15N2O2+: 279.1128, found 279.1132.
methyl (R)-2-(perfluorophenyl)indoline-1-carboxylate 2k 
Yield: 90%. ee: 95%. Hexanes/ethyl acetate = 7/1, Rf = 0.6. 1H NMR (600 MHz, CDCl3)
δ 7.89 and 7.51 (br, 1H), 7.26 – 7.24 (m, 1H), 7.17 (d, J = 7.4 Hz, 1H), 7.04 (t, J = 7.4 Hz, 
1H), 5.81 (br, 1H), 3.85 (br, 3H), 3.76 (dd, J = 16.5, 11.4 Hz, 1H), 3.12 (dd, J = 16.5, 4.8 
Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 152.80, 144.97 (md, J = 253.6 Hz), 141.89, 
140.94, 140.59 (md, J = 254.0 Hz), 137.51 (md, J = 251.4 Hz), 128.46, 127.92, 124.14, 
123.26, 116.47, 52.84, 35.78, 35.20. IR (neat, cm-1): 2961.76, 1713.96, 1503.70, 1484.98, 
1602.15, 1442.06, 1387.29, 1282.30, 1193.43, 1123.53, 1011.90, 752.80. HPLC analysis: 
ee = 95%. IA (99.5% hexanes: 0.5% isopropanol, 0.8 mL/min): tmajor = 33.47 min, tminor =
14.21 min. [α]20 D = -54.4 (c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C16H11F5NO2+:
344.0704, found 344.0708.
methyl (R)-2-(naphthalen-2-yl)indoline-1-carboxylate 2l 
Yield: 90%. ee: 94%. Hexanes/ethyl acetate = 7/1, Rf = 0.58. 1H NMR (600 MHz, CDCl3)
δ 7.99 (s, 1H), 7.80 – 7.77 (m, 3H), 7.64 (br, 1H), 7.46 – 7.43 (m, 2H), 7.31 – 7.28 (m, 
2H), 7.16 (d, J = 7.2 Hz, 1H), 7.03 (td, J = 7.5, 0.7 Hz, 1H), 5.63 and 5.62 (br, 1H), 3.78 
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(dd, J = 16.3, 10.6 Hz, 1H), 3.68 (s, 3H), 3.05 (dd, J = 16.3, 2.5 Hz, 1H). 13C NMR (150 
MHz, CDCl3) δ 153.82, 141.06, 133.28, 132.79, 128.72, 127.92, 127.77, 127.61, 126.14, 
125.74, 124.94, 123.77, 123.52, 123.10, 114.95, 62.48, 52.60, 37.99. IR (neat, cm-1):
2917.63, 2849.15, 1701.58, 1598.18, 1485.44, 1440.01, 1274.59, 1152.34, 1054.00, 
748.53. HPLC analysis: ee = 94%. IA (99% hexanes: 1% isopropanol, 0.8 mL/min): tmajor
= 27.96 min, tminor = 20.63 min. [α]20 D = 83.2 (c = 0.5, CHCl3). HRMS (ESI) (M+H+)
Calcd. for C20H18NO2+: 304.1332, found 304.1337.
methyl (R)-2-(4-vinylphenyl)indoline-1-carboxylate 2m Yield: 
57%. ee: 95%. Hexanes/ethyl acetate = 6/1, Rf = 0.50. 1H NMR (600 MHz, CDCl3) δ 7.92 
(s, 1H), 7.32 (d, J = 8.1 Hz, 2H), 7.26 – 7.24 (m, 1H), 7.15 – 7.10 (m, 3H), 7.01 (t, J = 7.4 
Hz, 1H), 6.67 (dd, J = 17.6, 10.9 Hz, 1H), 5.70 (d, J = 17.6 Hz, 1H), 5.45 and 5.43 (br, 
1H), 5.21 (d, J = 10.9 Hz, 1H), 3.72 (br, 3H), 3.71 (dd, J = 16.1, 10.4 Hz, 1H), 2.97 (dd, J
= 16.2, 2.6 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 153.70, 145.14, 143.34, 136.76, 
136.38, 128.06, 127.72, 126.50, 125.48, 124.89, 123.04, 114.91, 113.74, 62.12, 52.57, 
37.94. IR (neat, cm-1): 2952.07, 1705.42, 1483.20, 1439.26, 1382.70, 1271.60, 1136.01, 
1053.63, 733.20. HPLC analysis: ee = 95%. IA (99.5% hexanes: 0.5% isopropanol, 0.8 
mL/min): tmajor = 30.74 min, tminor = 22.49 min. [α]20 D = 40.8 (c = 0.5, CHCl3). HRMS 
(ESI) (M+H+) Calcd. for C18H18NO2+: 280.1332, found 280.1336.
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methyl (R)-2-(phenylethynyl)indoline-1-carboxylate 2n 
Yield: 50%. ee: 87%. Hexanes/ethyl acetate = 7/1, Rf = 0.60. 1H NMR (600 MHz, CDCl3)
δ 7.82 (s, 1H), 7.38 (d, J = 7.6 Hz, 2H), 7.30 – 7.19 (m, 5H), 7.01 (t, J = 7.4 Hz, 1H), 5.35 
and 5.33 (br, 1H), 3.91 (s, 3H), 3.58 (dd, J = 15.9, 10.2 Hz, 1H), 3.27 (dd, J = 15.9, 2.1 Hz, 
1H). 13C NMR (150 MHz, CDCl3) δ 153.38, 141.12, 131.77, 129.13, 128.31, 128.15, 
127.76, 124.78, 122.96, 122.56, 115.21, 88.74, 82.65, 52.83, 50.74, 36.47. IR (neat, cm-1): 
2916.84, 2848.92, 1708.75, 1598.12, 1485.02, 1441.52, 1385.53, 1269.92, 1192.02, 
1130.13, 1056.18, 755.55, 691.55. HPLC analysis: ee = 87%. IC (99% hexanes: 1% 
isopropanol, 0.8 mL/min): tmajor = 30.67 min, tminor = 34.95 min. [α]20 D = 18.0 (c = 0.5,
CHCl3). HRMS (ESI) (M+H+) Calcd. for C18H16NO2+: 278.1176, found 278.1180.
methyl (R)-2-(pyridin-2-yl)indoline-1-carboxylate 2o Yield: 93%. 
ee: 90%. Hexanes/ethyl acetate = 2/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 8.57 (d, J
= 4.7 Hz, 1H), 7.97 (s, 1H), 7.59 (t, J = 7.7 Hz, 1H), 7.26 – 7.23 (m, 1H), 7.16 – 7.12 (m, 
3H), 7.00 (t, J = 7.4 Hz, 1H), 5.60 and 5.58 (br, 1H), 3.74 (dd, J = 16.1, 10.9 Hz, 1H), 3.69 
(s, 3H), 3.14 and 3.12 (br, 1H). 13C NMR (150 MHz, CDCl3) δ 162.18, 153.83, 149.53, 
136.90, 129.08, 127.68, 124.93, 123.20, 122.21, 118.94, 118.83, 115.00, 63.64, 52.65, 
36.55. IR (neat, cm-1): 2922.76, 1709.13, 1591.33, 1484.77, 1465.88, 1265.66, 1058.53, 
738.98. HPLC analysis: ee = 90%. IC (95% hexanes: 5% isopropanol, 1.0 mL/min): tmajor
= 36.35 min, tminor = 29.75 min. [α]20 D = 130.4 (c = 0.5, CHCl3). HRMS (ESI) (M+H+)
Calcd. for C15H15N2O2+: 255.1128, found 255.1133.
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methyl (R)-2-(thiophen-3-yl)indoline-1-carboxylate 2p Yield: 97%. 
ee: 94%. Hexanes/ethyl acetate = 6/1, Rf = 0.60. 1H NMR (600 MHz, CDCl3) δ 7.86 (br, 
1H), 7.25 – 7.21 (m, 2H), 7.17 (d, J = 7.4 Hz, 1H), 7.08 (br, 1H), 7.01 (t, J = 7.4 Hz, 1H), 
6.90 (d, J = 4.7 Hz, 1H), 5.58 and 5.57 (br, 1H), 3.77 (br, 3H), 3.64 (dd, J = 16.0, 10.1 Hz, 
1H), 3.01 (dd, J = 16.0, 2.1 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 153.76, 144.00, 
141.89, 129.65, 127.68, 126.15, 125.36, 124.85, 123.02, 120.64, 115.19, 58.36, 52.56, 
36.96. IR (neat, cm-1): 2952.85, 1700.19, 1601.40, 1482.94, 1440.10, 1382.32, 1273.15, 
1054.83, 736.24. HPLC analysis: ee = 94%. IA (99.5% hexanes: 0.5% isopropanol, 0.8 
mL/min): tmajor = 34.25 min, tminor = 23.41 min. [α]20 D = 63.2 (c = 0.5, CHCl3). HRMS 
(ESI) (M+H+) Calcd. for C14H14NO2S+: 260.0740, found 260.0741.
methyl (R)-2-(benzo[b]thiophen-3-yl)indoline-1-carboxylate 2q 
Yield: 97%. ee: 94%. Hexanes/ethyl acetate = 6/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3)
δ 7.95 (s, 1H), 7.86 (d, J = 6.9 Hz, 1H), 7.69 (d, J = 6.9 Hz, 1H), 7.38 – 7.36 (m, 2H), 7.28 
(t, J = 7.6 Hz, 1H), 7.13 (d, J = 7.3 Hz, 1H), 7.10 (s, 1H), 7.02 (t, J = 7.4 Hz, 1H), 5.89 and 
5.87 (br, 1H), 3.75 (dd, J = 16.0, 10.4 Hz, 1H), 3.73 (br, 3H), 3.07 (dd, J = 16.0, 2.4 Hz, 
1H). 13C NMR (150 MHz, CDCl3) δ 153.73, 141.16, 137.54, 136.61, 127.81, 125.07, 
124.41, 124.10, 123.21, 123.12, 121.53, 121.31, 115.21, 58.03, 52.70, 36.15. IR (neat, cm-
1): 2917.57, 2849.54, 1706.67, 1600.89, 1484.33, 1441.52, 1388.37, 1273.64, 761.73. 
HPLC analysis: ee = 92%. IA (99% hexanes: 1% isopropanol, 0.8 mL/min): tmajor = 27.22 
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min, tminor = 21.61 min. [α]20 D = 127.2 (c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for 
C18H16NO2S+: 310.0896, found 310.0896.
methyl (S)-2-propylindoline-1-carboxylate 2r Yield: 65%. ee: 87%. 
Hexanes/ethyl acetate = 6/1, Rf = 0.65. 1H NMR (600 MHz, CDCl3) δ 7.78 (br, 1H), 7.17 
(t, J = 7.7 Hz, 1H), 7.14 (d, J = 7.4 Hz, 1H), 6.96 (t, J = 7.4 Hz, 1H), 4.45 (br, 1H), 3.84 
(s, 3H), 3.29 (dd, J = 16.0, 9.5 Hz, 1H), 2.75 (d, J = 16.0 Hz, 1H), 1.71 (br, 1H), 1.54 –
1.52 (m, 1H), 1.35 – 1.31 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (150 MHz, CDCl3)
δ 153.77, 130.42, 127.33, 124.83, 124.66, 122.68, 115.34, 59.33, 52.42, 36.75, 33.42, 
18.10, 13.98. IR (neat, cm-1): 2956.18, 2871.65, 2359.34, 2341.70, 1711.07, 1602.79, 
1487.15, 1443.56, 1393.64, 1291.74, 765.20. HPLC analysis: ee = 87%. IA (99.8% 
hexanes: 0.2% isopropanol, 0.8 mL/min): tmajor = 25.18 min, tminor = 18.77 min. [α]20 D =
27.2 (c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C13H18NO2+: 220.1332, found 
220.1332.
dimethyl (R)-indoline-1,2-dicarboxylate 2s Yield: 49%. ee: 81%. 
Hexanes/ethyl acetate = 5/1, Rf = 0.35. 1H NMR (600 MHz, CDCl3) δ 7.92 and 7.51 (s, br, 
1H), 7.22 (br, 1H), 7.13 (d, J = 7.4 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 4.94 (br, 1H), 3.93 
and 3.80 (br, 3H), 3.75 (s, 3H), 3.58 – 3.53 (m, 1H), 3.15 (d, J = 16.4 Hz, 1H). 13C NMR 
(150 MHz, CDCl3) δ 172.06, 152.93, 142.21, 127.98, 124.78, 124.36, 122.99, 114.79, 
59.99, 52.76, 52.53, 32.96 and 32.11 (a pair of s). IR (neat, cm-1): 2956.69, 1749.89, 
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1698.64, 1484.85, 1433.36, 1049.66, 1001.19, 751.73. HPLC analysis: ee = 81%. IA (95% 
hexanes: 5% isopropanol, 0.8 mL/min): tmajor = 17.40 min, tminor = 13.67 min. [α]20 D = 20.0
(c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C12H14NO4+: 236.0917, found 236.0925.
methyl (R)-2-(diethylcarbamoyl)indoline-1-carboxylate 2t Yield: 
92%. ee: 68%. Hexanes/ethyl acetate = 1/1, Rf = 0.35. 1H NMR (500 MHz, CDCl3) δ 7.93 
and 7.51 (d, J = 6.5 Hz, 1H), 7.20 – 7.16 (m, 1H), 7.09 (d, J = 7.1 Hz, 1H), 6.95 – 6.93 (m, 
1H), 5.18 and 5.09 (d, J = 8.4 Hz, 1H), 3.90 (s, 1H), 3.75 – 3.34 (m, 7H), 3.01 (d, J = 11.4 
Hz, 1H), 1.33 – 1.25 (m, 3H), 1.13 (t, J = 7.1 Hz, 3H). 13C NMR (150 MHz, CDCl3) major
rotamer: δ 170.42, 152.80, 143.04, 128.95, 127.89, 124.27, 122.60, 114.66, 57.94, 52.43, 
41.58, 40.71, 33.43, 14.44, 12.91. IR (neat, cm-1): 2976.38, 2936.18, 1715.66, 1652.06, 
1488.71, 1445.25, 1392.19, 1266.04, 1138.22, 1063.88, 740.66. HPLC analysis: ee = 68%. 
IA (92% hexanes: 8% isopropanol, 0.8 mL/min): tmajor = 38.78 min, tminor = 36.22 min. [α]20
D = 91.6 (c = 0.5, CHCl3). HRMS (ESI) (M+H+) Calcd. for C15H21N2O3+: 277.1547, found 
277.1550.
3.4.11 General Procedure for TEMPO Trapping Reactions
An oven-dried Schlenk tube was charged with 1.0 equivalent of sulfonyl hydrazone 
1 (0.1 mmol), [Co(Por)] (2 mol %) and Cs2CO3 (0.2 mmol). The Schlenk tube was then 
evacuated and back filled with nitrogen for 3 times. The Teflon screw cap was replaced 
with a rubber septum, TEMPO (2.5 equiv.) was added under nitrogen flow and methanol 
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(1.0 mL) was added via a gastight syringe. The Schlenk tube was then purged with nitrogen 
for 10 s and the rubber septum was replaced with a Teflon screw cap. The mixture was 
then stirred at RT or 40 oC. After 24 h, the reaction mixture was filtrated through a short 
pad of silica, concentrated under vacuum and purified by flash column chromatography. 
The fractions containing product were collected and concentrated under vacuum to afford 
the desired compound.
methyl (phenyl((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)(2-
(((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)phenyl)carbamate 3c Yield: 90%. ee:
93%. Hexanes/ethyl acetate = 8/1, Rf = 0.70. 1H NMR (600 MHz, CDCl3) δ 7.83 (d, J =
7.6 Hz, 1H), 7.41 (d, J = 7.3 Hz, 1H), 7.32 – 7.28 (m, 2H), 7.17 (s, 1H), 7.08 – 7.05 (m, 
5H), 4.30 (d, J = 13.7 Hz, 1H), 3.66 (d, J = 13.7 Hz, 1H), 3.87 and 3.64 (s, 3H), 1.65 – 1.34
(m, 18H), 1.12 – 1.01 (m, 12H), 0.89 – 0.77 (m, 6H). 13C NMR (150 MHz, CDCl3) δ
155.40, 138.01, 137.54, 133.91, 128.13, 127.83, 126.97, 126.81, 126.51, 125.80, 125.48, 
93.20, 72.79, 60.11, 59.31, 59.13, 52.60, 39.91, 39.64, 39.05, 32.98, 32.63, 32.49, 31.87, 
20.17, 19.85, 19.53, 16.49. IR (neat, cm-1): 2974.31, 2932.90, 1711.46, 1439.23, 1301.16, 
1026.18, 732.55, 700.86. HPLC analysis: ee = 93%. IA (99.7% hexanes: 0.3% isopropanol,
0.8 mL/min): tmajor = 8.05 min, tminor = 9.15 min. [α]20 D = -116.4 (c = 0.5, CHCl3). HRMS 
(ESI) (M+H+) Calcd. for C34H52N3O4+: 566.3952, found 566.3959.
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methyl (2-(((2,2,6,6-tetramethylpiperidin-1-yl)oxy)-
methyl)phenyl)(3-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)prop-1-en-1-yl)carbamate 
3u Yield: 72%. Hexanes/ethyl acetate = 8/1, Rf = 0.70. 1H NMR (600 MHz, CDCl3)
(Contains both E/Z isomers of enamine) δ 7.67 and 7.62 (d, J = 7.6 Hz, 1H), 7.44 – 7.29 
(m, 2.5 H), 7.18  and 7.12 (d, J = 7.6 Hz, and d, J = 6.6 Hz, 1H), 6.75 (br, 0.5 H), 4.82 –
4.78 (m, 0.5 H), 4.79 – 4.68 (m, 2H), 4.41 – 4.37 (m, 0.5 H), 4.17 (br, 1H), 3.67 (br, 3H), 
3.47 (br, 1H), 1.61 – 0.86 (m, 36H). 13C NMR (150 MHz, CDCl3) (Contains both E/Z 
isomers of enamine) δ 154.29, 136.83, 136.34, 136.12, 134.86, 131.00, 128.65, 128.48, 
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128.37, 128.20, 128.12, 128.02, 127.92, 127.65, 125.07, 109.41, 106.26, 75.54, 73.98, 
73.94, 71.71, 59.69, 59.62, 59.26, 58.90, 53.11, 53.06, 39.37, 39.28, 39.16, 32.64, 32.56, 
32.45, 29.37, 20.03, 19.82, 19.60, 16.81, 16.76. IR (neat, cm-1): 2977.25, 2930.79, 1715.52, 
1661.25, 1442.54, 1314.88, 1215.86, 766.94. HRMS (ESI) (M+H+) Calcd. for 
C30H50N3O4+: 516.3796, found 516.3807.
tert-butyl 2-cyclopropylindoline-1-carboxylate 2v Yield: 50%.
Hexanes/ethyl acetate = 8/1, Rf = 0.60. 1H NMR (500 MHz, CDCl3) δ 7.68 (s, 1H), 7.18 –
7.14 (m, 2H), 6.94 (t, J = 7.4 Hz, 1H), 4.00 (br, 1H), 3.29 (dd, J = 15.8, 9.4 Hz, 1H), 2.79 
(d, J = 15.8 Hz, 1H), 1.57 (s, 9H), 1.10 – 1.04 (m, 1H), 0.65 – 0.60 (m, 1H), 0.53 – 0.48
(m, 1H), 0.44 – 0.38 (m, 1H), 0.23 – 0.18 (m, 1H). 13C NMR (125 MHz, CDCl3) δ 152.78, 
142.28, 130.63, 127.20, 124.67, 122.32, 115.62, 80.67, 62.93, 34.14, 28.49, 16.43, 4.22, 
1.29. IR (neat, cm-1): 2976.54, 1695.12, 1603.06, 1482.27, 1387.98, 1167.23, 1138.53, 
1012.96, 740.25. HRMS (Dart+) Calcd. for C16H22NO2+: 260.1645, found 260.1651.
tert-butyl (4-((2,2,6,6-tetramethylpiperidin-1-yl)oxy)-
but-1-en-1-yl)(2-(((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl)phenyl)-carbamate 
3v Yield: 40%. Hexanes/ethyl acetate = 9/1, Rf = 0.70. 1H NMR (600 MHz, CDCl3) δ 7.63 
(d, J = 7.5 Hz, 1H), 7.34 (t, J = 7.4 Hz, 1H), 7.31 – 7.27 (m, 1H), 7.10 (d, J = 13.3 Hz, 1H), 
6.99 (d, J = 6.6 Hz, 1H), 4.72 – 4.67 (m, 2H), 4.25 (dt, J = 14.4, 7.3 Hz, 1H), 3.59 (t, J =
7.0 Hz, 2H), 2.13 (br, 2H), 1.48 – 1.00 (m, 45H). 13C NMR (150 MHz, CDCl3) δ 152.41,
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136.60, 135.91, 129.22, 128.69, 128.01, 127.73, 127.62, 107.54, 80.70, 74.11, 59.93, 
59.57, 39.64, 39.59, 33.06, 32.89, 29.22, 28.08, 20.35, 20.00, 17.09. IR (neat, cm-1):
2975.35, 2931.05, 1710.91, 1662.69, 1454.51, 1373.32, 1320.14, 1263.84, 1169.25, 
1048.75, 741.49. HRMS (ESI) (M+H+) Calcd. for C34H58N3O4+: 572.4422, found 
572.4424.
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CHAPTER 4                     
ENANTIOSELECTIVE SYNTHESIS OF 2-SUBSTITUTED 
TETRAHYDROFURANS BY CO(II)-CATALYZED RADICAL C–H
ALKYLATION
4.1 INTRODUCTION 
Due to their rich reaction profile, carbon-centered radicals, especially alkyl radicals, 
have been extensively explored as highly active intermediates for chemical synthesis.1
Despite their great potential, the application of alkyl radicals for practical organic synthesis 
has faced several long-standing challenges that are inherently associated with the “free” 
nature of these radical species and proceed typically under substrate control. In this regard,2
metalloradical catalysis (MRC) 3,4 has recently emerged as a conceptually new approach 
in addressing the aforementioned challenges through catalytic generation of metal-
stabilized organic radicals to regulate both reactivity and selectivity of their subsequent 
homolytic reactions.5 As stable open-shell metalloradical complexes, Co(II) complexes of 
D2-symmetric chiral amidoporphyrins [Co(D2-Por*)] exhibit the unusual capability of 
activating various diazo compounds such as donor-, acceptor-, and acceptor/acceptor-
substituted diazo reagents to generate α-Co(III)-alkyl radicals for various catalytic radical 
transformations with excellent control of both reactivity and stereoselectivity.6 Recently, 
we have further broadened the applications of Co(II)-based MRC by using in situ-
generated aliphatic diazo compounds for asymmetric C–H alkylation, permitting the 
formation of a wide array of optically active α-substituted pyrrolidine derivatives.7
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Scheme 4.1| Proposed Pathway for Synthesis of α-Substituted Tetrahydrofurans by 
Co(II)-Based Radical C–H Alkylation
To this end, we are intrigued to see whether this radical alkylation pathway could 
also be applied to the enantioselective synthesis of α-substituted tetrahydrofurans. Starting 
from the readily available aldehyde-derived sulfonylhydrazone 1’ (Scheme 4.1), we 
questioned, in particular, whether the aliphatic diazo compound could be even generated 
under much milder conditions. If so, could the rate of metalloradical activation of aliphatic 
diazo compounds still be effectively matched with their in situ-generation to avoid their 
accumulation, leading to a series of decomposition reactions?8 Moreover, upon the 
metalloradical activation to form α-Co(III)-alkyl radicals, it is equally critical to seek a 
suitable catalytic system to effectively induce the enantioselectivity in the subsequent 
radical hydrogen atom abstraction and radical substitution reaction. If the above concerns 
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could be well positively addressed, it would provide a general catalytic strategy for 
stereoselective radical synthesis of α-substituted tetrahydrofurans from aliphatic aldehyde-
derived tosylhydrazones, essentially via enantioselective C–C bond formation through the 
union of C–H and C=O units (Scheme 4.1).
Figure 4.1| Selected Biologically Active Compounds Containing Tetrahydrofuran
Moiety
As recurring core structures, α-substituted tetrahydrofurans prevail in a wide range 
of natural products and bioactive compounds (Figure 4.1). As a result, considerable efforts 
have been devoted to devise effective strategies for their asymmetric synthesis,9
nevertheless, few example has been reported for enantioselective construction of α-
substituted tetrahydrofurans from linear substrates via metallocarbene-based 
intramolecular C–H alkylation of aliphatic diazo compounds.10 In 2014, Che and 
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coworkers developed a ruthenium porphyrin-catalyzed system for diastereoselective 
intramolecular C–H insertion reaction with in situ-generated alkyl diazomethanes, which 
permits the formation of substituted tetrahydrofurans in high yields with excellent 
diastereoselectivity (Scheme 4.2).11 This offers a valuable synthetic pathway for the 
preparation of multisubstituted tetrahydrofurans from linear molecules, however, no 
asymmetric version has been demonstrated so far. The sluggish development might be in 
part due to the absence of chelating groups at the neighboring site of diazo carbon that 
poses inherent challenges for achieving positive stereoinduction.
Scheme 4.2| Ruthenium-Porphyrin-Catalyzed Cyclization of Tosylhydrazones to 
Construct Tetrahydrofurans and Pyrrolidines
As a new synthetic application, we have demonstrated a general synthetic strategy 
for the asymmetric formation of α-substituted tetrahydrofuran structures from flexible 
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aliphatic diazo compounds, which could be ultimately derived from the readily accessible 
aldehydes (Scheme 4.1). Supported by a D2-symmetric chiral amidoporphyrin, the Co(II)-
based metalloradical catalyst is able to activate aliphatic diazo compounds even at room 
temperature for enantioselective intramolecular radical alkylation of a broad range of 
C(sp3)–H bonds, affording a series of α-substituted chiral tetrahydrofuran compounds in 
high yields with excellent enantioselectivities. In addition to a good level of 
chemoselectivivity, the system also features tolerance of various functionalities as well as 
compatibility with a variety of heteroaryl groups.
4.2 RESULTS AND DISCUSSIONS 
4.2.1 Condition Optimization for Enantioselective Radical C–H Alkylation of
Aliphatic Diazo Precursors
To begin with, we synthesized aliphatic aldehyde-derived triisopropylphenyl 
sulfonylhydrazone 1a as the radical precursor, which is expected to generate the 
corresponding aliphatic diazo compound in situ under basic conditions (Table 4.1). 
Gratifyingly, even with achiral metalloradical catalyst [Co(P1)] (P1 = 3,5-DitBu-
IbuPhyrin),12 the desired C−H alkylation product 2-phenyl tetrahydrofuran (2a) was 
obtained in 55% yield in the presence of Cs2CO3 in methanol at 40 oC (entry 1), 
demonstrating the in situ-generation protocol could be well compatible with the radical 
catalytic cycle for productive radical alkylation.
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To achieve the enantioselective radical process, the first-generation metalloradical 
catalyst [Co(P2)] (P2 = 3,5-DitBu-ChenPhyrin),6h which has proven to be efficient in 
radical olefin cyclopropanation, was employed in the catalytic system. The desired product 
2a could be obtained with promising enantioselectivity (15% ee) albeit in a relative low 
yield (entry 2). By simply switching catalyst [Co(P2)] to [Co(P3)] (P3 = 2,6-DiMeO-
ChenPhyrin) with sterically bulkier 2,6-diMeO groups at the meso-positions, we were 
gratified to observe a significant level of enantiomeric excess as well as improved reaction 
yield (entry 3). This ligand buttressing effect led us to the exploration of another unique 
family of D2-symmetric chiral amidoporphyrins [Co(P4–P6)],6f which could be routinely 
synthesized from commercially available chiral amide (S)-(-)-2-tetrahydrofuran-
carboxamide and have been recognized to possess much more rigid and polar chiral 
environment due to the intramolecular O···H–N hydrogen bonding interactions. Indeed, 
with the employment of [Co(P4)] (P4 = 3,5-DitBu-ZhuPhyrin), the enantioselectivity was 
further improved to 44% ee (entry 4). While the sterically more congested catalyst 
[Co(P5)] (P5 = 2,6-DiMeO-ZhuPhyrin) could afford 2a in excellent yield of 92%, only 
20% ee was observed (entry 5). Remarkably, by using even bulkier [Co(P6)] (P6 = 2,4,6-
TriMe-ZhuPhyrin),7 it could facilitate the enantioselective radical alkylation process, by 
affording 2a in 44% yield with substantially improved enantioselectivity (entry 6). To
further enhance the enantioselectivity, we attempted to lower the reaction temperature 
down to room temperature. However, only trace amount of the desired product 2a was 
observed with remaining of starting material sulfonylhydrazone (entry 7). By replacing 
methanol with aprotic polar solvents or aromatic solvents, the desired product 2a could be 
obtained in varied yields with globally enhanced enantioselectivity at room temperature 
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(entries 8–14). Among them, tetrahydrofuran is the solvent of choice, where 2a could be 
delivered in 90% yield with 92% ee. (entry 12).
Table 4.1| Ligand and Solvent Effects on Formation of Tetrahydrofuran by Co(II)-
Catalyzed Radical C–H Alkylationa
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a Reactions were carried out with 1a (0.1 mmol) in the presence of Cs2CO3 (2.0 equiv.) by 
[Co(Por)] (2.0 mol %) in solvent (0.8 mL) for 24 h. b Isolated yields. c Enantiomeric excess 
was determined by chiral HPLC. Tris = 2,4,6-triisopropylphenyl sulfonyl; MTBE = Methyl 
tert-butyl ether; DME = Dimethoxylethane; THF = Tetrahydrofuran; PhCH3 = Toluene; 
PhH = Benzene.
4.2.2 Enantioselective Radical Alkylation of Various C–H Bonds
Under the optimized conditions, the applicability of this radical alkylation protocol 
was further evaluated by employing different substrates with various C–H bonds. As 
summarized in Table 4.2, tetrahydrofuran derivatives with various substituents at 2-
position could be enantioselectively constructed from the aliphatic aldehyde-derived 
sulfonylhydrazones via the Co(II)-catalyzed radical C–H alkylation. First, benzylic C–H 
substrates with various electronic and steric properties were subjected under the standard 
conditions (entries 1–12). As exemplified by the radical precursors 1a–1l, both electron-
rich as well as electron-poor benzylic C–H bonds could be radically abstracted and 
alkylated, delivering the desired alkylated products in up to 93% yield with up to 96% ee. 
The l  sensitivity of this system towards electronic properties of differnet C–H bonds is 
in good agreement with the hypothesized radical mechanism. It is noteworthy to mention 
that C–H substrates with Cl- or Br-atoms substituted at various positions (1c, 1g, 1i–1j) 
were all shown to be suitable candidates for the highly enantioselective radical process and 
the resulting compounds containing aryl halide moieties would allow for further 
transformations such as transition metal-catalyzed cross-coupling reactions. Moreover, the 
metalloradical alkylation system exhibited a high degree of tolerance toward functional 
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groups, as exemplified by the high-yielding formation of 2d and 2e bearing -CN and -NO2 
groups. Like other benzylic C–H substrates, 2-naphthalenyl-contained C–H bond was also 
competent in this system, forming alkylated product 2l in 82% yield with 92% ee (entry 
12).
Table 4.2| Enantioselective Construction of α-Substituted Tetrahydrofurans by 
[Co(P6)]-Catalyzed Radical C−H Alkylationa
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a Reactions were carried out with 1 (0.1 mmol) in the presence of Cs2CO3 (2.0 equiv.) by 
[Co(P6)] (2.0 mol %) in THF (0.8 mL) at RT for 24 h; Yields refers to isolated yields; 
Enantiomeric excess (ee) was determined by chiral HPLC; Tris = 2,4,6-triisopropylphenyl 
sulfonyl; THF = Tetrahydrofuran.
In addition, the Co(II)-based enantioselective radical alkylation reaction was 
further highlighted by its compatibility with substrates containing various heteroarenes, 
allowing for stereoselective construction of α-heteroaryl tetrahydrofurans. For example, 3-
indole-based diazo precursor 1m could be effectively activated by [Co(P6)] to construct 
2m in 82% yield with 94% ee at room temperature (entry 13). Likewise, this catalytic 
protocol could also be successfully applied for both benzothiophene- and benzofuran-based 
C–H substrates 1n and 1o to form the corresponding optically active α-heteroaryl 
tetrahydrofurans in high yields with varied enantioselectivities (entries 14-15). It was 
evident that the Co(II)-based catalytic system could be well suited to substrates containing 
potentially coordinating heteroaryl groups without poisoning the catalytic activity, a 
common challenge that plagues many transition metal-catalyzed reactions. The obtained 
compounds might also find valuable applications in pharmaceutical research and 
development, given that heteroarenes and tetrahydrofuran functionality are prevalent 
structural elements in natural and synthetic bioactive compounds.
Furthermore, less reactive allylic C–H bonds could also be homolytically activated. 
For example, allylic substrate 1p could be chemoselectively alkylated to form 
tetrahydrofuran derivatives 2p in 92% yield with 92% ee, without complication from the 
competitive cyclopropanation of the neighboring C=C bonds (entry 16).
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4.2.3 Mechanistic Evidences for the Proposed Stepwise Radical Pathway
To shed light on the underlying stepwise radical mechanism for this Co(II)-
catalyzed radical C–H alkylation, several mechanistic experiments were designed and 
conducted.
Scheme 4.3| Intramolecular Kinetic Isotope Effect of the C–H Activation Process
First, to examine the intramolecular kinetic isotope effect (KIE), mono-deuterated 
triisopropylphenyl sulfonylhydrazone 1c-D was synthesized. Under the standard 
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conditions, the use of [Co(P1)] as catalyst could catalyze the reaction effectively and 
generate both C–H and C–D alkylation products in 80% yield (Scheme 4.3). 1H-NMR 
analysis of the product mixture revealed an intramolecular KIE ratio of kH/kD = 3.1/1. This 
KIE value agrees well with the proposed C–H bond cleavage by hydrogen-atom abstraction 
(Scheme 4.1).
In addition, the resulting Co(III)-supported alkyl radical intermediates A (Scheme 
4.1) from the reaction of substrate 1a by [Co(P1)] could be directly detected by HRMS 
(C86H100CoN8O5+, m/z: calculated: 1383.7149, found: 1383.7249) (Scheme 4.4). The 
HRMS experiment was carried out in the absence of any additives such as formic acid, 
which commonly act as electron carriers for ionization, allowing for the detection of the 
molecular ion signals corresponding to Co(III)-alkyl radical (C86H100CoN8O5·) by the loss 
of one electron.
Scheme 4.4| The High Resolution Mass Spectroscopy (HRMS) Spectrum for Co(III)-
Supported Alkyl Radical Intermediate
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Lastly, the corresponding alkyl radical intermediate was also trapped by spin 
trapping reagent phenyl N-tert-butylnitrone (PBN) to give the characteristic EPR signal. 
As shown in Scheme 4.5, the resulting EPR spectrum (in red), which is assigned to PBN-
trapped Co(III)-supported alkyl radical intermediates, displays the characteristic triplet of 
doublet signal for alkyl radicals that are trapped by phenyl N-tert-butylnitrone (PBN). The 
spectrum has been simulated (in blue) with AN = 14.5, AH = 3.2, g = 2.006, which is 
consistent with the resulting O-centered radical with the hyperfine splitting by the 
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neighboring N and H atoms. The values are consistent with those for similar species 
reported in litrature.13
Scheme 4.5| Isotropic X-band EPR Spectrum of Phenyl N-tert-butylnitrone (PBN)-
trapped Co(III)-Supported Alkyl Radical Intermediate
Together, these experimental results provided strong evidence for the proposed 
radical mechanism through Co(II)-based metalloradical C–H alkylation (Scheme 4.1).
4.3 CONCLUSIONS
In summary, Co(II)-based metalloradical catalysis (MRC) has been successfully 
applied to aliphatic diazo compounds for enantioselective synthesis of α-substituted 
tetrahydrofuran analogs by radical C–H alkylation. Aliphatic alkoxylethyl diazomethanes 
Chapter 4. Enantioselective C–H Alkylation for 2-Substituted Tetrahydrofuran Synthesis 
were effectively generated in situ from corresponding sulfonylhydrazones and well served 
as radical precursors for Co(II)-based metalloradical catalysis (MRC) at room temperature. 
With the Co(II) complex of D2-symmetric chiral porphyrin [Co(2,4,6-TriMe-ZhuPhyrin)] 
as the catalyst, it enables the activation of different aliphatic diazo compounds at milder 
reaction conditions and undergoes effective alkylation of a broad range of C–H bonds, 
including benzylic, allylic and heteroaryl-adjacent C(sp3)–H bonds to afford the 
corresponding compounds in high yields with effective control of enantioselectivities. 
Remarkably, this Co(II)-based metalloradical system has demonstrated a series of attributes 
such as functional group tolerance, high chemoselectivity, as well as excellent 
compatibility with heteroaryl functionalities. This general radical C–H alkylation route via 
Co(II)-based metalloradical catalysis will hopefully provide a new retrosynthetic paradigm 
for approaching optically active α-substituted tetrahydrofuran derivatives by linking 
carbonyl groups (C=O) with various C–H bonds.
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4.4 EXPERIMENTAL SECTION
4.4.1 General Considerations
1H NMR spectra were recorded on a Varian INOVA 400 (400 MHz), 500 (500 
MHz) or a 600 (600 MHz) spectrometer. Chemical shifts are internally referenced to 
residual CHCl3 signal (δ 7.26 ppm). Data are reported as follows: chemical shift, 
integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, hept = 
heptet, br = broad, m = multiplet), and coupling constants (Hz). 13C NMR spectra were 
recorded on a Varian INOVA 500 (125 MHz), or 600 (150 MHz) spectrometers with 
complete proton decoupling. Chemical shifts are reported in ppm with residual CHCl3 as 
the internal standard (δ 77.0 ppm). High-resolution mass spectrometry was performed on 
a Micromass LCT ESI-MS and JEOL Accu TOF Dart at the Mass Spectrometry Facility, 
Boston College. The UV-Vis absorption spectra in the range 200-700 nm were measured 
with an Evolution 300 UV-VIS spectrophotometer using quartz cuvettes with 1.0 cm 
optical path length. HPLC measurements were carried out on a Shimadzu HPLC system 
with Chiralcel AD-H, and ChiralPak Immobilized columns: IA, IB, IC, ID, IE, and IF. 
Infrared (IR) spectra were recorded on a Termo Scientific Nicolet Is5 System. Frequencies 
are reported in wavenumbers (cm-1). Optical rotations were measured on a Rudolph 
Research Analytical AUTOPOL® IV digital polarimeter. The X-ray diffraction data were 
collected using Bruker Kappa APEX DUO diffractometer and a Rigaku HighFlux Homelab 
diffractometer. X-band EPR spectra were recorded on a Bruker EMX-Plus spectrometer 
(Bruker BioSpin).
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Unless otherwise noted, all C–H alkylation reactions were performed in oven-dried 
glassware under dry N2 atmosphere with standard schlenk vacuum line techniques.
Gastight syringes were used to transfer liquid reagents and solvents in catalytic reactions. 
Anhydrous solvents as well as other commercial reagents were purchased from Sigma-
Aldrich, Acros, Alfa Aesar, Strem, Oakwood Products Inc., TCI, or Matrix Scientific and 
used as received unless otherwise stated. Thin layer chromatography was performed on 
Merck TLC plates (silica gel 60 F254). Flash column chromatography was performed with 
ICN silica gel (60 Å, 230-400 mesh, 32-63 μm).
4.4.2 Procedure for HRMS Experiment
To an oven-dried Schlenk tube, sulfonylhydrazone 1a (0.05 mmol) and Cs2CO3
(2.0 equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen 
for 3 times. The Teflon screw cap was replaced with a rubber septum, and CH3CN (0.5 
mL) was added via a gastight syringe. The mixture was then stirred at 60 oC for 0.5 h. The 
resulting light yellow solution was then passed through a short pad of Celite (to get rid of 
base and salt) under the flow of nitrogen and the filtrate was collected in a HPLC vial (vial 
A, degassed and backfilled with argon). During the time, [Co(P1)] (2 mol %) was charged 
into another HPLC vial (vial B, degassed and backfilled with argon) and dissolved in 
CH3CN (0.5 mL). After mixing equal amount of solutions from vial A (0.1 mL) and vial B 
(0.1 mL), the sample was further diluted with CH3CN and immediately injected into HRMS 
instrument. The HRMS experiment was carried out in the absence of any additives such as 
formic acid, which commonly act as electron carriers for ionization, allowing for the 
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detection of the molecular ion signals corresponding to Co(III)-alkyl radical 
(C86H100CoN8O5·) by the loss of one electron.
4.4.3 Procedure for EPR Experiment
To an oven-dried Schlenk tube A, sulfonylhydrazone 1a (0.05 mmol) and Cs2CO3
(2.0 equiv.) were added. The Schlenk tube was then evacuated and backfilled with nitrogen 
for 3 times. The Teflon screw cap was replaced with a rubber septum, and benzene (0.5 
mL) was added via a gastight syringe. The mixture was then stirred at 60 oC for 0.5 h.
During the time, [Co(P1)] (4 mol %) was charged into another oven-dried Schlenk tube B. 
The Schlenk tube B was then evacuated and backfilled with nitrogen for 3 times. After 0.5
h, the resulting light yellow solution from tube A was passed through a short pad of Celite 
(to get rid of base and salt) under the flow of nitrogen and transferred to Schlenk tube B. 
The mixture was stirred for 1 min, followed by the addition of phenyl N-tert-butylnitrone 
(PBN, 0.05 mmol). The reaction mixture was stirred for 3 min and transferred into a 
degassed EPR tube (filled with argon) through a gastight syringe. The sample was then 
carried out for EPR experiment at room temperature (EPR settings: T = 298 K; microwave 
frequency: 9.37762 GHz; power: 6.325 mW; modulation amplitude: 1.0 G).
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4.4.4 General Procedure for 3-(benzyloxy)propan-1-ol Derivatives s1
Prepared according to the literature.14 To a suspension of sodium hydride (60% in 
oil, 12 mmol, 1 equiv.) in dry THF (50 mL) was added dropwise 1,3-propanediol (1 equiv.). 
The mixture was stirred at rt for 45 min. Bromide (1 equiv.) was added dropwise. The 
reaction mixture was stirred for 5 h to overnight using TLC to monitor the reaction. After 
completed, the reaction mixture was quenched by the addition of H2O (50 mL). The phases 
were separated, and the aqueous layer was extracted three times with Et2O (3 × 50 mL). 
The combined organic layers were washed with brine, dried over anhydrous Na2SO4,
filtered, and concentrated under vacuum. The crude material was then purified by flash 
column chromatography.
3-(benzyloxy)propan-1-ol s1-a Yield: 71%. Hexanes/ethyl 
acetate = 4/1. 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 4.53 (s, 2H), 3.78 (s, 
2H), 3.78 – 3.65 (m, 2H), 2.33 (s, 1H), 1.87 (p, J = 5.6 Hz, 2H). 13C NMR (100 MHz, 
CDCl3) δ 138.04, 128.41, 127.67, 127.61, 73.24, 69.34, 61.85, 32.09. IR (neat, cm-1):
3315.61, 2945.96, 2863.78, 1351.59, 1282.54, 1174.29, 1074.84, 1004.21, 926.92, 866.58, 
786.08, 750.21, 697.60. HRMS (ESI) ([M+H]+) Calcd. for C10H15O2+: 167.1067, found 
167.1066.
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3-((4-methoxybenzyl)oxy)propan-1-ol s1-b Yield: 68%.
Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 2H), 6.88 
(d, J = 8.6 Hz, 2H), 4.45 (s, 2H), 3.80 (s, 3H), 3.77 (q, J = 5.5 Hz, 2H), 2.31 (t, J = 5.4 Hz, 
1H), 1.90 – 1.81 (m, 2H).13C NMR (150 MHz, CDCl3) δ 159.23, 130.14, 129.26, 113.83,
72.92, 69.15, 62.02, 55.26, 32.06. IR (neat, cm-1): 3410.13, 2917.34, 2849, 70, 1512.36, 
1247.68, 1032.38, 819.75, 767.85. HRMS (ESI) ([M+H]+) Calcd. for C11H17O3+: 197.1172, 
found 197.1175.
3-((4-bromobenzyl)oxy)propan-1-ol s1-c Yield: 74%.
Hexanes/ethyl acetate = 4/1. 1H NMR (500 MHz, CDCl3) δ 7.47 (d, J = 8.4 Hz, 2H), 7.20 
(d, J = 8.5 Hz, 2H), 4.47 (s, 2H), 3.78 (q, J = 5.5 Hz, 2H), 3.65 (t, J = 5.8 Hz, 2H), 2.13 (t, 
J = 5.3 Hz, 1H), 1.90 – 1.85 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 137.11, 131.55,
129.22, 121.55, 72.49, 69.28, 61.74, 32.13. IR (neat, cm-1): 3324.30, 2918.83, 2859.51, 
1486.87, 1092.23, 1070.60, 1012.20, 803.82. HRMS (ESI) ([M+H]+) Calcd. for 
C10H14BrO2+: 245.0172, found 245.0175.
4-((3-hydroxypropoxy)methyl)benzonitrile s1-d Yield:
72%. Hexanes/ethyl acetate = 3/1. 1H NMR (500 MHz, CDCl3) δ 1H NMR (500 MHz, 
CDCl3) δ 7.64 (d, J = 8.0 Hz, 2H), 7.43 (d, J = 7.9 Hz, 2H), 4.58 (s, 2H), 3.80 (t, J = 5.8 
Hz, 2H), 3.69 (t, J = 5.9 Hz, 2H), 2.02 (s, 1H), 1.94 – 1.86 (m, 2H). 13C NMR (125 MHz, 
CDCl3) δ 143.71, 132.25, 127.65, 118.75, 111.46, 72.21, 69.52, 61.32, 32.18. IR (neat, cm-
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1): 3325.29, 2921.54, 2865.45, 2228.14, 1610.15, 1413.84, 1364.84, 1096.48, 820.25. 
HRMS (ESI) ([M+H]+) Calcd. for C11H14NO2+: 192.1019, found 192.1022.
3-((4-nitrobenzyl)oxy)propan-1-ol s1-e Yield: 71%. 
Hexanes/ethyl acetate = 3/1. 1H NMR (500 MHz, CDCl3) δ 8.21 (d, J = 8.7 Hz, 2H), 7.49 
(d, J = 8.7 Hz, 2H), 4.62 (s, 1H), 3.82 (q, J = 5.5 Hz, 1H), 3.71 (t, J = 5.9 Hz, 1H), 1.95 –
1.89 (m, 2H). 13C NMR (125 MHz, CDCl3) δ 147.41, 145.75, 127.66, 123.69, 71.96, 69.57, 
61.30, 32.20. IR (neat, cm-1): 3234.15, 2922.50, 2865.86, 1604.34, 1518.37, 1345.09,
1105.59, 859.44, 738.98. HRMS (ESI) ([M+H]+) Calcd. for C10H14NO4+: 212.0917, found 
212.0915.
3-((2-fluorobenzyl)oxy)propan-1-ol s1-f Yield: 74%. 
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 7.38 (td, J = 7.5, 1.5 Hz, 1H), 
7.27 (tdd, J = 7.4, 5.3, 2.0 Hz, 1H), 7.12 (td, J = 7.5, 0.8 Hz, 1H), 7.05 – 7.02 (m, 1H), 4.58 
(s, 2H), 3.77 (dd, J = 10.1, 5.1 Hz, 2H), 3.68 (t, J = 5.8 Hz, 2H), 2.25 (s, 1H), 1.88 – 1.84
(m, 2H). 13C NMR (150 MHz, CDCl3) δ 160.74 (d, J = 246.9 Hz), 129.92 (d, J = 4.3 Hz), 
129.45 (d, J = 8.2 Hz), 125.10 (d, J = 14.7 Hz), 124.09 (d, J = 3.5 Hz), 115.26 (d, J = 21.5 
Hz), 69.54, 66.73, 61.72, 32.09. IR (neat, cm-1): 3315.41, 2921.45, 2868.07, 1586.89, 
1490.66, 1455.32, 1229.03, 1181.81, 1086.94, 759.19. HRMS (ESI) ([M+H]+) Calcd. for 
C10H14FO2+: 185.0972, found 185.0973.
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3-((2-bromobenzyl)oxy)propan-1-ol, s1-g Yield: 82%.
Hexanes/ethyl acetate = 4/1. 1H NMR (500 MHz, CDCl3) δ 7.54 (d, J = 8.0 Hz, 1H), 7.44 
(d, J = 7.6 Hz, 1H), 7.31 (t, J = 7.5 Hz, 1H), 7.16 (t, J = 7.7 Hz, 1H), 4.59 (s, 2H), 3.81 (t, 
J = 5.6 Hz, 2H), 3.74 (t, J = 5.8 Hz, 2H), 2.20 (s, 1H), 1.91 (p, J = 5.8 Hz, 2H).13C NMR 
(125 MHz, CDCl3) δ 137.36, 132.61, 129.12, 129.05, 127.43, 122.84, 72.58, 69.73, 61.72, 
32.17.IR (neat, cm-1): 3279.51, 2917.31, 2850.57, 1469.05, 1439.20, 1361.97, 1101.40, 
1027.54, 752.36. HRMS (ESI) ([M+H]+) Calcd. for C10H14BrO2+: 245.0172, found 
245.0175.
3-((2-methylbenzyl)oxy)propan-1-ol, s1-h Yield: 86%. 
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 7.30 (d, J = 7.0 Hz, 1H), 7.23 
– 7.17 (m, 3H), 4.52 (s, 2H), 3.79 (s, 2H), 3.68 (t, J = 5.8 Hz, 2H), 2.34 (s, 3H), 2.26 (s, 
1H), 1.88 (p, J = 5.8 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 136.60, 135.89, 130.26, 
128.51, 127.89, 125.78, 71.68, 69.43, 61.90, 32.15, 18.74. IR (neat, cm-1): 3314.21, 
2917.25, 2849.24, 1462.02, 1363.33, 1090.09, 746.14. HRMS (ESI) ([M+H]+) Calcd. for 
C11H17O2+: 181.1223, found 181.1221.
3-((3-bromobenzyl)oxy)propan-1-ol, s1-i Yield: 75%. 
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 7.49 (d, J = 6.7 Hz, 1H), 7.42 
(t, J = 7.4 Hz, 1H), 7.27 – 7.20 (m, 2H), 4.49 (s, 2H), 3.80 (dd, J = 12.3, 6.4 Hz, 2H), 3.66 
(dd, J = 12.6, 6.6 Hz, 2H), 2.15 (s, 1H), 1.91 – 1.86 (m, 2H). 13C NMR (150 MHz, CDCl3)
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δ 140.43, 130.71, 130.49, 130.00, 125.99, 122.53, 77.21, 77.00, 76.79, 72.36, 69.33, 61.55, 
32.13. IR (neat, cm-1): 3313.35, 2920.71, 2862.46, 1570.41, 1472.79, 1427.58, 1360.07, 
1199.88, 1085.60, 1069.55, 779.53, 670.74. HRMS (ESI) ([M+H]+) Calcd. for 
C10H14BrO2+: 245.0172, found 245.0172.
3-((3,4-dichlorobenzyl)oxy)propan-1-ol s1-j Yield: 85%. 
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 7.42 – 7.40 (m, 2H), 7.15 (dd, 
J = 8.2, 1.6 Hz, 1H), 4.46 (s, 2H), 3.78 (t, J = 5.7 Hz, 2H), 3.64 (t, J = 5.9 Hz, 2H), 2.13 (s, 
1H), 1.87 (p, J = 5.8 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 138.45, 132.53, 131.57, 
130.42, 129.36, 126.67, 71.79, 69.32, 61.43, 32.14. IR (neat, cm-1): 3324.08, 2918.97, 
2862.04, 1471.41, 1389.13, 1349.79, 1204.22, 1103.57, 1031. 49, 818.39. HRMS (ESI) 
([M+H]+) Calcd. for C10H13Cl2O2+: 235.0287, found 235.0285.
3-((3,5-dimethoxybenzyl)oxy)propan-1-ol s1-k Yield: 
70%. Hexanes/ethyl acetate = 2/1. 1H NMR (600 MHz, CDCl3) δ 6.48 (d, J = 2.2 Hz, 2H), 
6.38 (t, J = 2.2 Hz, 1H), 4.46 (s, 2H), 3.78 (s, 9H), 3.64 (t, J = 5.8 Hz, 2H), 2.31 (s, 1H), 
1.87 (p, J = 5.7 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 160.87, 140.51, 105.26, 99.64, 
73.13, 69.20, 61.74, 55.31, 32.16. IR (neat, cm-1): 3386.49, 2917.81, 2849.08, 1735.10, 
1596.52, 1461.60, 1203.86, 832.43. HRMS (ESI) ([M+H]+) Calcd. for C12H19O4+:
227.1278, found 227.1282.
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3-(naphthalen-2-ylmethoxy)propan-1-ol s1-l, Yield: 85%.
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 7.85 – 7.83 (m, 3H), 7.77 (s, 
1H), 7.50 – 7.46 (m, 3H), 4.69 (s, 2H), 3.81 (t, J = 5.6 Hz, 2H), 3.71 (t, J = 5.8 Hz, 2H), 
2.33 (s, 1H), 1.90 (p, J = 5.8 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 135.51, 133.22, 
132.97, 128.25, 127.83, 127.67, 126.41, 126.12, 125.89, 125.60, 73.35, 69.35, 61.87, 
32.13. IR (neat, cm-1): 3280.02, 2924.42, 2869.46, 1365.11, 1344.90, 1079.21, 1021.38, 
861.96, 767.02, 745.80. HRMS (ESI) ([M+H]+) Calcd. for C14H17O2+: 217.1223, found 
217.1226.
tert-butyl 3-((3-hydroxypropoxy)methyl)-1H-indole-1-
carboxylate s1-m Yield: 75%. Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3)
δ 8.13 (s, 1H), 7.63 (d, J = 7.7 Hz, 1H), 7.57 (s, 1H), 7.34 – 7.32 (m, 1H), 7.27 – 7.25 (m, 
1H), 4.67 (s, 2H), 3.76 (t, J = 5.7 Hz, 2H), 3.68 (t, J = 5.8 Hz, 2H), 1.86 (p, J = 5.7 Hz, 
2H), 1.67 (s, 9H). 13C NMR (150 MHz, CDCl3) δ 149.64, 135.70, 129.59, 124.62, 122.76, 
119.39, 117.44, 115.27, 83.75, 68.99, 64.92, 61.80, 32.11, 28.18. IR (neat, cm-1): 3339.03, 
2929.42, 2863.88, 1731.61, 1451.57, 1370.11, 1349.14, 1256.77, 1159.96, 1091.42, 
768.36, 748.22. HRMS (ESI) ([M+H]+) Calcd. for C17H24NO4+: 306.1700, found 306.1703.
3-((3,4-dichlorobenzyl)oxy)propan-1-ol s1-n Yield: 58%. 
Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3) δ 7.87 – 7.85 (m, 2H), 7.41 –
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7.35 (m, 3H), 4.77 (s, 2H), 3.77 (t, J = 5.7 Hz, 2H), 3.70 (t, J = 5.8 Hz, 2H), 2.16 (s, 1H), 
1.87 (p, J = 5.8 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 140.61, 138.01, 133.10, 124.73, 
124.52, 124.20, 122.78, 122.01, 69.11, 67.52, 61.63, 32.12. IR (neat, cm-1): 3280.79, 
2918.56, 2850.55, 1460.77, 1427.42, 1103.29, 1073.53, 758.60, 734.34. HRMS (ESI) 
([M+H]+) Calcd. for C12H15O2S+: 223.0787, found 223.0788.
3-(benzofuran-2-ylmethoxy)propan-1-ol, Yield: 65%. 
Hexanes/ethyl acetate = 3/1. 1H NMR (600 MHz, CDCl3) δ 7.55 (d, J = 7.6 Hz, 1H), 7.48 
(d, J = 8.2 Hz, 1H), 7.23 – 7.21 (m, 1H), 7.23 – 7.21 (m, 1H), 6.69 (s, 1H), 4.62 (s, 2H), 
3.78 (d, J = 2.8 Hz, 2H), 3.73 (t, J = 5.9 Hz, 2H), 2.17 (s, 1H), 1.88 (p, J = 5.8 Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ 155.14, 154.09, 127.98, 124.40, 122.76, 121.05, 111.31,
105.65, 69.34, 65.59, 61.44, 32.09. IR (neat, cm-1): 3276.90, 2918.19, 2867.39, 1453.47, 
1364.64, 1254.86, 1087.03, 943.21, 754.04. HRMS (ESI) ([M+H]+) Calcd. for C12H15O3+:
207.1016, found 207.1019.
3-((2-methyl-3-phenylallyl)oxy)propan-1-ol, Yield: 54%.
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 7.34 (t, J = 7.6 Hz, 2H), 7.28 
(d, J = 7.2 Hz, 2H), 7.22 (t, J = 7.3 Hz, 1H), 6.49 (s, 1H), 4.04 (s, 2H), 3.81 (q, J = 5.5 Hz, 
2H), 3.65 (t, J = 5.8 Hz, 2H), 2.36 (t, J = 5.3 Hz, 1H), 1.91 – 1.87 (m, 5H). 13C NMR (150 
MHz, CDCl3) δ 137.36, 134.88, 128.87, 128.09, 127.00, 126.49, 77.35, 69.18, 62.04, 
32.10, 15.39. IR (neat, cm-1): 3348.40, 2917.14, 2853.89, 1738.09, 1490.79, 1443.61, 
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1352.47, 1091.26, 747.50, 700.22. HRMS (ESI) ([M+H]+) Calcd. for C13H19O2+: 207.1380, 
found 207.1382.
4.4.5 General Procedure for Preparation of 3-(benzyloxy)propanal Derivatives s2
To a solution of s1 (4 mmol, 1.0 equiv.) in DCM (30 mL) was added portion-wise 
Dess-Martin periodinane (6 mmol, 1.5 equiv.) reagent at 0 oC. The mixture was stirred at 
rt and using TLC to monitor the reaction. After completed, the reaction mixture was diluted 
with 50 mL of diethyl ether, followed by slow addition of a 1:1:1 mixture of saturated 
aqueous sodium thiosulfate solution (15 mL), saturated aqueous sodium bicarbonate (15 
mL), and water (15 mL, total volume 45 mL). The resulting biphasic mixture was stirred 
vigorously for 0.5 h resulting in two layers. The layers were separated and the aqueous 
layer was extracted three times with diethyl ether. The ethereal solution was then washed 
three times with water and once with brine; the combined organic layers were dried over 
anhydrous Na2SO4, filtered, and concentrated under vacuum. The crude material was then 
purified by flash column chromatography.
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3-(benzyloxy)propanal s2-a, known compound.2f Yield: 80%. 
Hexanes/ethyl acetate = 10/1. 1H NMR (400 MHz, CDCl3) δ 9.80 (s, 1H), 7.37 – 7.28 (m, 
5H), 4.54 (s, 2H), 3.82 (t, J = 6.1 Hz, 2H), 2.70 (td, J = 6.1, 1.8 Hz, 2H). 13C NMR (100 
MHz, CDCl3) δ 201.08, 137.82, 128.43, 127.76, 127.68, 73.25, 63.82, 43.86.
3-((4-methoxybenzyl)oxy)propanal s2-b Yield: 90%.
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.78 (s, 1H), 7.25 (d, J = 8.5 
Hz, 2H), 6.89 – 6.87 (m, 2H), 4.46 (s, 2H), 3.80 (s, 3H), 3.78 (t, J = 6.1 Hz, 2H), 2.68 (td, 
J = 6.1, 1.8 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 201.19, 159.29, 129.91, 129.33, 
113.78, 72.90, 63.50, 55.26, 43.86. IR (neat, cm-1): 2918.19, 2852.81, 1723.15, 1612.21, 
1513.55, 1248.97, 1095.84, 1034.43, 820.62. HRMS (ESI) ([M+H]+) Calcd. for C11H15O3+:
195.1016, found 195.1018.
3-((4-bromobenzyl)oxy)propanal s2-c Yield: 80%. 
Hexanes/ethyl acetate = 8/1. 1H NMR (600 MHz, CDCl3) δ 9.80 (s, 1H), 7.47 (d, J = 8.1 
Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 4.48 (s, 2H), 3.80 (t, J = 6.0 Hz, 2H), 2.71 (t, J = 6.0 Hz, 
2H). 13C NMR (150 MHz, CDCl3) δ 200.77, 136.88, 131.54, 129.25, 121.62, 72.48, 63.93, 
43.82. IR (neat, cm-1): 2918.58, 2849.34, 2358.68, 2340.54, 1723.00, 1487.79, 1394.23, 
1094.26, 1012.14, 909.68, 759.81, 735.52. HRMS (ESI) ([M+H]+) Calcd. for C10H12BrO2+:
243.0015, found 243.0018.
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4-((3-oxopropoxy)methyl)benzonitrile s2-d Yield: 90%.
Hexanes/ethyl acetate = 6/1.1H NMR (600 MHz, CDCl3) δ 9.81 (s, 1H), 7.62 (d, J = 8.3 
Hz, 2H), 7.42 (d, J = 8.3 Hz, 2H), 4.57 (s, 2H), 3.84 (t, J = 6.0 Hz, 2H), 2.74 (td, J = 6.0, 
1.6 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 200.40, 143.43, 132.25, 127.67, 118.74, 
111.40, 72.24, 64.47, 43.79. IR (neat, cm-1): 2864.34, 2359.09, 2228.99, 1723.52, 1265.37, 
1094.89, 819.05, 735.18, 703.51. HRMS (ESI) ([M+H]+) Calcd. for C11H12NO2+:
190.0863, found 190.0865.
3-((4-nitrobenzyl)oxy)propanal s2-e Yield: 75%. 
Hexanes/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 9.83 (s, 1H), 8.20 (d, J = 8.6 
Hz, 2H), 7.48 (d, J = 8.5 Hz, 2H), 4.63 (s, 3H), 3.87 (t, J = 6.0 Hz, 2H), 2.76 (td, J = 6.0, 
1.5 Hz, 2H).13C NMR (150 MHz, CDCl3) δ 200.43, 147.41, 145.46, 127.65, 123.64, 71.95, 
64.40, 43.76. IR (neat, cm-1): 2917.76, 2850.05, 1720.17, 1602.96, 1514.88, 1341.68, 
1104.89, 849.98, 737.61, 693.68. HRMS (ESI) ([M+H]+) Calcd. for C10H12NO4+:
210.0761, found 210.0765.
3-((2-fluorobenzyl)oxy)propanal s2-f Yield: 75%. Hexanes/ethyl 
acetate = 8/1. 1H NMR (500 MHz, CDCl3) δ 9.80 (s, 1H), 7.39 (td, J = 7.4, 1.2 Hz, 1H), 
7.29 – 7.26 (m, 1H), 7.13 (t, J = 7.5 Hz, 1H), 7.06 – 7.02 (m, 1H), 4.60 (s, 2H), 3.85 (t, J
= 6.1 Hz, 2H), 2.71 (td, J = 6.1, 1.8 Hz, 2H). 13C NMR (125 MHz, CDCl3) δ 200.98, 160.70 
(d, J = 246.7 Hz), 129.98 (d, J = 4.1 Hz), 129.51 (d, J = 8.2 Hz), 124.87 (d, J = 14.6 Hz), 
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124.11 (d, J = 3.4 Hz), 115.24 (d, J = 21.5 Hz), 66.62 (d, J = 3.7 Hz), 64.10, 43.77. IR 
(neat, cm-1): 2915.91, 2849.02, 1722.13, 1491.74, 1455.84, 1093.29, 761.37. HRMS (ESI) 
([M+H]+) Calcd. for C10H12FO2+: 183.0816, found 183.0818.
3-((2-bromobenzyl)oxy)propanal s2-g Yield: 85%. Hexanes/ethyl 
acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 9.83 (s, 1H), 7.54 (d, J = 8.0 Hz, 1H), 7.43 
(dd, J = 7.6, 0.4 Hz, 1H), 7.31 (t, J = 7.5 Hz, 1H), 7.15 (td, J = 7.9, 1.1 Hz, 1H), 4.60 (s, 
2H), 3.90 (t, J = 6.0 Hz, 2H), 2.74 (td, J = 6.0, 1.7 Hz, 2H). 13C NMR (150 MHz, CDCl3)
δ 200.96, 137.14, 132.53, 129.06, 127.42, 122.72, 72.46, 64.40, 43.79. IR (neat, cm-1): 
2917.57, 2848.19, 1723.23, 1469.56, 1439.25, 1105.20, 755.13. HRMS (ESI) ([M+H]+)
Calcd. for C10H12BrO2+: 243.0015, found 243.0015.
3-((2-methylbenzyl)oxy)propanal s2-h Yield: 88%. Hexanes/ethyl 
acetate = 6/1. 1H NMR (500 MHz, CDCl3) δ 9.80 (s, 1H), 7.29 (d, J = 6.7 Hz, 1H), 7.23 –
7.17 (m, 3H), 4.53 (s, 2H), 3.83 (t, J = 6.1 Hz, 2H), 2.70 (t, J = 6.0 Hz, 2H), 2.33 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 201.08, 136.74, 135.65, 130.29, 128.63, 127.99, 125.77, 
71.72, 63.90, 43.85, 18.73. IR (neat, cm-1): 2916.69, 2848.97, 1723.53, 1462.16, 1360.93, 
1259.04, 1093.09, 746.99. HRMS (ESI) ([M+H]+) Calcd. for C11H15O2+: 179.1067, found 
179.1068.
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3-((3-bromobenzyl)oxy)propanal s2-i Yield: 82%. Hexanes
/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 9.81 (s, 1H), 7.47 (s, 1H), 7.41 (d, J =
7.5 Hz, 1H), 7.25 – 7.19 (m, 2H), 4.49 (s, 2H), 3.81 (t, J = 6.1 Hz, 2H), 2.72 (t, J = 6.1 Hz, 
2H). 13C NMR (150 MHz, CDCl3) δ 200.96, 137.14, 132.53, 129.06, 127.42, 122.72, 72.46, 
64.40, 43.79. IR (neat, cm-1): 2918.58, 2849.80, 1724.38, 1570.50, 1473.42, 1358.20, 
1110.63, 781.22. HRMS (ESI) ([M+H]+) Calcd. for C10H12BrO2+: 243.0015, found 
243.0013.
3-((3,4-dichlorobenzyl)oxy)propanal s2-j Yield: 85%.
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.80 (s, 1H), 7.40 (d, J = 8.1 
Hz, 2H), 7.14 (dd, J = 8.2, 1.6 Hz, 1H), 4.47 (s, 2H), 3.81 (t, J = 6.0 Hz, 2H), 2.72 (td, J =
6.0, 1.6 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 200.56, 138.19, 132.50, 131.60, 130.38, 
129.33, 126.67, 71.78, 64.07, 43.76. IR (neat, cm-1): 2917.20, 2849.55, 1723.77, 1471.54, 
1386.84, 1106.48, 1031.69, 819.23, 689.43. HRMS (ESI) ([M+H]+) Calcd. for 
C10H11Cl2O2+: 233.0131, found 233.0135.
3-((3,5-dimethoxybenzyl)oxy)propanal s2-k Yield: 70%.
Hexanes/ethyl acetate = 4/1. 1H NMR (600 MHz, CDCl3) δ 9.80 (s, 1H), 6.48 (s, 2H), 6.39 
(s, 1H), 4.47 (s, 2H), 3.80 (t, J = 6.4 Hz, 2H), 3.79 (s, 6H), 2.70 (t, J = 6.0 Hz, 2H). 13C
NMR (150 MHz, CDCl3) δ 201.01, 160.90, 140.27, 105.33, 99.74, 73.16, 63.79, 55.31, 
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43.86. IR (neat, cm-1): 2917.75, 2849.22, 1725.15, 1598.01, 1462.77, 1260.62, 1205.03, 
1155.88, 1094.56, 805.93. HRMS (ESI) ([M+H]+) Calcd. for C12H17O4+: 225.1121, found 
225.1124.
3-(naphthalen-2-ylmethoxy)propanal s2-l Yield: 80%.
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.82 (s, 1H), 7.84 (dd, J = 8.2, 
3.2 Hz, 3H), 7.77 (s, 1H), 7.50 – 7.44 (m, 3H), 4.70 (s, 2H), 3.86 (t, J = 6.1 Hz, 2H), 2.72 
(td, J = 6.1, 1.8 Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 200.56, 138.19, 132.50, 131.60, 
130.38, 129.33, 126.67, 71.78, 64.07, 43.76. IR (neat, cm-1): 2920.54, 2850.47, 1723.46, 
1368.19, 1096.92, 820.38, 754.45. HRMS (ESI) ([M+H]+) Calcd. for C14H15O2+: 215.1067, 
found 215.1068.
tert-butyl 3-((3-oxopropoxy)methyl)-1H-indole-1-
carboxylate s2-m Yield: 75%. Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3)
δ 9.77 (s, 1H), 8.14 (s, 1H), 7.62 (d, J = 7.8 Hz, 1H), 7.57 (s, 1H), 7.35 – 7.32 (m, 1H), 
7.27 – 7.24 (m, 1H), 4.69 (s, 2H), 3.83 (t, J = 6.1 Hz, 2H), 2.68 (td, J = 6.1, 1.7 Hz, 2H), 
1.67 (s, 9H). 13C NMR (150 MHz, CDCl3) δ 201.07, 149.61, 135.71, 129.53, 124.67, 
124.64, 122.74, 119.51, 117.21, 115.24, 83.76, 64.95, 63.48, 43.83, 28.17. IR (neat, cm-1):
2977.10, 2933.22, 2868.02, 1726.58, 1450.80, 1368.59, 1347.76, 1255.39, 1154.34, 
1087.95, 1016.67, 855.00, 748.08. HRMS (ESI) ([M+H]+) Calcd. for C17H22NO4+:
304.1543, found 304.1543.
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3-(benzo[b]thiophen-3-ylmethoxy)propanal s2-n Yield: 85%.
Hexanes/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) δ 9.77 (s, 1H), 7.86 (t, J = 8.9 
Hz, 2H), 7.41 – 7.35 (m, 3H), 4.79 (s, 2H), 3.85 (t, J = 6.0 Hz, 2H), 2.70 (td, J = 6.0, 1.7 
Hz, 2H). 13C NMR (150 MHz, CDCl3) δ 200.96, 140.63, 137.99, 132.88, 124.93, 124.55, 
124.21, 122.76, 122.16, 67.57, 63.70, 43.80. IR (neat, cm-1): 2917.78, 2849.70, 1722.24, 
1460.76, 1427.55, 1104.62, 760.04, 735.84. HRMS (ESI) ([M+H]+) Calcd. for C12H13O2S+:
221.0631, found 221.0632.
3-(benzofuran-2-ylmethoxy)propanal s2-o Yield: 88%.
Hexanes/ethyl acetate = 5/1. 1H NMR (600 MHz, CDCl3) δ 9.79 (s, 1H), 7.56 (d, J = 7.7 
Hz, 1H), 7.48 (d, J = 8.2 Hz, 1H), 7.30 – 7.27 (m, 1H), 7.22 (t, J = 7.4 Hz, 1H), 6.70 (s, 
1H), 4.63 (s, 2H), 3.89 (t, J = 6.1 Hz, 2H), 2.72 (td, J = 6.1, 1.5 Hz, 2H). 13C NMR (150 
MHz, CDCl3) δ 200.72, 155.17, 153.84, 127.96, 124.48, 122.80, 121.10, 111.33, 105.90, 
65.66, 64.05, 43.75. IR (neat, cm-1): 2918.01, 2849.87, 1722.59, 1453.78, 1362.48, 
1254.64, 1091.15, 942.89, 755.45. HRMS (ESI) ([M+H]+) Calcd. for C12H13O3+: 205.0859, 
found 205.0861.
(E)-3-((2-methyl-3-phenylallyl)oxy)propanal, Yield: 90%. 
Hexanes/ethyl acetate = 6/1. 1H NMR (600 MHz, CDCl3) 9.83 (s, 1H), 7.34 (t, J = 7.6 Hz, 
2H), 7.29 (d, J = 7.1 Hz, 2H), 7.22 (t, J = 7.3 Hz, 1H), 6.50 (s, 1H), 4.05 (s, 2H), 3.81 (t, J
= 6.1 Hz, 2H), 2.71 (td, J = 6.1, 1.8 Hz, 2H), 1.89 (d, J = 1.1 Hz, 3H). 13C NMR (150 MHz, 
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CDCl3) δ 201.08, 137.30, 134.74, 128.85, 128.08, 127.16, 126.50, 76.79, 63.51, 43.86, 
15.33. IR (neat, cm-1): 2918.77, 2852.10, 1723.61, 1491.52, 1447.26, 1353.86, 1118.10, 
751.06, 701.46. HRMS (ESI) ([M+H]+) Calcd. for C13H17O2+: 205.1223, found 205.1226.
4.4.6 The Synthetic Procedure for Triisopropyl Sulfonylhydrazone Derivatives 1
To a stirred solution of pure 2,4,6-triisopropylbenzenesulfonohydrazide 
(TrisNHNH2, 2 mmol, 1 equiv.) in THF (10.0 mL) at 0 oC, aldehyde s2 (1 equiv.) was 
added dropwise (or portionwise if solid). The reaction was monitored by TLC. After the 
reaction was completed, the solvent was removed directly under reduced pressure, and the 
crude solid was further purified by flash column chromatography.
N'-(3-(benzyloxy)propylidene)-2,4,6-triisopropyl-
benzenesulfonohydrazide, 1-a Yield: 85%. Hexanes/ethyl acetate = 5/1, Rf = 0.48. 1H
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NMR (600 MHz, CDCl3) δ 8.78 and 7.64 (s, 1H), 7.36 – 6.84 (m, 8H), 4.55 and 4.43 (s, 
1H), 4.30 – 4.15 (m, 2H), 3.61 – 3.57 (m, 2H), 2.94 – 2.86 (m, 1H), 2.50 (dd, J = 11.7, 6.3 
Hz, 1.25H) and 2.43 (q, J = 5.7 Hz, 0.75 H), 1.27 – 1.24 (m, 18H). 13C NMR (150 MHz, 
CDCl3) δ 153.27 and 153.07, 151.30, 148.29 and 146.79, 137.90 and 136.96, 131.40 and
131.18, 128.55 and 128.39, 127.98 and 127.83, 127.68 and 127.63, 123.78 and 123.73, 
73.44 and 72.98, 67.05 and 66.71, 34.14 and 32.83, 29.78, 28.63, 24.80, 23.52. IR (neat, 
cm-1): 3224.85, 2961.17, 1599.51, 1395.35, 1155.78, 1119.83, 883.67, 657.75. HRMS 
(ESI) ([M+H]+) Calcd. for C25H37N2O3S+: 445.2519, found 445.2509.
2,4,6-triisopropyl-N'-(3-((4-methoxybenzyl)oxy)-
propylidene)benzenesulfonohydrazide, 1-b Yield: 88%. Hexanes/ethyl acetate = 4/1, Rf
= 0.40. 1H NMR (500 MHz, CDCl3) δ 8.85 and 7.58 (s, 1H), 7.24 – 7.06 (m, 5H), 6.90 –
6.82 (m, 2H), 4.48 and 4.35 (s, 1H), 4.26 – 4.14 (m, 2H), 3.79 and 3.80 (s, 3H), 3.57 – 3.53 
(m, 2H), 2.93 – 2.86 (m, 1H), 2.48 (dd, J = 11.7, 6.3 Hz, 1H), 2.40 (q, J = 5.7 Hz, 1H), 
1.27 – 1.24 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 153.39 and 153.34, 151.32, 147.60
and 147.38, 146.21, 145.56, 144.45, 131.11, 127.94 and 127.62, 123.81 and 123.62, 72.25
and 71.67, 67.61, 34.14, 32.76, 29.91, 28.31, 24.79, 23.51.IR (neat, cm-1): 3212.26, 
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2954.66, 1511.41, 1465.98, 1244.89, 1171.14, 1039.02, 662.77. HRMS (ESI) ([M+H]+)
Calcd. for C26H39N2O4S+: 475.2625, found 475.2617.
N'-(3-((4-bromobenzyl)oxy)propylidene)-2,4,6-triiso-
propylbenzenesulfonohydrazide, 1-c Yield: 90%. Hexanes/ethyl acetate = 5/1, Rf = 0.43. 
1H NMR (600 MHz, CDCl3) δ 8.70 and 7.65 (s, 1H), 7.47 and 7.43 (d, J = 8.3 Hz, 2H), 
7.21 (t, J = 5.1 Hz, 0.75H) and 6.84 (t, J = 5.7 Hz, 0.25H), 7.19 – 7.16 (m, 4H), 4.49 and 
4.37 (s, 2H), 4.25 – 4.15 (m, 2H), 3.60 – 3.57 (m, 2H), 2.94 – 2.87 (m, 1H), 2.50 (dd, J =
11.6, 6.3 Hz, 1.5H) and 2.43 (q, J = 5.7 Hz, 0.5H), 1.26 – 1.24 (m, 18H). 13C NMR (150 
MHz, CDCl3) δ 153.33 and 153.17, 151.31, 148.01 and 146.55, 136.95 and 135.99, 131.69
and 131.49, 131.28 and 131.14, 129.42 and 129.20, 123.79 and 123.76, 121.93 and 121.53, 
72.69 and 72.18, 67.13 and 66.91, 34.14 and 32.79, 29.90, 28.53, 24.79, 23.52. IR (neat, 
cm-1): 3209.14, 2957.18, 2866.01, 1596.97, 1463.48, 1296.56, 1167.81, 1037.36, 844.29, 
662.85. HRMS (ESI) ([M+H]+) Calcd. for C25H36BrN2O3S+: 523.1625, found 523.1606.
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N'-(3-((4-cyanobenzyl)oxy)propylidene)-2,4,6-triiso-
propylbenzenesulfonohydrazide, 1d Yield: 82%. Hexanes/ethyl acetate = 5/1, Rf = 0.43. 
1H NMR (600 MHz, CDCl3) δ 8.62 and 7.84 (s, 1H), 7.63 and 7.59 (d, J = 8.1 Hz, 2H), 
7.42 and 7.36 (d, J = 8.0 Hz, 2H), 7.24 (t, J = 5.1 Hz, 0.75H) and 6.85 (t, J = 5.7 Hz, 0.25H), 
7.17 and 7.17 (s, 2H), 4.59 and 4.47 (s, 1H), 4.24 – 4.15 (m, 2H), 3.66 (t, J = 5.7 Hz, 1H) 
and 3.63 (t, J = 6.4 Hz, 1H), 2.94 – 2.87 (m, 1H), 2.53 (dd, J = 11.7, 6.2 Hz, 1H) and 2.47 
(q, J = 5.7 Hz, 1H), 1.26 – 1.23 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 153.3 and 153.30, 
151.31, 147.63 and 146.31, 143.55 and 142.52, 132.38 and 132.19, 131.14 and 131.09, 
127.86 and 127.62, 123.79, 118.75 and 118.65, 111.70 and 111.32, 72.46 and 71.91, 67.53
and 67.49, 34.13 and 32.75, 29.89, 28.36, 24.78 and 24.76, 23.51. IR (neat, cm-1): 3211.76, 
2958.73, 2929.21, 2866.98, 2227.58, 1597.12, 1167.10, 818.42, 662.14. HRMS (ESI) 
([M+H]+) Calcd. for C26H36N3O3S+: 470.2472, found 470.2481.
2,4,6-triisopropyl-N'-(3-((4-nitrobenzyl)oxy)-
propylidene)benzenesulfonohydrazide, 1e Yield: 80%. Hexanes/ethyl acetate = 5/1, Rf =
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0.43. 1H NMR (600 MHz, CDCl3) δ 8.58 (s, 0.75H) and 7.81 (s, 0.25H), , 8.20 and 8.16 
(d, J = 8.6 Hz, 2H), 7.48 (d, J = 8.6 Hz, 0.5H) and 7.41 (d, J = 8.3 Hz, 1.5H), 7.24 (t, J =
5.1 Hz, 0.75H) and 6.86 (t, J = 5.7 Hz, 0.25H),  7.17 (s, 2H), 4.64  and 4.52 (s, 2H), 4.26 –
4.16 (m, 2H), 3.68 (t, J = 5.7 Hz, 0.5H), 3.65 (t, J = 6.4 Hz, 1.5H), 2.94 – 2.87 (m, 1H), 
2.54 (dd, J = 11.6, 6.2 Hz, 1.5H), 2.48 (q, J = 5.6 Hz, 0.5H), 1.26 – 1.24 (m, 18H). 13C
NMR (150 MHz, CDCl3) δ 153.39 and 153.33, 151.31, 147.59 and 147.33, 146.26, 145.58, 
144.51, 131.11 and 131.04, 127.91 and 127.61, 123.80 and 123.60, 72.19 and 71.64, 67.60
and 67.57, 34.12 and 32.76, 29.90, 28.32, 24.78 and 24.76, 23.50. IR (neat, cm-1): 3209.22, 
2959.35, 2929.28, 2867.09, 1597.73, 1523.17, 1461.68, 1343.44, 1166.36, 883.46, 663.20, 
564.39. HRMS (ESI) ([M+H]+) Calcd. for C25H36N3O5S+: 490.2370, found 490.2390.
N'-(3-((2-fluorobenzyl)oxy)propylidene)-2,4,6-triiso-
propylbenzenesulfonohydrazide, 1f Yield: 88%. Hexanes/ethyl acetate = 5/1, Rf = 0.45.
1H NMR (600 MHz, CDCl3) δ 8.65 and 7.64 (s, 1H), 7.44 – 7.28 (m, 1.5H) and 7.26 – 7.24 
(m, 0.5H), 7.21 (t, J = 5.2 Hz, 0.75H) and 6.84 (t, J = 5.7 Hz, 0.25H), , 7.17 and 7.16 (s, 
2H), 7.14 – 6.99 (m, 2H), 4.62 and 4.49 (s, 2H), 4.24 – 4.15 (m, 2H), 3.65 (t, J = 5.7 Hz, 
0.5H) and 3.61 (t, J = 6.4 Hz, 1.5H), 2.92 – 2.87 (m, 1H), 2.50 (dd, J = 11.8, 6.3 Hz, 1.5H), 
2.43 (q, J = 5.7 Hz, 0.5H), 1.26 – 1.24 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 161.48
and 159.87, 153.28 and 153.11, 151.30, 148.20 and 146.64, 131.35 and 131.16, 130.22 and
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129.97, 129.81 and 129.48, 125.00 and 124.90, 124.39 and 124.09, 123.78 and 123.74, 
115.29 and 115.15, 67.34 and 67.02, 66.70 and 66.42, 34.14 and 32.77, 29.90, 28.52, 24.78, 
23.52. IR (neat, cm-1): 2958.40, 2928.30, 2868.48, 1599.08, 1456.60, 1151.84, 881.86, 
756.75, 660.84. HRMS (ESI) ([M+H]+) Calcd. for C25H36FN2O3S+: 463.2425, found 
463.2420.
N'-(3-((2-bromobenzyl)oxy)propylidene)-2,4,6-triiso-
propylbenzenesulfonohydrazide 1g Yield: 85%. Hexanes/ethyl acetate = 5/1, Rf = 0.46. 
1H NMR (500 MHz, CDCl3) δ 8.62 and 7.57 (s, 1H), 7.54 and 7.52 (dd, J = 8.0, 1.0 Hz, 
2H), 7.42 and 7.36 (dd, J = 7.6, 1.4 Hz, 2H), 7.32 (td, J = 7.5, 1.0 Hz, 1H), 7.24 (t, J = 5.3 
Hz, 0.7H) and 6.89 (t, J = 5.6 Hz, 0.3H), 7.17 and 7.16 (s, 2H), 7.13 and 7.26 (td, J = 7.8, 
1.6 Hz, 1H), 4.62 and 4.49 (s, 2H), 4.23 – 4.14 (m, 2H), 3.70 (t, J = 5.7 Hz, 0.65H), 3.66 
(t, J = 6.4 Hz, 1.35H), 2.94 – 2.85 (m, 1H), 2.54 (dd, J = 11.6, 6.3 Hz, 1.35H) and 2.47 (dd, 
J = 11.4, 5.7 Hz, 0.65H), 1.27 – 1.23 (m, 18H). 13C NMR (125 MHz, CDCl3) δ 153.29 and 
153.11, 151.32, 148.21 and 146.69, 137.23, 132.62 and 132.53, 131.37 and 131.17, 129.35
and 129.33, 129.11 and 129.02, 127.66 and 127.40, 123.79 and 123.69, 122.82 and 122.76, 
72.65 and 72.27, 67.62 and 67.30, 34.14 and 32.81, 29.92, 28.51, 24.80, 23.52. IR (neat, 
cm-1): 3212.41, 2964.09, 2926.76, 2869.85, 1598.22, 1438.82, 1157.54, 1019.73, 878.43, 
659.07. HRMS (ESI) ([M+H]+) Calcd. for C25H36BrN2O3S+: 523.1625, found 523.1627.
Chapter 4. Enantioselective C–H Alkylation for 2-Substituted Tetrahydrofuran Synthesis 
2,4,6-triisopropyl-N'-(3-((2-methylbenzyl)oxy)-
propylidene)benzenesulfonohydrazide, 1h Yield: 92%. Hexanes/ethyl acetate = 5/1, Rf
= 0.47. 1H NMR (600 MHz, CDCl3) δ 8.70 and 7.59 (s, 1H), 7.28 – 7.25 (m, 0.75H) and 
6.84 (t, J = 5.6 Hz, 0.25H), 7.23 – 7.06 (m, 6H), 4.57 and 4.43 (s, 2H), 4.24 – 4.15 (m, 2H), 
3.60 (t, J = 6.3 Hz, 2H), 2.94 – 2.87 (m, 1H), 2.50 (dd, J = 11.8, 6.2 Hz, 1.5H), 2.42 (q, J
= 5.7 Hz, 0.5H), 2.32 and 2.26 (s, 3H), 1.27 – 1.24 (m, 18H). 13C NMR (150 MHz, CDCl3)
δ 153.28 and 153.07, 151.31 and 151.26, 148.36 and 146.78, 136.76 and 136.64, 135.75
and 134.85, 131.41 and 131.18, 130.40 and 130.24, 128.79 and 128.49, 128.19 and 127.92, 
125.86 and 125.77, 123.79 and 123.73, 71.76 and 71.45, 67.16 and 66.62, 34.15 and 32.87,
29.91, 28.59, 24.80, 23.53, 18.83 and 18.71. IR (neat, cm-1): 3201.67, 2958.41, 2867.70, 
1598.99, 1460.38, 1425.05, 1152.31, 1092.57, 882.48, 738.87, 661.45. HRMS (ESI) 
([M+H]+) Calcd. for C26H39N2O3S+: 459.2676, found 459.2693.
N'-(3-((3-bromobenzyl)oxy)propylidene)-2,4,6-triiso-
propylbenzenesulfonohydrazide 1i Yield: 91%. Hexanes/ethyl acetate = 5/1, Rf = 0.46. 
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1H NMR (600 MHz, CDCl3) δ 8.62 and 7.64 (s, 1H), 7.55 – 7.23 (m, 3H), 7.22 (t, J = 5.0 
Hz, 0.75H) and 6.84 (t, J = 5.6 Hz, 0.25H), 7.18 – 7.17 (m, 3H), 4.51 and 4.38 (s, 2H), 4.24 
– 4.15 (m, 2H), 3.61 – 3.57 (m, 2H), 2.94 – 2.87 (m, 1H), 2.51 (dd, J = 11.7, 6.3 Hz, 1.35H) 
and 2.43 (q, J = 5.7 Hz, 0.65H), 1.27 – 1.24 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 
153.31 and 153.16, 151.30, 147.97 and 146.53, 140.31 and 139.37, 131.13 and 131.06, 
130.72 and 130.62, 130.45 and 130.25, 129.99, 126.30 and 126.00, 123.79 and 123.76, 
122.55 and 122.50, 72.57 and 72.12, 67.27 and 66.94, 34.04 and 32.77, 29.77, 28.44, 24.80, 
23.52. IR (neat, cm-1): 3212.46, 2956.46, 2865.72, 1597.14, 1462.40, 1165.77, 1104.87, 
883.46, 778.18, 664.33. HRMS (ESI) ([M+H]+) Calcd. for C25H36BrN2O3S+: 523.1625, 
found 523.1625.
N'-(3-((3,4-dichlorobenzyl)oxy)propylidene)-2,4,6-
triisopropylbenzenesulfonohydrazide 1j Yield: 92%. Hexanes/ethyl acetate = 5/1, Rf =
0.45. 1H NMR (500 MHz, CDCl3) δ 8.60 and 7.73 (s, 1H), 7.42 – 7.34 (m, 2H), 7.22 (t, J
= 5.1 Hz, 0.75H) and 6.84 (t, J = 5.6 Hz, 0.25H), , 7.17 (s, 2H), 7.08 (dd, J = 8.2, 1.9 Hz, 
1H), 4.48 and 4.36 (s, 2H), 4.24 – 4.14 (m, 2H), 3.62 – 3.57 (m, 2H), 2.92 – 2.87 (m, 1H), 
2.51 (dd, J = 11.6, 6.4 Hz, 1.3H) and 2.44 (q, J = 5.7 Hz, 0.7H), 1.26 – 1.24 (m, 18H). 13C
NMR (125 MHz, CDCl3) δ 153.35 and 153.24, 151.30, 147.76 and 146.38, 138.28 and
137.34, 132.59 and 132.45, 131.96 and 131.55, 131.16 and 131.12, 130.65 and 130.38, 
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129.50 and 129.29, 126.97 and 126.67, 123.79, 72.00 and 71.52, 67.31 and 67.06, 34.14
and 32.75, 29.90, 28.37, 24.79, 23.51. IR (neat, cm-1): 3209.21, 2957.31, 2930.18, 2866.48, 
1597.03, 1462.47, 1296.39, 1167.29, 1104.74, 883.98, 817.88, 664.11, 564.71. HRMS 
(ESI) ([M+H]+) Calcd. for C25H35Cl2N2O3S+: 513.1740, found 513.1741.
N'-(3-((3,5-Dimethoxybenzyl)oxy)propylidene)-
2,4,6-triisopropylbenzenesulfonohydrazide 1k Yield: 90%. Hexanes/ethyl acetate = 5/1, 
Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 8.82 and 7.58 (s, 1H), 7.21 (t, J = 5.1 Hz, 0.7H) 
and 6.85 (t, J = 5.7 Hz, 0.3H), 7.17 and 7.16 (s, 2H), 6.46 and 6.43 (s, 2H), 6.39 and 6.37 
(s, 1H), 4.49 and 4.37 (s, 2H), 4.25 – 4.15 (m, 2H), 3.78 (s, 6H), 3.59 – 3.56 (m, 2H), 2.93 
– 2.87 (m, 1H), 2.50 (dd, J = 12.1, 6.1 Hz, 1.3H) and 2.43 (q, J = 5.6 Hz, 0.7H), 1.26 –
1.24 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 160.98 and 160.87, 153.29 and 153.10,
151.34 and 151.29, 148.32 and 146.91, 140.33 and 139.33, 131.34 and 131.17, 123.79 and
123.73, 105.45 and 105.42, 100.24 and 99.62, 73.36 and 72.95, 67.05 and 66.67, 55.38 and
55.31, 34.14 and 32.84, 29.94 and 29.91, 28.65, 24.79, 23.52. IR (neat, cm-1): 2957.32, 
2867.92, 1597.55, 1460.34, 1428.19, 1203.65, 1152.06, 1059.12, 883.05, 661.95. HRMS 
(ESI) ([M+H]+) Calcd. for C27H41N2O5S+: 505.2731, found 505.2732.
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2,4,6-triisopropyl-N'-(3-(naphthalen-2-ylmethoxy)-
propylidene)benzenesulfonohydrazide 1l Yield: 87%. Hexanes/ethyl acetate = 5/1, Rf =
0.44. 1H NMR (600 MHz, CDCl3) δ 8.83 (s, 1H) and 7.52 (s, 1H), 7.89 – 7.71 (m, 4H), 
7.48 – 7.38 (m, 3H), 7.22 (t, J = 5.2 Hz, 0.65H) and 6.86 (t, J = 5.8 Hz, 0.35H), 7.16 (s, 
2H), 4.72 and 4.59 (s, 2H), 4.26 – 4.16 (m, 2H), 3.64 – 3.61 (m, 2H), 2.92 – 2.85 (m, 1H), 
2.52 (dd, J = 11.8, 6.1 Hz, 1.3H) and 2.44 (q, J = 5.7 Hz, 0.7H), 1.26 – 1.23 (m, 18H). 13C
NMR (150 MHz, CDCl3) δ 153.30 and 153.10, 151.34 and 151.31, 148.36 and 146.81,
135.37 and 134.38, 133.22, 128.47 and 128.23, 127.98 and 127.83, 127.67, 126.77, 126.46,
126.22, 126.14 and 126.07, 125.92, 125.63 and 125.58, 123.79 and 123.75, 73.60 and
73.13, 67.07 and 66.80, 34.15 and 32.87, 29.92, 28.69, 24.80, 23.52. IR (neat, cm-1):
3207.88, 2958.29, 2867.50, 1599.43, 1461.03, 1319.48, 1152.48, 1124.57, 881.53, 815.88, 
660.69. HRMS (ESI) ([M+H]+) Calcd. for C29H39N2O3S+: 495.2676, found 495.2662.
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tert-butyl 3-((3-(2-((2,4,6-triisopropylphenyl)-
sulfonyl)hydrazineylidene)propoxy)methyl)-1H-indole-1-carboxylate, 1m Yield: 
82%. Hexanes/ethyl acetate = 4/1, Rf = 0.46. 1H NMR (600 MHz, CDCl3) δ 8.79 and 7.53 
(s, 1H), 8.13 (s, 1H), 7.60 – 7.57 (m, 2H), 7.34 – 7.31 (m, 1H), 7.23 (t, J = 7.6 Hz, 1H), 
7.17 (s, 2H), 7.15 (t, J = 5.1 Hz, 0.7H) and 6.81 (t, J = 5.7 Hz, 0.3H), 4.72 and 4.58 (s, 1H), 
4.25 – 4.15 (m, 2H), 3.60 – 3.58 (m, 2H), 2.93 – 2.86 (m, 1H), 2.48 (dd, J = 11.8, 6.3 Hz, 
1.25H) and 2.39 (q, J = 5.7 Hz, 0.75H), 1.67 (s, 9H), 1.26 – 1.24 (m, 18H). 13C NMR (150 
MHz, CDCl3) δ 153.25 and 153.06, 151.28, 149.60, 148.33 and 146.76, 135.68, 131.46
and 131.19, 129.54 and 129.35, 125.15, 124.70 and 124.63, 123.77 and 123.73, 122.89 and 
122.70, 119.50 and 119.38, 117.28 and 116.36, 115.26 and 115.24, 83.88 and 83.77, 66.63
and 66.19, 64.88 and 64.58, 34.13 and 32.82, 29.93 and 29.89, 28.17, 24.79, 23.51. IR 
(neat, cm-1): 2959.97, 2930.32, 2868.50, 1731.77, 1599.45, 1451.40, 1368.95, 1255.90, 
1152.25, 1088.25, 746.22, 661.28. HRMS (ESI) ([M+H]+) Calcd. for C32H46N3O5S+:
584.3153, found 584.3143.
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N'-(3-(benzo[b]thiophen-3-ylmethoxy)propylidene)-
2,4,6-triisopropylbenzenesulfonohydrazide, 1n Yield: 85%. Hexanes/ethyl acetate = 
4/1, Rf = 0.47. 1H NMR (600 MHz, CDCl3) δ 8.76 and 7.71 (s, 1H), 7.88 – 7.79 (m, 2H), 
7.39 – 7.29 (m, 3H), 7.18 (s, 2H), 7.16 (t, J = 5.2 Hz, 0.7H) and 6.82 (t, J = 5.6 Hz, 0.3H), 
4.81 and 4.68 (s, 2H), 4.26 – 4.16 (m, 2H), 3.65 – 3.59 (m, 2H), 2.94 – 2.87 (m, 1H), 2.49 
(dd, J = 11.7, 6.2 Hz, 1.3H) and 2.41 (q, J = 5.7 Hz, 0.7H), 1.27 – 1.25 (m, 18H). 13C NMR 
(150 MHz, CDCl3) δ 153.27 and 153.13, 151.29, 148.18 and 146.72, 140.59, 137.97 and
137.79, 132.90 and 132.06, 131.36 and 131.19, 125.48 and 124.80, 124.60 and 124.51, 
124.35 and 124.16, 123.78 and 123.75, 122.74, 122.10 and 122.04, 67.44 and 67.23, 66.89
and 66.49, 34.12 and 32.80, 29.89, 28.46, 24.79, 23.51. IR (neat, cm-1): 3200.82, 2957.90, 
2867.22, 1598.92, 1460.58, 1425.96, 1317.52, 1152.20, 1102.53, 1070.93, 881.20, 756.58, 
660.44. HRMS (ESI) ([M+H]+) Calcd. for C27H37N2O3S2+: 501.2240, found 501.2237.
N'-(3-(benzofuran-2-ylmethoxy)propylidene)-2,4,6-
triisopropylbenzenesulfonohydrazide, 1o Yield: 80%. Hexanes/ethyl acetate = 4/1, Rf =
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0.43. 1H NMR (600 MHz, CDCl3) δ 8.62 and 7.77 (s, 1H), 7.31 – 7.26 (m, 1H), 7.23 – 7.21
(m, 1H), 7.20 (t, J = 5.2 Hz, 0.7H) and 6.84 (t, J = 5.7 Hz, 0.3H), , 7.17 (s, 2H), 6.71 and 
6.63 (s, 1H), 4.64 and 4.51 (s, 2H), 4.26 – 4.17 (m, 2H), 3.70 (t, J = 5.7 Hz, 0.7H) and 3.65
(t, J = 6.5 Hz, 1.3H), 2.90 (hept, J = 6.9 Hz, 1H), 2.50 (dd, J = 11.7, 6.4 Hz, 1.3H) and 2.43 
(q, J = 5.7 Hz, 0.7H), 1.27 – 1.24 (m, 18H). 13C NMR (150 MHz, CDCl3) δ 155.16 and
155.12, 153.89 and 153.27, 153.17 and 153.12, 151.31 and 151.27, 147.84 and 146.61, 
131.32 and 131.16, 127.93 and 127.88, 124.58 and 124.42, 123.76 and 123.73, 122.84 and
122.77, 121.16 and 121.06, 111.40 and 111.28, 106.24 and 105.76, 67.28 and 67.02, 65.64
and 65.34, 34.12 and 32.71, 29.88, 28.42, 24.78, 23.50. IR (neat, cm-1): 3208.79, 2959.39, 
2929.46, 2867.69, 1595.86, 1454.43, 1165.50, 1101.37, 940.01, 885.26, 662.51. HRMS 
(ESI) ([M+H]+) Calcd. for C27H37N2O4S+: 485.2468, found 485.2463.
2,4,6-triisopropyl-N'-3-(((E)-2-methyl-3-
phenylallyl)oxy)propylidene)benzenesulfonohydrazide, 1p Yield: 90%. Hexanes/ethyl 
acetate = 4/1, Rf = 0.47. 1H NMR (600 MHz, CDCl3) δ 8.89 and 7.76 (s, 1H), 7.34 – 7.31 
(m, 2H), 7.29 (d, J = 7.0 Hz, 1H), 7.26 – 7.20 (m, 2.7H) and 6.89 (t, J = 5.7 Hz, 0.3H), 7.17 
(s, 2H), 6.48 and 6.44 (s, 1H), 4.30 – 4.17 (m, 2H), 4.07 and 3.94 (s, 2H), 3.62 (t, J = 5.6 
Hz, 0.75H) and 3.57 (t, J = 6.5 Hz, 1.25H), 2.93 – 2.86 (m, 1H), 2.51 (dd, J = 11.7, 6.4 Hz, 
1.25H) and 2.46 (dd, J = 11.3, 5.7 Hz, 0.75H), 1.89 and 1.81 (s, 3H), 1.28 – 1.25 (m, 18H). 
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13C NMR (150 MHz, CDCl3) δ 153.26 and 153.07, 151.30, 148.28, 146.88, 137.31 and
137.08, 134.84 and 134.00, 131.40 and 131.19, 128.88 and 128.09, 127.11, 126.48, 123.74, 
77.70 and 77.06, 66.78 and 66.64, 34.14 and 32.87, 29.92 and 29.87, 28.67, 24.81 and 
24.78, 23.52, 15.42. IR (neat, cm-1): 2957.72, 2927.19, 2867.29, 1598.95, 1460.64, 
1361.95, 1316.87, 1163.73, 1152.35, 881.15, 745.83, 661.15. HRMS (ESI) ([M+H]+)
Calcd. for C27H37N2O4S+: 485.2832, found 485.44.
4.4.7 General Procedure for [Co(P6)]-Catalyzed Enantioselective Radical C–H
Alkylation
An oven-dried Schlenk tube was charged with sulfonyl hydrazone 1 (0.1 mmol), 
[Co(P6)] (2 mol %) and Cs2CO3 (0.2 mmol). The Schlenk tube was then evacuated and 
back filled with nitrogen for 3 times. The Teflon screw cap was replaced with a rubber 
septum, THF (0.8 mL) was added via a gastight syringe. The Schlenk tube was then purged 
with nitrogen for 30 s and the rubber septum was replaced with a Teflon screw cap. The 
mixture was then stirred at RT. After 24 h, the reaction mixture was filtrated through a 
short pad of silica gel, concentrated under vacuum and purified by flash column 
chromatography. The fractions containing product were collected and concentrated under 
vacuum to afford the desired compound 2.
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(S)-2-phenyltetrahydrofuran 2a Known compound.2f Yield: 90%. 
Hexanes/ethyl acetate = 10/1, Rf = 0.35. 1H NMR (400 MHz, CDCl3) δ 7.40 – 7.09 (m, 
1H), 4.87 (t, J = 7.2 Hz, 1H), 4.08 (dd, J = 14.8, 7.0 Hz, 1H), 3.92 (dd, J = 14.5, 7.6 Hz, 
1H), 2.30 (td, J = 12.5, 7.0 Hz, 1H), 2.05 – 1.90 (m, 1H), 1.79 (ddd, J = 16.0, 12.2, 7.7 Hz, 
1H). 13C NMR (100 MHz, CDCl3) δ 143.41, 128.23, 127.06, 125.58, 80.63, 68.62, 34.57, 
25.99. IR (neat, cm-1): 2970.44, 2866.20, 1737.63, 1492.89, 1451.35, 1060.06, 754.81. 
HPLC analysis: ee = 92%. ADH (100% hexanes, 0.8 mL/min): tmajor = 41.49 min, tminor =
50.92 min. [α]20 D = -8.6 (c = 0.5, CHCl3).
(S)-2-(4-methoxyphenyl)tetrahydrofuran 2b Known compound.15
Yield: 91%. Hexanes/ethyl acetate = 6/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 7.26 (d, 
J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H), 4.83 (t, J = 7.2 Hz, 1H), 4.08 (dd, J = 14.4, 7.5 
Hz, 1H), 3.91 (td, J = 8.0, 6.3 Hz, 1H), 3.80 (s, 3H), 2.30 – 2.25 (m, 1H), 2.06 – 1.95 (m, 
2H), 1.82 – 1.76 (m, 1H). 13C NMR (150 MHz, CDCl3) δ 158.78, 135.31, 126.93, 113.67, 
80.42, 68.46, 55.26, 34.44, 26.05. IR (neat, cm-1): 2950.38, 2866.99, 1612.68, 1511.76, 
1242.25, 1056.98, 1033.29, 827.29. HPLC analysis: ee = 91%. IF (99% hexanes, 0.8 
mL/min): tmajor = 26.04 min, tminor = 28.58 min. [α]20 D = -15.6 (c = 0.5, CHCl3).
(S)-2-(4-bromophenyl)tetrahydrofuran 2c Yield: 92%. Hexanes/ethyl 
acetate = 8/1, Rf = 0.40 1H NMR (600 MHz, CDCl3) δ 7.45 (d, J = 8.4 Hz, 2H), 7.21 (d, J
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= 8.4 Hz, 2H), 4.84 (t, J = 7.2 Hz, 1H), 4.08 (dd, J = 15.0, 6.9 Hz, 1H), 3.93 (dd, J = 15.0, 
7.2 Hz, 1H), 2.31 (td, J = 12.9, 6.8 Hz, 1H), 2.02 – 1.97 (m, 2H), 1.74 (dq, J = 12.3, 7.8 
Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 142.56, 131.31, 127.31, 120.77, 79.98, 68.70, 
34.62, 25.93. HRMS (ESI) ([M+H]+) Calcd. for C10H12BrO+: 227.0066, found 227.0060. 
IR (neat, cm-1): 2943.11, 2864.95, 1485.52, 1068.49, 1023.69, 821.29. HPLC analysis: ee
= 95%. IE (99.8% hexanes, 0.8 mL/min): tmajor = 24.57 min, tminor = 27.92 min. [α]20 D = -
51.6 (c = 0.5, CHCl3).
(S)-4-(tetrahydrofuran-2-yl)benzonitrile 2d Yield: 90%.
Hexanes/ethyl acetate = 8/1, Rf = 0.30. 1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 
2H), 7.43 (d, J = 8.3 Hz, 2H), 4.93 (t, J = 7.2 Hz, 1H), 4.10 (dd, J = 15.0, 6.9 Hz, 1H), 3.96 
(dd, J = 15.0, 7.5 Hz, 1H), 2.38 (td, J = 13.0, 7.1 Hz, 1H), 2.04 – 1.98 (m, 2H), 1.74 (dq, J
= 12.3, 7.8 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ 149.20, 132.15, 126.13, 118.93, 
110.80, 79.81, 68.93, 34.68, 25.91. HRMS (ESI) ([M+H]+) Calcd. for C11H11NO+:
174.0913, found 174.0912. IR (neat, cm-1): 2923.56, 2868.89, 2226.75, 1610.33, 1067.01, 
841.80. HPLC analysis: ee = 95%. IF (99% hexanes, 0.8 mL/min): tmajor = 37.09 min, tminor
= 39.60 min. [α]20 D = -25.2 (c = 0.5, CHCl3).
(S)-2-(4-nitrophenyl)tetrahydrofuran 2e Yield: 75%. Hexanes/ethyl 
acetate = 6/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 8.18 (d, J = 8.8 Hz, 2H), 7.49 (d, J
= 8.8 Hz, 2H), 4.98 (t, J = 7.3 Hz, 1H), 4.12 (dd, J = 15.0, 7.0 Hz, 1H), 3.98 (dd, J = 14.5, 
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7.7 Hz, 1H), 2.41 (td, J = 12.8, 7.2 Hz, 1H), 2.07 – 1.98 (m, 2H), 1.76 (dq, J = 12.4, 7.8 
Hz, 1H).13C NMR (150 MHz, CDCl3) δ 151.29, 147.06, 126.16, 123.59, 79.66, 69.00, 
34.78, 25.93. HRMS (ESI) ([M+H]+) Calcd. for C10H12NO3+: 194.0812, found 194.0802. 
IR (neat, cm-1): 2940.96, 2878.74, 1603.94, 1513.34, 1339.90, 1064.01, 847.74, 746.99, 
697.42. HPLC analysis: ee = 95%. IF (99% hexanes, 0.8 mL/min): tmajor = 40.09 min, tminor
= 41.82 min. [α]20 D = -21.2 (c = 0.5, CHCl3).
(S)-2-(2-fluorophenyl)tetrahydrofuran 2f Yield: 75%. Hexanes/ethyl 
acetate = 9/1, Rf = 0.45. 1H NMR (600 MHz, CDCl3) δ 7.45 (t, J = 7.5 Hz, 1H), 7.24 – 7.20
(m, 1H), 7.12 (t, J = 7.5 Hz, 1H), 7.02 – 6.98 (m, 1H), 5.14 (t, J = 7.1 Hz, 1H), 4.10 (dd, J
= 14.5, 7.1 Hz, 1H), 3.94 (dd, J = 14.7, 7.3 Hz, 1H), 2.40 (dq, J = 13.4, 6.8 Hz, 1H), 2.00 
(p, J = 7.0 Hz, 2H), 1.79 (dq, J = 15.2, 7.6 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 159.78 
(d, J = 245.6 Hz), 130.81 (d, J = 13.4 Hz), 128.37 (d, J = 8.1 Hz), 126.77 (d, J = 4.7 Hz), 
123.95 (d, J = 3.3 Hz), 115.03 (d, J = 21.3 Hz), 75.05 (d, J = 2.4 Hz), 68.67, 33.48, 25.95. 
HRMS (ESI) ([M+H]+) Calcd. for C10H12FO+: 167.0867, found 167.0866. IR (neat, cm-1): 
2927.17, 2869.89, 1486.48, 1455.96, 1230.70, 1064.79, 760.04. HPLC analysis: ee = 90%. 
IA (100% hexanes, 0.8 mL/min): tmajor = 32.01 min, tminor = 34.76 min. [α]20 D = -21.6 (c =
0.5, CHCl3).
(S)-2-(2-bromophenyl)tetrahydrofuran 2g Yield: 78%. Hexanes/ethyl 
acetate = 8/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 7.50 (dd, J = 7.1, 4.3 Hz, 2H), 7.30 
Chapter 4. Enantioselective C–H Alkylation for 2-Substituted Tetrahydrofuran Synthesis 
(t, J = 7.5 Hz, 1H), 7.10 (td, J = 7.8, 1.5 Hz, 1H), 5.16 (t, J = 7.0 Hz, 1H), 4.17 (dd, J =
13.6, 7.6 Hz, 1H), 3.96 (dd, J = 15.0, 7.3 Hz, 1H), 2.54 (dt, J = 14.0, 7.2 Hz, 1H), 2.02 –
1.93 (m, 2H), 1.69 (dt, J = 14.6, 7.1 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 143.18, 
132.48, 128.33, 127.39, 126.55, 121.31, 79.81, 69.12, 33.35, 25.76. HRMS (ESI) ([M+H]+)
Calcd. for C10H12BrO+: 227.0066, found 227.0067. IR (neat, cm-1): 2945.59, 2866.07, 
1466.24, 1439.40, 1069.77, 1022.85, 754.04. HPLC analysis: ee = 90%. IE (99.8% 
hexanes, 0.8 mL/min): tmajor = 19.48 min, tminor = 22.94 min. [α]20 D = -44.8 (c = 0.5, CHCl3).
(S)-2-(o-tolyl)tetrahydrofuran 2h Yield: 84%. Hexanes/ethyl acetate = 8/1, 
Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 7.45 (d, J = 7.6 Hz, 1H), 7.20 (t, J = 7.4 Hz, 1H), 
7.17 – 7.12 (m, 2H), 5.07 (t, J = 7.2 Hz, 1H), 4.16 (dt, J = 13.5, 6.9 Hz, 1H), 3.94 (dd, J =
15.1, 7.2 Hz, 1H), 2.36 (dt, J = 12.8, 7.3 Hz, 1H), 2.32 (s, 3H), 2.05 – 1.97 (m, 2H), 1.69 
(ddd, J = 15.5, 12.3, 7.4 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 141.79, 134.15, 130.09, 
126.73, 125.96, 124.51, 77.94, 68.61, 33.13, 26.01, 19.21. HRMS (ESI) ([M+H]+) Calcd. 
for C11H15O+: 163.1117, found 163.1124. IR (neat, cm-1): 2947.16, 2864.46, 1485.17, 
1460.71, 1064.47, 753.25. HPLC analysis: ee = 94%. IE (99.8% hexanes, 0.8 mL/min):
tmajor = 23.28 min, tminor = 28.95 min. [α]20 D = -69.6 (c = 0.5, CHCl3).
(S)-2-(3-bromophenyl)tetrahydrofuran 2i Yield: 88%. Hexanes/ethyl 
acetate = 8/1, Rf = 0.40. 1H NMR (600 MHz, CDCl3) δ 7.49 (s, 1H), 7.37 (d, J = 7.7 Hz, 
1H), 7.24 (d, J = 7.7 Hz, 1H), 7.19 (t, J = 7.7 Hz, 1H), 4.86 (t, J = 7.1 Hz, 1H), 4.09 (dd, J
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= 14.8, 7.0 Hz, 1H), 3.93 (dd, J = 14.8, 7.4 Hz, 1H), 2.33 (td, J = 12.9, 6.9 Hz, 1H), 2.03 –
1.97 (m, 2H), 1.77 (dq, J = 12.4, 7.7 Hz, 1H). 13C NMR (150 MHz, CDCl3) δ 146.00, 
130.10, 129.84, 128.61, 124.18, 122.47, 79.85, 68.77, 34.64, 25.91. HRMS (ESI) ([M+H]+)
Calcd. for C10H12BrO+: 227.0066, found 227.0062. IR (neat, cm-1): 2947.42, 2868.36, 
1596.40, 1567.98, 1474.11, 1425.29, 1207.38, 1063.85, 781.60. 758.50. HPLC analysis: 
ee = 96%. IE (99.8% hexanes, 0.8 mL/min): tmajor = 28.81 min, tminor = 24.82 min. [α]20 D =
-18.8 (c = 0.5, CHCl3).
(S)-2-(3,4-dichlorophenyl)tetrahydrofuran 2j Yield: 93%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.45. 1H NMR (600 MHz, CDCl3) δ 7.43 (d, J = 1.9 Hz, 
1H), 7.38 (d, J = 8.3 Hz, 1H), 7.15 (dd, J = 8.3, 1.9 Hz, 1H), 4.84 (t, J = 7.1 Hz, 1H), 4.08 
(dd, J = 15.0, 6.9 Hz, 1H), 3.93 (dd, J = 15.2, 7.0 Hz, 1H), 2.33 (dq, J = 13.4, 6.7 Hz, 1H), 
2.02 – 1.97 (m, 2H), 1.74 (dq, J = 12.3, 7.7 Hz, 1H). 13C NMR (150 MHz, CDCl3) 143.99, 
132.35, 130.80, 130.22, 127.56, 124.93, 79.35, 68.81, 34.63, 25.87. HRMS (ESI) ([M+H]+)
Calcd. for C10H11Cl2O+: 217.0181, found 217.0177. IR (neat, cm-1): 2948.17, 2868.14, 
1737.97, 1468.76, 1068.35, 1029.96, 822.24. HPLC analysis: ee = 94%. IE (99.8% 
hexanes, 0.8 mL/min): tmajor = 24.77 min, tminor = 21.86 min. [α]20 D = -51.2 (c = 0.5, CHCl3).
(S)-2-(3,5-dimethoxyphenyl)tetrahydrofuran 2k Yield: 84%. 
Hexanes/ethyl acetate = 7/1, Rf = 0.36. 1H NMR (600 MHz, CDCl3) δ 6.50 (d, J = 2.3 Hz, 
2H), 6.35 (t, J = 2.3 Hz, 1H), 4.85 (t, J = 7.1 Hz, 1H), 4.08 (dd, J = 14.7, 7.1 Hz, 1H), 3.93 
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(dt, J = 14.4, 7.3 Hz, 1H), 3.79 (s, 6H), 2.33 – 2.28 (m, 1H), 2.02 – 1.95 (m, 2H), 1.80 (ddd, 
J = 15.8, 12.3, 7.6 Hz, 1H).13C NMR (150 MHz, CDCl3) δ 160.78, 146.18, 103.43, 99.05, 
80.51, 68.69, 55.31, 34.50, 25.89. HRMS (ESI) ([M+H]+) Calcd. for C12H17O3+: 209.1172, 
found 209.1172. IR (neat, cm-1): 2938.45, 2837.90, 1596.64, 1460.05, 1427.53, 1362.12, 
1204.01, 1153.86, 1054.85, 837.18. HPLC analysis: ee = 92%. IF (99% hexanes, 0.8 
mL/min): tmajor = 45.28 min, tminor = 54.63 min. [α]20 D = -12.4 (c = 0.5, CHCl3).
(S)-2-(naphthalen-2-yl)tetrahydrofuran 2l Yield: 82%. 
Hexanes/ethyl acetate = 8/1, Rf = 0.37. 1H NMR (600 MHz, CDCl3) δ 7.83 – 7.80 (m, 4H), 
7.49 – 7.43 (m, 3H), 5.07 (t, J = 7.2 Hz, 1H), 4.18 (dd, J = 14.9, 7.0 Hz, 1H), 4.01 (dd, J =
14.4, 7.8 Hz, 1H), 2.44 – 2.37 (m, 1H), 2.09 – 2.04 (m, 2H), 1.93 – 1.87 (m, 1H). 13C NMR 
(150 MHz, CDCl3) δ140.87, 133.27, 132.76, 128.05, 127.86, 127.61, 125.98, 125.54, 
124.00, 80.75, 68.80, 34.59, 26.05. HRMS (ESI) ([M+H]+) Calcd. for C14H15O+: 199.1117, 
found 199.1107. IR (neat, cm-1): 2942.71, 2864.80, 1739.39, 1510.59, 1066.69, 820.29, 
749.89. HPLC analysis: ee = 92%. IE (99% hexanes, 0.8 mL/min): tmajor = 25.03 min, tminor
= 23.48 min. [α]20 D = -13.2 (c = 0.5, CHCl3).
tert-butyl (S)-3-(tetrahydrofuran-2-yl)-1H-indole-1-carboxylate 2m 
Yield: 82%. Hexanes/ethyl acetate = 5/1, Rf = 0.35. 1H NMR (600 MHz, CDCl3) δ 8.14 (s, 
1H), 7.60 (d, J = 7.8 Hz, 1H), 7.52 (s, 1H), 7.33 – 7.30 (m, 1H), 7.25 – 7.22 (m, 1H), 5.14 
(t, J = 6.6 Hz, 1H), 4.10 (dt, J = 13.7, 6.7 Hz, 1H), 3.95 – 3.92 (m, 1H), 2.38 – 2.33 (m, 
Chapter 4. Enantioselective C–H Alkylation for 2-Substituted Tetrahydrofuran Synthesis 
1H), 2.11 – 2.01 (m, 3H), 1.67 (s, 9H). 13C NMR (150 MHz, CDCl3) δ 149.76, 135.97, 
128.85, 124.36, 122.50, 122.45, 122.07, 119.69, 115.31, 83.50, 74.59, 68.15, 32.03, 28.20, 
25.94. HRMS (ESI) ([M+H]+) Calcd. for C17H22NO3+: 288.1594, found 288.1587. IR (neat, 
cm-1): 2934.05, 2864.11, 1732.09, 1452.86, 1373.60, 1256.91, 1160.14, 1060.23, 749.28.
HPLC analysis: ee = 94%. IF (99% hexanes, 0.8 mL/min): tmajor = 26.09 min, tminor = 35.72 
min. [α]20 D = -7.6 (c = 0.5, CHCl3).
(S)-2-(benzo[b]thiophen-3-yl)tetrahydrofuran 2n Yield: 86%. 
Hexanes/ethyl acetate = 6/1, Rf = 0.36. 1H NMR (500 MHz, CDCl3) δ 7.86 (dd, J = 7.1, 
1.2 Hz, 1H), 7.80 (dd, J = 7.0, 1.2 Hz, 1H), 7.39 – 7.33 (m, 3H), 5.27 (dd, J = 10.3, 3.4 Hz, 
1H), 4.16 – 4.12 (m, 1H), 3.99 – 3.95 (m, 1H), 2.45 – 2.39 (m, 1H), 2.10 – 1.99 (m, 3H).
13C NMR (125 MHz, CDCl3) δ 141.02, 138.15, 137.43, 124.23, 123.90, 122.87, 122.19, 
121.23, 76.64, 68.32, 32.17, 25.85. HRMS (ESI) ([M+H]+) Calcd. for C12H13OS+:
205.0682, found 205.0679. IR (neat, cm-1): 2851.82, 2922.35, 1736.96, 1459.60, 1428.18, 
1256.96, 1066.63, 760.04, 733.84. HPLC analysis: ee = 95%. IF (99.5% hexanes, 0.8 
mL/min): tmajor = 24.53 min, tminor = 28.72 min. [α]20 D = -37.2 (c = 0.5, CHCl3).
(S)-2-(tetrahydrofuran-2-yl)benzofuran 2o Yield: 90%. 
Hexanes/ethyl acetate = 6/1, Rf = 0.36. 1H NMR (600 MHz, CDCl3) δ 7.53 (d, J = 7.6 Hz, 
1H), 7.46 (d, J = 8.2 Hz, 1H), 7.25 (dd, J = 11.3, 4.0 Hz, 1H), 7.20 (t, J = 7.4 Hz, 1H), 6.63 
(s, 1H), 5.08 (t, J = 6.8 Hz, 1H), 4.08 (dd, J = 14.3, 7.5 Hz, 1H), 3.95 (dd, J = 14.1, 7.8 Hz, 
1H), 2.33 – 2.27 (m, 1H), 2.21 (tt, J = 14.3, 6.4 Hz, 1H), 2.15 – 2.09 (m, 1H), 2.07 – 2.00 
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(m, 1H). 13C NMR (150 MHz, CDCl3) δ 158.15, 155.01, 128.15, 123.95, 122.61, 120.86, 
111.20, 102.98, 74.31, 68.65, 30.67, 25.87. IR (neat, cm-1): 2920.16, 2849.85, 1737.73, 
1454.23, 1254.54, 1055.47, 806.97, 753.20. HRMS (ESI) ([M+H]+) Calcd. for C12H13O2+:
189.0910, found 189.0905. HPLC analysis: ee = 76%. IF (99.5% hexanes, 0.8 mL/min):
tmajor = 25.73 min, tminor = 29.14 min. [α]20 D = -3.6 (c = 0.5, CHCl3).
(S, E)-2-(1-phenylprop-1-en-2-yl)tetrahydrofuran 2p Yield: 92%. 
Hexanes/ethyl acetate = 6/1, Rf = 0.36. 1H NMR (600 MHz, CDCl3) δ 7.32 (t, J = 7.6 Hz, 
2H), 7.28 (d, J = 7.2 Hz, 2H), 7.20 (t, J = 7.2 Hz, 1H), 6.55 (s, 1H), 4.39 (t, J = 7.3 Hz, 
1H), 4.00 (dd, J = 14.8, 6.9 Hz, 1H), 3.88 (dd, J = 14.0, 7.7 Hz, 1H), 2.14 – 2.08 (m, 1H), 
2.01 – 1.93 (m, 2H), 1.84 (d, J = 1.0 Hz, 3H), 1.80 – 1.74 (m, 1H). 13C NMR (150 MHz, 
CDCl3) δ 138.55, 137.84, 128.91, 127.98, 126.22, 124.46, 83.94, 68.66, 30.93, 26.05, 
13.92. HRMS (ESI) ([M+H]+) Calcd. for C13H17O+: 189.1274, found 189.1265. IR (neat, 
cm-1): 2960.35, 2917.51, 2850.47, 1737.65, 1259.18, 1056.20, 806.54, 699.91. HPLC 
analysis: ee = 92%. ID (99.7% hexanes, 0.8 mL/min): tmajor = 21.69 min, tminor = 20.35 min.
[α]20 D = -13.2 (c = 0.5, CHCl3).
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Spectral Data for Chapter 2
Enantioselective Synthesis of Chiral 
Dihydrobenzofurans with in Situ-generated Donor-



























































































































































Spectral Data for Chapter 3
Enantioselective Radical Process for Synthesis of 
Chiral Indolines by Co(II)-Based Metalloradical
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ethyl benzyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono)methyl)phenyl) carbamate 1-b
ethyl benzyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono)methyl)phenyl) carbamate 1-b
methyl benzyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-c 





methyl (3-methoxybenzyl)(2-((2-((2,4,6-triisopropylphenyl) sulfonyl) 
hydrazono)methyl)phenyl)carbamate 1-e














































methyl (benzo[b]thiophen-3-ylmethyl)(2-((2-((2,4,6-triisopropyl phenyl) 
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-q
methyl (benzo[b]thiophen-3-ylmethyl)(2-((2-((2,4,6-triisopropyl phenyl) 
sulfonyl)hydrazono)methyl)phenyl)carbamate 1-q
methyl butyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-r 
methyl butyl(2-((2-((2,4,6-triisopropylphenyl)sulfonyl)hydrazono)methyl)phenyl)carbamate 1-r 
methyl N-(methoxycarbonyl)-N-(2-((2-((2,4,6-triisopropylphenyl) sulfonyl) 
hydrazono)methyl)phenyl)glycinate 1-s 
























methyl (R)-2-(4-methoxyphenyl)indoline-1-carboxylate 2d 
methyl (R)-2-(4-methoxyphenyl)indoline-1-carboxylate 2d 
methyl (R)-2-(4-methoxyphenyl)indoline-1-carboxylate 2d 
methyl (R)-2-(4-methoxyphenyl)indoline-1-carboxylate 2d 
methyl (R)-2-(3-methoxyphenyl)indoline-1-carboxylate 2e 
methyl (R)-2-(3-methoxyphenyl)indoline-1-carboxylate 2e 
methyl (R)-2-(3-methoxyphenyl)indoline-1-carboxylate 2e 
methyl (R)-2-(3-methoxyphenyl)indoline-1-carboxylate 2e 
methyl (R)-2-(o-tolyl)indoline-1-carboxylate 2f 
methyl (R)-2-(o-tolyl)indoline-1-carboxylate 2f 
methyl (R)-2-(o-tolyl)indoline-1-carboxylate 2f 
methyl (R)-2-(o-tolyl)indoline-1-carboxylate 2f 
methyl (R)-2-(2-chlorophenyl)indoline-1-carboxylate 2g 
methyl (R)-2-(2-chlorophenyl)indoline-1-carboxylate 2g 
methyl (R)-2-(2-chlorophenyl)indoline-1-carboxylate 2g 





methyl (R)-2-(4-nitrophenyl)indoline-1-carboxylate 2i 
methyl (R)-2-(4-nitrophenyl)indoline-1-carboxylate 2i 
methyl (R)-2-(4-nitrophenyl)indoline-1-carboxylate 2i 
methyl (R)-2-(4-nitrophenyl)indoline-1-carboxylate 2i 
methyl (R)-2-(4-cyanophenyl)indoline-1-carboxylate 2j 
methyl (R)-2-(4-cyanophenyl)indoline-1-carboxylate 2j 
methyl (R)-2-(4-cyanophenyl)indoline-1-carboxylate 2j 
methyl (R)-2-(4-cyanophenyl)indoline-1-carboxylate 2j 
methyl (R)-2-(perfluorophenyl)indoline-1-carboxylate 2k 
methyl (R)-2-(perfluorophenyl)indoline-1-carboxylate 2k 
methyl (R)-2-(perfluorophenyl)indoline-1-carboxylate 2k 
methyl (R)-2-(perfluorophenyl)indoline-1-carboxylate 2k 
methyl (R)-2-(naphthalen-2-yl)indoline-1-carboxylate 2l 
methyl (R)-2-(naphthalen-2-yl)indoline-1-carboxylate 2l 
methyl (R)-2-(naphthalen-2-yl)indoline-1-carboxylate 2l 
methyl (R)-2-(naphthalen-2-yl)indoline-1-carboxylate 2l 
methyl (R)-2-(4-vinylphenyl)indoline-1-carboxylate 2m 
methyl (R)-2-(4-vinylphenyl)indoline-1-carboxylate 2m 
methyl (R)-2-(4-vinylphenyl)indoline-1-carboxylate 2m 
methyl (R)-2-(4-vinylphenyl)indoline-1-carboxylate 2m 
methyl (R)-2-(phenylethynyl)indoline-1-carboxylate 2n 
methyl (R)-2-(phenylethynyl)indoline-1-carboxylate 2n 
methyl (R)-2-(phenylethynyl)indoline-1-carboxylate 2n 
methyl (R)-2-(phenylethynyl)indoline-1-carboxylate 2n 
methyl (R)-2-(pyridin-2-yl)indoline-1-carboxylate 2o 
methyl (R)-2-(pyridin-2-yl)indoline-1-carboxylate 2o 
methyl (R)-2-(pyridin-2-yl)indoline-1-carboxylate 2o 









methyl (S)-2-propylindoline-1-carboxylate 2r 
methyl (S)-2-propylindoline-1-carboxylate 2r 
methyl (S)-2-propylindoline-1-carboxylate 2r 
methyl (S)-2-propylindoline-1-carboxylate 2r 
dimethyl (R)-indoline-1,2-dicarboxylate 2s 
dimethyl (R)-indoline-1,2-dicarboxylate 2s 
dimethyl (R)-indoline-1,2-dicarboxylate 2s 
dimethyl (R)-indoline-1,2-dicarboxylate 2s 
methyl (R)-2-(diethylcarbamoyl)indoline-1-carboxylate 2t 
Note: The broad spectrum was due to the amide rotamers
methyl (R)-2-(diethylcarbamoyl)indoline-1-carboxylate 2t 
Note: The spectrum contains a mixture of amide rotamers and the major rotamer was labelled.
methyl (R)-2-(diethylcarbamoyl)indoline-1-carboxylate 2t 











Note: The spectrum contains  E/Z isomers of C=C bond. 
Note: The spectrum contains  E/Z isomers of C=C bond. 
methyl (2-(((2,2,6,6-tetramethylpiperidin-1-yl)oxy)methyl) phenyl)(3-((2,2,6,6-
tetramethylpiperidin-1-yl)oxy)prop-1-en-1-yl)carbamate 3u 
tert-butyl 2-cyclopropylindoline-1-carboxylate 2v 







Spectral Data for Chapter 4
Enantioselective Synthesis of 2-Substituted 
Tetrahydrofurans via Co(II)-Catalyzed 



































































Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-(benzyloxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-((4-methoxybenzyl)oxy)propylidene)benzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-((4-methoxybenzyl)oxy)propylidene)benzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((4-bromobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((4-bromobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
N'-(3-((4-cyanobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((4-cyanobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-((4-nitrobenzyl)oxy)propylidene)benzenesulfonohydrazide
2,4,6-triisopropyl-N'-(3-((4-nitrobenzyl)oxy)propylidene)benzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((2-fluorobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide 
N'-(3-((2-fluorobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide 
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((2-bromobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
N'-(3-((2-bromobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-((2-methylbenzyl)oxy)propylidene)benzenesulfonohydrazide
2,4,6-triisopropyl-N'-(3-((2-methylbenzyl)oxy)propylidene)benzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((3-bromobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
N'-(3-((3-bromobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((3,4-dichlorobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
N'-(3-((3,4-dichlorobenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-((3,5-Dimethoxybenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
N'-(3-((3,5-Dimethoxybenzyl)oxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-(naphthalen-2-ylmethoxy)propylidene)benzenesulfonohydrazide
2,4,6-triisopropyl-N'-(3-(naphthalen-2-ylmethoxy)propylidene)benzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones





Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-(benzo[b]thiophen-3-ylmethoxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide 
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-(benzo[b]thiophen-3-ylmethoxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide 
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-(benzofuran-2-ylmethoxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide 
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
N'-(3-(benzofuran-2-ylmethoxy)propylidene)-2,4,6-triisopropylbenzenesulfonohydrazide 
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-(((E)-2-methyl-3-phenylallyl)oxy)propylidene)benzenesulfonohydrazide
Note: The spectrum contains a mixture of both cis- and trans-isomers of the sulfonylhydrazones
2,4,6-triisopropyl-N'-(3-(((E)-2-methyl-3-phenylallyl)oxy)propylidene)benzenesulfonohydrazide
(S)-2-phenyltetrahydrofuran
(S)-2-phenyltetrahydrofuran
(S)-2-phenyltetrahydrofuran
(S)-2-phenyltetrahydrofuran
(S)-2-(4-methoxyphenyl)tetrahydrofuran
(S)-2-(4-methoxyphenyl)tetrahydrofuran
(S)-2-(4-methoxyphenyl)tetrahydrofuran
(S)-2-(4-methoxyphenyl)tetrahydrofuran
(S)-2-(4-bromophenyl)tetrahydrofuran
(S)-2-(4-bromophenyl)tetrahydrofuran
(S)-2-(4-bromophenyl)tetrahydrofuran
(S)-2-(4-bromophenyl)tetrahydrofuran
(S)-4-(tetrahydrofuran-2-yl)benzonitrile
(S)-4-(tetrahydrofuran-2-yl)benzonitrile
(S)-4-(tetrahydrofuran-2-yl)benzonitrile
(S)-4-(tetrahydrofuran-2-yl)benzonitrile
(S)-2-(4-nitrophenyl)tetrahydrofuran
(S)-2-(4-nitrophenyl)tetrahydrofuran
(S)-2-(4-nitrophenyl)tetrahydrofuran
(S)-2-(4-nitrophenyl)tetrahydrofuran
(S)-2-(2-fluorophenyl)tetrahydrofuran
(S)-2-(2-fluorophenyl)tetrahydrofuran
(S)-2-(2-fluorophenyl)tetrahydrofuran
(S)-2-(2-fluorophenyl)tetrahydrofuran
(S)-2-(2-bromophenyl)tetrahydrofuran
(S)-2-(2-bromophenyl)tetrahydrofuran
(S)-2-(2-bromophenyl)tetrahydrofuran
(S)-2-(2-bromophenyl)tetrahydrofuran
(S)-2-(o-tolyl)tetrahydrofuran
(S)-2-(o-tolyl)tetrahydrofuran
(S)-2-(o-tolyl)tetrahydrofuran
(S)-2-(o-tolyl)tetrahydrofuran
(S)-2-(3-bromophenyl)tetrahydrofuran
(S)-2-(3-bromophenyl)tetrahydrofuran
(S)-2-(3-bromophenyl)tetrahydrofuran
(S)-2-(3-bromophenyl)tetrahydrofuran
(S)-2-(3,4-dichlorophenyl)tetrahydrofuran
(S)-2-(3,4-dichlorophenyl)tetrahydrofuran
(S)-2-(3,4-dichlorophenyl)tetrahydrofuran
(S)-2-(3,4-dichlorophenyl)tetrahydrofuran
(S)-2-(3,5-dimethoxyphenyl)tetrahydrofuran
(S)-2-(3,5-dimethoxyphenyl)tetrahydrofuran
(S)-2-(3,5-dimethoxyphenyl)tetrahydrofuran
(S)-2-(3,5-dimethoxyphenyl)tetrahydrofuran
(S)-2-(naphthalen-2-yl)tetrahydrofuran
(S)-2-(naphthalen-2-yl)tetrahydrofuran
(S)-2-(naphthalen-2-yl)tetrahydrofuran
(S)-2-(naphthalen-2-yl)tetrahydrofuran
tert-butyl (S)-3-(tetrahydrofuran-2-yl)-1H-indole-1-carboxylate
tert-butyl (S)-3-(tetrahydrofuran-2-yl)-1H-indole-1-carboxylate
tert-butyl (S)-3-(tetrahydrofuran-2-yl)-1H-indole-1-carboxylate
tert-butyl (S)-3-(tetrahydrofuran-2-yl)-1H-indole-1-carboxylate
(S)-2-(benzo[b]thiophen-3-yl)tetrahydrofuran
(S)-2-(benzo[b]thiophen-3-yl)tetrahydrofuran
(S)-2-(benzo[b]thiophen-3-yl)tetrahydrofuran
(S)-2-(benzo[b]thiophen-3-yl)tetrahydrofuran
(S)-2-(tetrahydrofuran-2-yl)benzofuran
(S)-2-(tetrahydrofuran-2-yl)benzofuran
(S)-2-(4-methoxyphenyl)tetrahydrofuran
(S)-2-(tetrahydrofuran-2-yl)benzofuran
(S,E)-2-(1-phenylprop-1-en-2-yl)tetrahydrofuran
(S,E)-2-(1-phenylprop-1-en-2-yl)tetrahydrofuran
(S,E)-2-(1-phenylprop-1-en-2-yl)tetrahydrofuran
(S,E)-2-(1-phenylprop-1-en-2-yl)tetrahydrofuran
